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Df\ VII) l)/\RRELL A.RRINCJTON. Calpain 10: Mitochondrial Localization. FLlnction~

and Suhstrates. (Lndcr the direction

or RIC'K S(~HNELLMANN)
Abstract

The calpain tll1l1ily of cysteine protcases has undergone intense study since its
discovery ill 1976. Although IHlll1erOliS functions and proteolytic substrates have been
linked to this 14-nlcnlber Elnl1ly, little is knovv'n about the five atypical calpain isofornls.
Over the past 25 years. investigators have identified 'calpain-like' acti\'ities in
nlitochondrial fractions isolated fronl various tissues. The studies undertaken in this
dissertation

\~/erc

designed to positively identify the nlitochondrial calpain present in

renal corticallllitochondria (RCM) and to e111cidatc its function and proteolytic targets
under both basal and C'a 2-""-challenged conditions.
We iticnti fled the RCrY1 calpain as calpain 10 by both inl111Ulloblot analysis and
via confocal nlicroscopy. We also found that Ca 2+ -induced lllitochondrial respiratory
dysfunction \vas the result ofcalpain-nlcdiatcd proteolysis of the C0l11plex I electron
transport chain subunits NDUFV2 and ND6. In addition, \ve delllonstrated that calpain
I () plays ,\ role in the Cornultion of the 1l1enlbranc pcrnlcability transition (IVIPT) pore as
cva1uatcd by confocal analysis and 111itochondrial svvelling assays.
The infection ofprinlary renal proxinlal tubule cells (RPTC) using an adcnoviral
cassette expressing calpain 1O-specific shRT\A. produced a variety of phenotypes

involving both 111itochondrial physiology and cell survival. Mitochondrial respiration and
1l1CI11branc potential vvere unchanged in virally-treatcd cells \vhile ATP levels vvcrc
increased 2-fold by day five post-infection. Increases in cellular A TP were associated
\\i·ith decreased ATP synthase

f)

proteolysis and increased synthesis of the sanle protein.

XII1

In

additiol1~

rcsu It

0

cell survival was signifIcantly decreased by day 5 post-infection and was a

r caspasc-depcndent apoptosis.
Calpain lOis the only gcnc that has been genetically linked to Type II

diabetes~

and its role in this disease process is believcd to be associated \"lith calpain 1(fs function
as a 1l1cdiator oi'glucose 111ctabolisn1 and insulin handling. \Ve identified the Type II
diabetes susceptibility gene ORP 150 as a putative calpain 10 substrate. ORP150 \vas
found to be dually targeted to both the ER and 1l1itochondrial fractions of rat RPTC.
C'haractcrization of this n10leculc dCI110nstratcd that its induction is 111cdiated by both
global and nlitochondrial-spccific insults and that ORP150 is a proteolytic target for
calpain 10,
In SLl111111ary, these results den10l1stratc the il11portal1ce of ca1pain 10 under both

physiologic(ll and pathological conditions. Our data also suggest that calpain ] 0 111ay
serve to integrate Illultiplc signaling events. thereby regulating ccllular ATP levels and
survival J11cchanisnls. These studies provide further insight into the biology of calpain 10
1

and its role in Ca +-induced n1itochondrial dysfllllction~ and
evidellce

Sli

111ay

provide biochenlical

nicicnt to define calpain 10 as a potential target for therapeutic intervention

in discasc statcs Illcdiatcd by the dysregulatioll of cel1ular Ca 2+ honlcostasis.

XlV

(:HAPTER 1
RE\lIE\V OF AC=Ul'E RENAL FAILURE AND CALPAIN BIOLOGY

Acute Renal Failure
Acute renal failure CARF) is a signi ficant clinical flnding that can be precipitated
by a host of f~lctors ..ARF affects approxinlately

5°~)

of all hospital adnl1ssions and can

carry a nlortality rate of 50(;;;) in the general population (1) and up to

9()(1~

in aged or

critically i II patients (2). Clinically. ARF is oHcn a di fficult diagnosis to 111ake because

there arc

110

accepted diagnostic criteria as in acute lung injury or sepsis (2).

HO\NCVer~

i-\RF can generally be defined as an increase in nitrogenolls \vaste products such as blood
urea nitrogen and serUlll creatinine found in conjunction \vith a decreased glo111crular
1~ltratioll

rate (CJFR) and urine output (3). In hospital-acquired ARF, up to 75(10 of all

cases arc the result of acute tubular necrosis (ATN), although this llloniker is sOlne\vhat
of a 1l1isnOnlcr because renal
/\pprox i1l1alcly

35-50(!~)

f~lillirc

ill hUlllans is rarely due to frank cel1ular necrosis.

of ATN can be linked to

and after Inajor surgery, and

7(1~)

sepsis~

20-25(Yo to hypovolell1ia during

to radiocontrast agents (3).

/\RF can be subdivided into three categories including prerenal, intrarcnal, and

postrenal etiologies (2,3) (Fig. 1-1). Prerenal causes of ARF include

VOlU111e

depletion

fron1 surgery. traunla, or crush injuries and drug-induced ARF in patients \vith bilateral

renal artery stenosis. Intrarcnal .ARF is

1110St

often associated 'vvith ischenlia and

nephrotoxin-induced acute tubular necrosis, followed by renal dysfunction associated

\vith vascular

danlagc~

glolllcruloncphritis, and drug-induced acute interstitial nephritis

(3). Postrenal Cornls of ARF are generally caused by obstructive disorders including

col1ccting tubule obstruction or blockage oCextrarenal structures such as ureters, valves,
or the urethra in 111en with prostatic hypertrophy

(2~

3).

Prerenal
Sudden and severe drop in
blood pressure (shock) or
interruption of blood flow to
the kidneys from severe injury
or illness.
Intrarenal
Direct damage to the kidneys
by inflammation, toxins,
drugs, infection, or reduced
blood supply.
Postrenal
Sudden obstruction of urine
outflow due to enlarged
prostate, kidney stones,
bladder tumor, or injury.
Adapted from: http://www.orthowomenshealth
Ibladder/images/bladder_image1.jpg

Figure 1-1. Schematic diagram of the three major types of acute renal failure
(ARF). Acute renal failure can originate from numerous causes, but can be easily
grouped into three categories including prerenal, intrarenal, and Postrenal ARF. The
most common cause of hospital-acquired ARF is intrarenal ARF.

3

Since acute tubular necrosis is responsible ror n10st cases of ARF. the renlaindcr
of this discllssion \vill focus on the pathophysiology and 1110lccular ll1cchanis1l1S oCthis
Conn of renal daillagc. [)ccrcascs in GFR during ARF can be n1cchanistically divided
into t\\'o categories: vascular and tubular. In established ARF, renal blood nOv\! is

reduced to 30-50(!lo with a selective reduction to the outer 11ledulla. In the early phase of
ARF, decreases in renal perfusion pressure initiate constriction of efferent arterioles.
outer nlcdul1ary congestion, and activation of tubuloglo1l1erular feedback (3), The renal
vasculature bcconles hypersensitive to vasoconstrictors SLich as cndothclin. adenosine,
angiotensin] I. throlnboxanc

/\2.

Icukotriencs, and syn1pathetic nerve stin1ulation.

Conversely, the vasculature hecol11es hyposensitive to vasodilators sLlch as nitric oxide,
prostaglandin F 2 , acetylcholine. and bradykinin. Later stages of vascular danlage are
hallnlarkcd by structural danlagc to endothelial
release

or inllanllllatory nlcciiators.

cells~

leukocyte

infi)tration~

and the

Tubular danlagc to renal epithelial cells is the secolld

111ajor COlllpOllcnt of the decreased GFR seen during ARF. This dan1age ll1anifests itself

as tubular obstruction. interstitial inflanlnlation, and tubular backleak of filtrate (2-4).
Histologically. ARF is typi fled by the loss of cellular polarity and 111icrovi]lar
brush border n1CIllbranes in the proxinla] tubule cells, cellular
illftltratioll~

vacuolatjon~

leukocyte

desqua1l1ation of tile tubular epitheliunl, interstitial edenla, and dilatation of

the tubular lunlcll (2-4). (Fig. 1-2).

4

Acute Tubular
Necrosis

Normal Tubules

Figure 1-2. Histological comparison of normal and necrotic renal tubules.
The above histological sections are H&E stained kidney slices demonstrating both
normal renal epithelia and epithelia post-ischemia. Notice the thick appearance of the
normal tubules versus the thin, desquamous epithelia from the necrotic tissue. The tubule
lumen is also dilated and filled with red blood cells and cellular debris (cellular casts).

5

Interestingly, frank cellular necrosis in hunlan ARF is not a C0111111011 finding and
is usually lin1itcd to the SJ segnlent of the proxin1al tubule and
lin1b

or Henle"s loop (2-4).

Ho\vevcr~

111cdullary

thick ascending

ill n10st anin1allllodels of ARF, necrosis is fairly

\vicicsprccld. Investigators have suggested that this

111ay

be an artifact of the n1ethods used

to induce ARF in anin1al n10dels sllch as severe ischen1ia (renal artery occlusion) and

high doses

or con1n1011 nephrotoxic agents as listed in Table 1-1

(2). Recent evidence

suggests that the nlajority oftuhular cell injury in hun1an ARF is sublethal cell injury and
apoptosis (2. 4).

Table 1-1.

(~ommon

A.RF-inducing drugs and xenohiotics

~()!?&tI~_,!!!d_Q_~h_e!§c:Ogenous Causes of Acute Renal Failure

.--~=~-=-J

I

I

I

Contrast Media

Analgesics

t

NSAIDs

Anesthetics

HIV Protease Inhibitors

Bunamiodyl

Indinavir

Diatrizoate

Rotanavir

I

I

lopanoic Acid
Enflurane

Recreational Drugs

lothalamate

Methoxyflurane

Amphetamines

I
!
I

Diuretics
ACE Inhibitors

Heroin
Mercurials

Captopril

i

I

Others

Ticrynafen

Bacterial Toxins

Antibiotics
Acyclovir

Chemotherapeutics and

Chinese Herbs

Immunosuppresants

Dextrans

Aminoglycosides

5-azacitidine

EDTA

Amphotericin B

Carboplatin

!:-aminocaproic acid

BaCitracin

Cisplatin

Heavy Metals

Cephalosporins

Cyclosporin A

Industrial Chemicals

Foscarnet

Tacrolimus

Organic Solvents

Pentamidine

D-peniciliamine

Pesticides

Polymyxin

Ifosfamide

Radiation

Sulfonamide

Interferon

Tetracyclines

Methotrexate

Vancomycin

Mitomycin

II

or'i IB

Nitrosourea

Anti-ulcer Agents
I

Plicamycin
Cimetldine

Interleukin 2

l_____ ._____. ._. __ . _. Milk-_8_lk_8_li-'..(_1n_8_X_C_8_S_S,---)____________.
I
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Silicone
Snake or Insect Venom

I

I

~ecrosis.

During renal ischell1ia. necrosis is a C01111110n haI1n1ark of dan1agc and

is seen prinlarily in the proxinlal tuhule (5). The severe ATP depletion seen during
ischc111ic insult leads to llun1crous dOw11strcalll effects including in1pairnlent of
lipogenesis~

protein synthesis, lllenlbrane transport (5.6), and the disruption of the

plaS111(1 n1e111hranc Na' /I( t ATPase (6, 7). Inlpairn1ent of the Na+/K+ ATPase leads to
increased cytosolic calciu111 levels via a plasnla lllell1brane Na+;Ca++ exchanger (8). This
i11crease in cytosolic {l'ce calciunl activates nUIl1erous cellular proteases and
phospholipascs \vhich extend cytoskeletal dalllage and u1tin1ately in1pair 11litochondrial
viabi lity plunging the cel1s into an even lllorc severe A TP deficit (5, 7). Recently, Dong
e/

0/ have also sho\vn that prolonged ischclllia and ATP depiction can create porous

defects in the plasn1a 1l1cIllbrane ofnladinc darby canine kidney cells which can be
inhibited in the presence of glycine and decreased pH (9, 10). In

vivo~

during kidney

repcrfusion, cytoprotective tissue glycine is washed out and pH values return to nornlal
exacerbating already dinlinishcd ATP stores (11 ).
The rcpcrfusion of ischclllic tissue Vvould seen1 beneficial to the oxygen-deprived

cells orthc cortical nephron. Ho\vcver, reperfusion injury after tissue hypoxia is perhaps
as deleterious as the ischenlia itsel r due to the generation of reactive oxygen species
(RC)S) ( 12).

Cell u lar ROS are generated in part by C0l11plexes I and I I I of the

nlitochondrial electron transport

chain~

lipoxygenases, cyclooxygenases, plasllla

1l1elllbrane NADPH oxidase, the xanthine oxidase systenl, and by 11lixed-function
oxidases found ill the cndoplaslllic reticu1utll (5, 7.13,14). The inhibition ofROS
generali on by agents such as dcsfcroxanline ( 15), allopurinol (16). catalase ( 17); and
ostcopontin (5, 18) or the scavenging or free radicals by glutathione, vitanlin

8

E~

quercetin

(19). curclllllin (20) or superoxidc disll1utasc to nanle a few have a11 been sho\vn to
protect against ischcnlia/rcpcrfusion injury in various anin1al 1110dels. Repcrfusion injury
is also enhanced by the fornlation ofperoxynitritc and reactive nitrogen species fr0l11 the
reaction bct\veen supcroxidcs and nitric oxide (NO), a Inoleculc sho\vn to be uprcgulated
during ischenlia/rcpcrfusion injury (14,21-25). Increases in cellular ROS lead to the

peroxidation of lipid 1l1enlbrancs, protein denaturation, carbohydrate danlagc, and DNA
strand breaks (5, 26, 27). These alterations in cellular constituents can then lead to
sublethal dysfullction, necrosis, apoptosis, or to signals for cell survival path\vays (7).
()xidative danlagc to proteins during ischenlia/repcrfusion injury is beyond the
scope oCthis discllssion, but plays a significant role in renal cell necrosis.

Hovvevcr~

the

r)NA strand breaks induced by cellular ROS lead to a very specific response v.;hich

severely exacerbates the energy depiction already present during ischenlic injury. The
cleavage of double stranded DNA leads to the activation of the nuclear enzynlc poly
(ADP-ribosc) polYlllerase (PARP). Pi\RP catalyzes the transfer of ADP-ribosc

fl'01l1

nicotinanlidc adenine dinucleotide (NAO) to nuclear protein species. During periods of
high ROS generation., PARP beC01l1eS overactivated leading to a severe depletion of total
cellular NAl) and further ATP depletion

(5~

27,28).

Oxidative danlage to lipids during ischenlia/reperfusion injury is quite deleterious
to cell survival and can lead to leaky llle1l1brancs and inlpaired function of iOll

pUlllpS

and

other CIl:lYllHltic processes (5). Cellular lipid profiles also change during
ischenlia/rcpcrfusion injury ,via the activation of phospholipase A 2 • Previous studies have
shown thaC in J11any injury 1l10dcls, the activation of phospholipase A2 correlates to the
degree of f~ttty acid release and the extent of tubular cell injury (29-31). Not only are free
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fatty acids and lysophospholipids directly toxic to

cells~

but the 1110st C01111110n sn-2

f~ltty

acid, arachidonic acid, is a kno\vn potentiator of oxidative dan1agc (5) and source of
vasoconstrictive cicosanoids (12,32).

Apoptosis. Renal cell apoptosis is a COn1111011 feature in expcrin1cntalnl0dcis of
acute ischclllic and toxicant-induced rcnal injury (33-36). It is

difficult~

ho\vever, to

quanti fy the contributions Illude by necrosis and apoptosis in ARF in vivo. t\1uch of this

StCIl1S fronl the

f~lCl

that £1poptosis occurs early-on (1-3 hours) after ischenlic injury, \vhilc

it lllay take days for the histological evidence of necrosis to be detern1ined (33, 37) .
.A.poptosis is the preferred and controlled nlethod of cell death and is essential for
111allY

processes sLIch as orgallogenesis, nornlal cellular turnover, and the deletion of

potentially neoplastic cells (38). Apoptosis is initiated after llun1crouS cellular insults and
nlay proceed via an intrinsic (1l1itochondrial) or extrinsic (death reccptor-nlcdiatcd)
path\vay. l\poptosis is often the 1110re prevalent 1'orn1 of cell death seen in less severe
cases of ARF (36) and occurs nl0stly in the distal tubular cells. Apoptosls is

1l10rC

frequently seen in the distal tubule cells due to their substantial reliance on glycolysis for
ATP production (7 ~ ]9-41 ), thereby n1aking thCll1 1l10re resistant to necrotic ce11 death.
The stress-activated protein kinase (SAPK) p54 c-Jun N-tcrlllinal kinase has heen
illlplicated in cell injury after renal ischenlia as wcll and is activated after injury in both
proxinlal and distal tubule cells. The extracellular signal-related kinase (ERK) is
activated only ill the distal cells and nlay also help explain 'why the distal epithelia is
nlorc sensitive to apoptotic cell death (5, 42, 43).
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The 111cchanis1l1S involved in the induction of renal cell apoptosis arc not
conlplctcly understood and arc I110St likely ll1ultifactorial, but n1ay include the loss of
cel1-1l1atrix and cell-cell adhesions and a reduction in extracellular survival signals (5,33.
44) slIch as IGF-l,

EGF~

HB-EGF, and HGF (45, 46). Studies by Dagher and colleagues

have also sl1o\\/n that renal epithelial cells are quite sensitive to GTP levels. Techniques
developed in their laboratory to selectively deplete GTP have cicnlonstratcd enhanced
renal apoptosis (]], 47) as opposed to the necrotic phenotype seen after severe A. TP
depletion (J5).
Regardless orthe signal for apoptosis, this fornl of cell death has been shown to
proceed by 1\vo l11cchanisl11S in renal epithelia after ischclllic injury; the intrinsic and
extrinsic apoptotic pathways. Extrinsic apoptosis is initiated through ligand binding to
one of a variety of death receptors. TNF and FasL-induced apoptosis have been
thoroughly evaluated in renal cells, and in fact, both cytokines arc produced by renal
epithelia and by infiltrating leukocytes (45, 46). Nearly all renal cell types express
receptors for both TNF and FasL, but vary in their sensitivity to these cytokines (33, 4(),

48-52). Ligand binding ofthcsc lethal signaling 1l1olecules induces death receptor
oligoillcrization, the recruitnlent of adaptor nlolecuies, forn1at10n of the death-inducing

signaling conlplcx (DISC), activation ofcaspasc-8, and the downstreanl activation of
en-ector caspases

(45~

53). Type I cells arc quite sensitive to death receptor activation

\vhilc Type II cells lllLlst Sil1111ltancollsly engage and activate Bid and the intrinsic
apoptotic path\vay (53).
;\ctivation oCthe intrinsic apoptotic patln"ray involves the recruitnlent of
procaspascs, and it is clear that procaspases are activated by both cytotoxic and ischenlic

1I

injury to renal epithelia in cell culture (Lau, Edelstein, Hortclano) and ill vivo (34,
54)(DacI11Cn 200 I ~ Shi 2000, Sana). Initiation of the ll1itochondria-nlediatcd apoptotic

progral11 begins \'vith the release of cytochrOtllC c, \vhich 1l1ay be enhanced or inhibited by
lllel11bers orthe 8c1-2

f~llllily

of proteins (Sax, Bak, Bid, Bcl-2, Bel-xL) (45).

CytochrOlllc c then recruits other adaptor proteins including APAF-l and caspasc 9_
thereby fonlling \\'11at is known as the apoptosoille (45). This cell death cOlllplex goes on

to activate the effector caspasc. caspasc 3 (33). Quite noteworthy is the fact that
expression levels of caspascs and the pro-apoptotic Bcl-2 fanlily 1l1enlbers (Bax, Bak, and
Bad) all increase in renal epithelia after ischcnlic injury (55-58). Pancaspase inhibitors

have been used and sho\vn to be renoprotective against ischenlia/reperfusion injury in
aninlai 1l1odcls, hOvvcvcf, the lack of inhibitor selectivity has slo\\'ed efforts in
deciphering \\'l1ich effector caspascs are actually involved (34). Efforts to generate
caspase knockout nlicc have nlet \vith linlited success as \\fell. For

and colleagues de1l10nstrated that caspasc 1 -/-

11l1Ce

eXaJllplc~

Melnikov

\vere less susceptible to

ischcnlia/repcrCusion injury. but sho\\'cd no decrease in cellular apoptosis (33_ 59).
Hopefully', the generation ofnlorc specific and less toxic caspase inhibitors \vill allo\v for
the inhibition of apoptosis and subsequent I/R injury, providing a llluch needed therapy

for A.RF.

l\,lechanisms of Renal C:ell Repair and Regeneration After ARF. As a result
ofacLltc renal ischclllia or toxicant-induced injury, renal epithelial dysfullction is
typically charactcri7cd by the loss of cellular apical/basal polarity, cytoskelctal
redistribution, severe ;\ TP

dcpletion~

Illitochondrial dysfunctioll, inlpaircd solute
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transport. and decreased ion

pUll1P

activity including the Nat/K+ ATPase (2. 60-()4).

After the initial dan1age to the renal epitheliull1, cells either die via necrosis or apoptosis.
The renlaining tubular cells subsist in a sublethally injured state, poised to undergo the

conlplcx process

or regenerating the destroyed renal parenchynla (1,33, (5).

The

prevailing dognla concerning renal cell regeneration is that sublethally injured tubular

cells restore cellular function, de-difTerentlate via the epithelial-to-nlcsenchynlal (EMT)
transition. proliferate, nligratc, and finally re-differentiate to restore nlorphologic and
physiologic function to the danlagcd nephron (Fig. 1-3) (2, 6()-70). Recent data also

suggests the involvenlent of stenl cells in the regenerative process. Investigators have
identi fied the presence
the bone

1l1aITO\V

0

r both endogenous renal

steIll cells and those originating fro111

in aninlalll10dcls of acute renal failure (71-77). Ho\vever. the

signilicancc of these findings are still unclear.
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Figu re t -3. Proposed mechanism of renal cell repair and regeneration
t) Renal epithelia begin as differentiated and quiescent COlU111nar epithelia. 2) After
ischenlic injury, nUlllerous renal cells die via necrosis and apoptosis depending on the

local level or insult in thcir area of hypoxia. 3) Sonlc cells are suhlethally injured and do
not die. 'fhese cells lose their polarity and 1l1any of their physiological function. and can
either initiate the repair process inl111ediately or dedifferentiate into nlescnchynlal-like
eells \vhieh express vinlcntin. 4) Sublethally injured epithelial cells begin to Inigratc and
proliferate to fill in denuded regions of the tubular IU111en. 5) The epithelial cells finally
rcdiffcrcntiatc back into quiescent tubular cells and regain their polarity and
physiological functions.

Ischelnia

Reperfusi on

Prolmation /
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There is a signiflcant increase in cellular proliferation by surviving proxinlal
tubular cells alter ischclllia/rcperfusion injury in both anilllal 1l10dcls (()5, 78) and hUlllClll

cases of acute tubular necrosis

(65~

79) as nlcasured by peNA staining and incorporation

of [J H1 thynlidine into nuclear DNA. Proli ferating cells take

011

appearance and rcselllblc nlcscnchynlal cells with 1lattened cell

a new nl0rphologic
bodics~

loss ofa brush

border, and the dc-eli rrerentiatcd expression of enlbryonic proteins such as vinlcntin and
NC Arv1 (hS, 70, 78, 80). In nlany

\Nays~

dedifferentiated rena] epithelial cells recapitulate

the cellular ontogeny 0 f renal organogenesis.
During the proliferative phase of renal cell regeneration, it is heconling quite
evident that nUlllerOUS gro\vth factors, of an autocrine and paracrinc nature, are necessary

to support and stinlulatc renal cell gro\vth. This idea is supported hy observations that
exogenously adlllinistcred gro\vth factors such as epidcnl1al gro\vth
like gro\vth

f~lclor

f~lctor

(EGF), insulin-

1 (lCiF~ I ), hepatocyte gro\vth factor (HGF), fibroblast gro\vth nlctor

(FCiF). heparin-binding EGF (HB-EGF), bone 1l1orphogcnic protcin-7 (BMP-7), and
transi'ornling gro\vth 1'actor-0 (TGF-P) pr01110te cellular proliferation ill vitro and enhance
renal recovery after ischenlia/repcrfusion injury (81-88). While quite effective in 3ninlal
1l1odcls, only onc of these growth factors has been evaluated in

hUl11anS

(lGF-I). In this

clinical trial, it \vas found that trcatnlcnt of patients \vith rcconlhinant JGF- I did not

inlprovc renal function in subjects \vith conlorbidities (45,89). It should be noted,
ho\vcvcr, that gro\vth

f~lctor

reginlens for llLlIllan trials \vould havc to be adnlinistcrcd on

all acute rather than chronic basis to avolcf potential adverse effects caused by grcnvth

factor-Illcdiatcd overproduction of cells or by the stinlulation of occult neoplastic cells.

The nligration of renal proxinlal tubule cells to denuded areas of the tubular
IUl11Cn is crucial for the structural and functional recovery of the nephron. C0111n1011
1l1odcls used to study renal ccllllligration after injury utilize the nlcchanical scrape
technique ( I, 70, t)O, 91) as vv'cll as the usc of lllodel nephrotoxicants sllch as

dichlorovinylcysteinc (DCYC) (90).

Interestingly~

incubation of renal tubular cells vvith

u ration vvith EGF(70 90) and HGF (92)
nrowth factors has varyin bu effects on n1i b
'
.

b

~

stinlltlating and TCiF-{) (90) inhibiting this process, respectively.
A,ncr the sLlcccssfulnligration and proliferation orrenal tubular cells fol1o\ving
ischeI11ia/reperfusion injury, the restoration of epithelial function begins. Functional
repair ofproxinlal tubule cells prinlarily includes the restoration ofnlenlbrane transport
and nlctabolic functions (1). Key to the repair process is the reattachnlent of cells to the

bascnlcnt 1l1cnlbranc, a process nlediated by collagen I\! and intcgrin binding (93.94).
Follo\Ning bascnlcnt 1l1Cnlbrane reattachlllent nletabolic and transport processes such as
Na')K+ ATPase activity, Na+~coupled glucose transport~ and ll1itochondrial function
return to norn1al thereby restoring nephron physiology. The lllolecular nlcchanisnls
driv'ing this return of function arc not cOl11pletely understood at the present, and a deeper
understanding orthc signaling path\vays responsible for renal repair is needed before \ve
can begin to develop inlprovcd therapies for patients in thc setting ofpost-ischcnlic rcnal
1nJ ury.

TherHpeutic StrHtegies.

NU111erOLlS

studies in aninlal

1110dels

have shown the

efficacy of a variety of therapeutic agcnts in prcventing ischclllia/repcrfusion injury in the

k idncy. These agents provide renal protection through various 111echanis111s ranging frolll
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the inhibition of oxidative danlage to the stinlulatioll of pro-survival signaling path\\fays,

and include the list of 1l101ecules in Table 1-2, including gro\vth factors, antioxidants,
vasodilators and lllodulators of vascular tone, poly (ADP-ribose) synthetase (PARS)

inhibitors, protease inhibitors, Na+/Ca~+ exchanger and calciu111 channel antagonists,
iNC)S inhibitors, tyrosine kinase inhibitors, anti-illflanl111atory agents, diuretics, PP.AR-y
agonists, and adenosine receptor agonists.
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Table 1-2. Preventative therapies for ARF

~~~~~~-iative Therapi~s for ARF in Anima-I- M~Od~I-S--=-~

EGF
IGF-1
HB-EGF

(81 85)
(84)
(82,83)
(86)
(82)

BMP-7
Thyroxine
Ghrelin

(87, 88)
(95)
(96)

Vitamin E

(97)

j

Antioxidants

Ethyl pyruvate
Curcumin
Carvedilol
Quercitin
Naringin
Edavarone
Pyrrol id ine d ith iocarbamate
U-74500A

Mesna
Tempol
Allopurinol
Erdosteine

(104 )
(105)
(106)
(107)
(108)
(109)
(110)
(111 )

Sod ium N itropusside
Phosphoramidon

(105)
(105)

Oestrogen

( 112)

80-123

(113 )
(114 )
(115)

N-acetylcysteine
Resveratrol
Alpha-lipoic acid

Vasodilators and Modulators
of Vascular Tone

(98)
(99)
(100)
(19,99)
(101 )
(102)
(103)

Simvastatin
SB209670

LU 135252
Tezosentan
SM-19712
L-754,142
TAK-044
Moisidomine

(116)
(117)
(118)
( 119)
(120)
(121 )

I

I PARS Inhibitors

, 3-aminobenzamide
1,5-dihydroxyisoquinolone

I

L________~_

Nicotinamide
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(26)
(26)
(26)

Protease Inhibitors

Cal 1-1
Calpastatin
Ac-YVAO-CMK
PSI
Lactacystin
Aprotinin

(122)
(123)
(124,125)
(126)
(127)
(128)

Verapamil
Nifedipine
Diltiazem
NZ-105
KB-R7943
SN-6
SEA0400

(129,130)
( 130)
(131 )
(132)
(133)
(134)
( 135)

iNOS Inhibitors

1400W
GW274150

(136)
( 137)

Tyrosine Kinase Inhibitors
Anti-inflammatory Agents

Tyrphostin AG 126
Docosahexaenoic acid
Sevoflurane
Olprinone
Indomethacin
Rofecoxib
Minocycline
L-glycine
Antithrombin
Cerivastatin
FR167653
1nterleu kin-1 0
Alpha-Melanocyte
Stimulating Hormone

(138)
(139)
(140)
(141 )
(142)
(142)
(143 )
(144 )
(145)
(146)
(147)
(148)

Diuretics

Furosemide
Piretanide

(150)
(151 )

PPAR Agonists

L-165041
Rosiglitazone

(152)
(153)

CGS-21680
ATL-146e

(154 )
( 155)

Ca

2

+

Channel Inhibitors

I

(149)

I

I

I

Adenosine Receptor Agonists

~_._. __ .__

I

I

---~~--
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\Vhile it is clear that anin1al 1110dcls ofrcna) ischcI11ia/repcrfusion injury arc
valuable tools for studying the protective effects of rcnoacti vc COll1pouncis, the translation
of this research to 11LlllUlll beings is lacking, Many COll1poLlnds that have been evaluated
in hUlllLln trials have

f~lile(L

posing nUll1erous questions concerning efficacy and variation

between hUll1all and £1llin1al 1110dcls. One ll1ajor issue concerning hUll1an therapy in acute
renal failure is related to the tinlc of drug adnlinistration. ARF in hunlans is rather
insidious and is often goes undiagnosed in its early phase rendering 111any possible drug
therapies ineffective, and since 1110st a11i111al studies initiate drug adnlinistration before the
onset ofischclllia, it 1l1ay be too latc in 111any cases ofhulllatl ARF to intervene before the
ll1ajority of dalllagc has occurred. \\lith this in

nlind~

it lllay prove beneficial to elucidate

ll1echanis1l1S of enhancing post-ischenlic repair as opposed to inhibiting the initial cellular
dan1age itse) r

lVlitochondrial dysfunction during renal ischemia/reperfusion injury.
Mitochondrial dysfullction is a n1ajor hal1n1ark ofischenlia/reperfusion injury in
nU1l1erOUS ccllnlodcls (156, 157). l\1itochondria arc the 111ajor source of cellular ATP
generation in 1110St tissues. Consequently, cell types vvith high ATP den1ands, slIch as
proxilnal tubule cel1s, arc quite sensitive to ischcI11ic injury. Alterations in 1l1itochondrial
111orphology and function after ischcnlia/reperfusion injury are nUlllerous and include

swelling and rupture orthe outer n1cn1brane (158-162), generation oCreactivc oxygen and
nitrogen species (24, 1()3, 1(4). inlpaired respiratory function (130, 165-171.). increases

in intranlitochondrial calciunl (172), and the release of apoptogenic proteins due to the
opening of ll1Clllbranc pcrl11eability transition (\1 PT) pores or gross rupture of the outer
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1l1CI11brallC ( 173-1 75). Variolls 1l1echanisI11S have been proposed to account for the
lllitochondrial changes seen during ischc1l1ia/reperfusion injury (Fig. 1-4).
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Figure 1-4. Schematic diagram of Ca 2+-induced mitochondrial dysfunction
Mitochondrial Ca2+ overload is a common finding in many tissues during
ischemiaireperfusion injury. Briefly, Ca2+ is taken up into the cell and subsequently into
the mitochondria via a ruthenium red-sensitive Ca2+ uniporter. This increase in
mitochondrial Ca2+ induces phospholipase activity, but decreases mitochondrial
membrane potential, adenine nucleotide translocator activity, and total adenine nucleotide
levels. If the cells do not proceed to necrotic cell death as a result of severe energy
depletion, their mitochondria may progress towards a more swollen phenotype in which
they have decreased electron transport chain activities, increased ROS and RNS species,
and can ultimately signal apoptosis if they swell and rupture.

23

These nlechanisnls range fronl nlitochondrial calciunl accunlulation (172). loss of inner
111enlbrane potential (L1'I'I11) (168, 176), adenine nucleotide depletion (177, 178), inlpaired
adenine nucleotide translocator (ANT) activity (168. 176, 177), stinlulation of
1l1itochol1drial phospholipases (29, 167, 168, 176, 179-182), or 1110St likely a conlbination

ofn1ore than one of these events. !Viany of these changes in nlitochondrial viability
ultinlatcly lead to cell death via necrosis or apoptosis.

A.lthollgh there are nlany injurious stinlllli to the nlitochondrion during
ischenli,v'rcpcrfusioll. 111any of these insults converge onto respiratory dysfunction, l'viPT
and the release of cytochronle c resulting in necrosis and/or apoptosis.

The renlainder

of this discussion \vill focus prinHtrily on the role ofcalciulll-induced 1l1itochondrial
dysfullction \vith particular attention paid to calciunl-1l1cdiatcd deficiencies ill the

fUllction of' the electron transport chain.
Cellular calciulll levels arc regulated by llU111erOUS nlechanisllls. the

1110St

inlportant oC\vhich include receptor and voltage-nlediated channels, Na+-/Ca

2t

exchangers. and ('a 2 ATPases (183). Equally inlportant during ischenlia/rcperfusion
+

injury arc plasnla 1l1CI11hrallC Na+!K+ ATPases \vhich falter during ischenlia-induccd ATP
depletion. This ion

pUll1P

failure drives Nat extrusion through the Na+/Ca
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exchanger

resulting in elevated cytosolic free calciull1 concentrations. NOr111al cytosolic free

calciulll cOllcentrations have been deternlined in cultured renal epithelial cells (LLC-PK 1
and IRPTC) and hover at approxinlatlely 100 11M (175, 184). During ischenlia,
intracellular calciulll concentrations can rise to over 300 11M as denlonstraled by Tanaka
cl (//

in a nlodcl of renal chenlical hypoxia (Antinlycin A treatnlcnt) (175) and to levels in

excess of 1()

~lf\1

ill isolated kidney proxinlal tubules (Antinlycin A treatll1cnt) (185).
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]'vlitochondrial calciu111 uptake is functionally linked to oxidative phosphorylation
via its dependence on an intact nlel11brane potential across the inner ll1ell1brane (181).
Moderate anlollnts of calcillnl uptake actllally stinlulate oxidative phosphorylation
181, 18(), 187). Ho\vevcr, higher concentrations of Ca

(176~

2+11l lead to inner 111enlbralle

depolari/,ation. resulting in a large efflux of Ca 2+111 (172. 181, 188), an inability to
cfTcctively buffer cytosolic Ca

21

,

and reperfusion-phasc elevations in cytosolic and

nlitochondrial free Call (172), One well-studied effect of ischenlia-induced elevations in

Ca 2

I III

is the i nei llct io 11

0

f the M PT pore ( 189- 1(2), a p henonlenoll \vell doc Ulllen ted in

renal ischenlia/rcperfusioin 1l1odels (175, 185, 193-198).
In generaL fornlation orthe i\1PT pore requires the rutheniulll
2(0) accunlulation ofCa

red~sensitive (199,

2+ in the Initochondrial nlatrix (201). The all10unt ofCa 1;

necessary for pore fornlation varies between species (1 77 ~ 202) and the organ SystClll
Crolll \vhich the 1l1itochondria \vere isolated (203-205). Mitochondria1 Ca

1
j

acculludatioll

is singularly sufficient to induce MPT in nU111erOUS tissues including liver (206), heart
(18(»), adrenal cortex (187), and kidney (207, 2(8), but can be induced by a host of other
!~lctors

such as phosphate, oxidizing agents, sulfllydryl reagents, adenine nucleotide

translocator (J\NT) ligands, pyrophosphates. uncoupling agents, fatty acids, and
increased pH (201). MPT pore inhibitors include. hut arc not linlited to, respiratory
substrates, adenine l1uclcotidcs,

di~

and trivalent cations, conlpctitors ofcalciulll binding,

free radical scavengers, oligonlycin, protons, polyanlincs. sulfhydryl reducing agents,
BSA, and cyclosporin A (201). The MPT pore itself is believed to be COll1posed
prilllarily of tile outer 111enlbrane voltage-dependent anion channel (VDAC) (209) and the
inner 1l1Cnlbrane adenine nucleotide tran510cator (ANT) (177), with the fornlcr acting as
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the pore channel and the latter functioning as a regulatory protein (201). Growing
evidence is novv suggesting that the pore nlay actually be a protein supercolnplex knO\\/1l
as the lllitochondrial tllcgachanncl (MMC) Illade up of a VDAC dinlcr in close contact
with the inner Illclllbranc ANT (210), The f\1PT pore dianleter is cstinlated at 2-3
allo\\/s the 1110VClllent of 1l101eculcs < 1500 Oa into and out orthe

nl11

nlitochondria(20()~

and

211 ~

2i

212), Sustained Ca -induccd opening orthe MPT pore can lead to 1l1atrix s\velling~

rllpture ortlle outer ll1itochondrial111clllbrane, and the release ofproapoptotic proteins
such as cytochronlc c and S111ac/Diablo(213). These progenitors orthe intrinsic apoptotic
path\vay proceed to induce progranlnled cell death by activation of dOVv'l1streanl effector
caspascs. It should also be Iloted that nl0dulators oCapoptosis fronl the Bcl-2 f(:unily of
proteins are kno\vll to interact v.:ith \'DAC and to nlodulate the open or closed state of the
pore (2 13 -2 15),

l'v1itochondrial calciuIl1 accun1Ltlation plays a 1l1ajor role in 111itochondrial
nlcn1branc function and in perpetuating ischcn1ic injury (181). Mitochondria act as
intracellular calciuI11 sinks (21 ()), \\'ith a Ca 1-t uptake Km of ~5-1 0 ~ll\1 (217). /\rnold

cf

uf

have previollsly nlcasurcd renal n1itochondrial Ca 2 + (Ca 1+ 11l ) levels before and after
rcperfusion in a rat kidney 1l10dcl of ischclnia/reperfusion injury (172). In this study,

ll1itochondria \vcrc isolated in the presence ofrutheniul11 red to block calciu1l1 uptake
induced bY;/1 ,';fro isolatioll lllCthods. The investigators found sinlilar levels ofCa 2+ m in
both shanl-opcratcd and ischcll1ic kidneys inl111ediately prior to reperfusion (-,15-16 nn101
Ca>/111g 111itochondrial protein), that these levels rcn1ained constant in shanl unin1als and

increased to ()() nn101 ('a 2+-/nlg protein after 24 hours ofrcperfusion in the ischenlic
kidneys( 172). This rise in Ca~+ 111 ",vas directly linked to respiratory dysfunction and

decreases

ill

acceptor-control ratios indicating a role for Ca ~ in ischenlia-induccd
2

111itochondrial dysfunction. Mohaupt cl a/ have sho\vn sinlilar increases ill 11litochondrial
ca1ciulll ancr rCllal ischc111ia \vith C011C0111ita111 decreases in A TP levels (Fig. 1-5) (2] 8).
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Figure 1-5. Mitochondrial Ca 2+ increases while ATP synthesis decreases during
ischemia.
The above ex perinlent conducted by Mohaupt e/ ol den10nstrates the significant increases
seen in nlitochondrial Ca 2 levels after renal ischenlia which can be blocked in the
presence of the Ca 2 channel blocker verapan1il. Likewise~ verapan1il can also preserve
cellular ATP leve ls after an ischel11ic event. These data den10nstrate an in1portant
pathological role played by Ca2+ during ischenl1a/reperfusion injury. Note: Figure taken
fronl (218).
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It is clear that renal ischcnlia/reperfusion injury significantly increases
111itochondrial calciulll concentrations (171 ~ 172,218-220). Longstanding evidence f)'onl
studies exanlining ischcnlia/reperfusion injury in IlU111erOUS organ systenls provide
supportive data linking ischenlic injury to deficits in 111itochondrial respiration (171-173,

108,218.221,222) and nlore specifically to defects in COlllplex I activity (167, 198,223226). These observations suggest the involvcnlcnt of a speci fic calci ulll-nlcdiated target
necessary for the function OfC01l1plex I. Tvv'o attractive nlcchanis1l1S of calciunldependent 1l1itochondrial respiratory dysfunction include the activation ofnlitochondrial

phospholipases (227-229) and of endogenous 111itochondrial calpains (230-233).

('alpain activation and renal failure. Renal ischenliairepcrfusion injury is
1l1ediated in large part by increases in total cellular calciulll. This increase in cytosolic

free Ca~· sets the stage for calciull1-induced danlagc nlcdiated by the activation of
proteases~

phospholipases., nitric oxide synthase, and protein kinases to nanlC a fcvv.

these calciul11-scnsitive

enzynles~

()f

calpains represent an interesting class of proteins \vhich

nlay be involved in the progression of ARF due to their diversity and subccl1ular

distrihution. CaJpains, a class

ofcalciunl~sensitive

cysteine proteases, are inlplicatcd in a

variety of hUI11al1 disease states in which there is a dysregulation of cellular calciulll
hon1cos1asi s.
1V1any cellular calpain substrates have been identified to date including a nUI11bcr

orcytoskclctal proteins (paxillin. talin, vinculin., ct!l-spectrin) (234, 235). Recent studies

hy Liu

e/

01 suggest that calpain-lllediated degradation of these cytoskeletal proteins leads

to the progressive loss ofplasnla nlcnlbranc pernleability to ions, subsequent loss of
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nlenlbrane integrity, and renal cell oncos1s (235). Nunlerous in vitro studies have also
shovvn thc protective effects of dissinlilar calpain inhibitors on cell death induced by
antinlycin /\ (236-240), hypoxia/reoxygenation (238,239), tetratluroethyl-L-cysteine
(nephrotoxic halocarbon), bronlohydroquinone (nephro-toxic quinone), tbutylhydroperoxidc (nlodcl oxidant), and ionon1ycin (Ca2+ ionophore) (241,242). In
addition, calpain inhibitors have been shown to protect nlitochondrial function in ce11
culture 1110dels as denlollstrated by Harrinlan et al (236).
Recent \\/ork by Chattcljee and colleagues have shown the ill vi\Jo protection
afforded by calpain inhibitor 1 (Cal 1-1) against renal ischen1ia/repcrfusion injury in the
rat (122). Pretreatn1ent with Cal 1-1 in this study preserved renal histology, decreased
SerLlnl urea, creatinine, ganlnla GT, AST, NAG, and FE(Na) and significantly inlproved
creatinine clearance as cOlllpared to controls. Cal 1-1 also significantly reduced kidney
MPO activity and MDl\ levels. Interestingly, decreases in iNOS and COX-2 levels \vcrc
also observed, suggesting the involvenlent of nuclear factor-kappa B (NF-K B) (122).
Taken together these data suggest a role for calpain isoforn1s in the progression of acute
renal failure through actions on structural proteins of the cytoskeleton, through regulation
of gene expression, and on n1itochondrial viability. More work, however, is llccessary to
evaluate the diverse roles played by calpain in the pathogenesis of acute renal failurc.

(~alpains

The Calpain-Calpastatin System. The calpains are a superfanlily of cysteine

protcases first descrihed and purified by Dayton et al in 1976 (243, 244). The calpains
arc \vcll conserved anlong eukaryotes with various calpain genes expressed in fungi. (',
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c!cga!l.\'~ I)r()s()phi!a~

and n1an1n1als (245). Within the vertebrate fanlily, there are 14

large subunit ca1pain isoforn1s and a 28 kDa sn1a11 calpain subunit

(245)~

son1C of\vhich

are ubiquitously expressed (246) and S0111e that display a nlore tissue-specific distribution
(247-240).

The seenlingly ubiquitous calpain fanlily nlenlbers consist of calpains 1,2,

4,5,7,9, and 10 (245,250-254). The nlore tissue-specific isofornls have nlRNAs
expressed in the testes (calpain 11 ~ (255, 256)), skeletal nluscle (calpain
sn100th nlllscle (calpain 8a, 8b; (247)), the testes and lung (calpain
placenta (calpain

6~

13~

3a~ (257))~

(255)), the

(258)), and in the skin up to 16 days after birth (calpain

The calpain fanlily can be further subdivided into what are ternled

~vpical

12~

(259)).

and atypical

calpains (Fig. 1-6) (245). The typical calpains consist of those isofornls containing a
pcnta-EF hand calciunl binding nl0tifin Donlian IV and are c0111prlsed of cal pains 1,2,3,
8, (), 1 1,

12~

13, and 14. The atypical ca1pains lack a penta-EF hand d01l1ain, contain a

highly divergent C -tern1inal don1ain, and consist of ca1pains 5, 6,7, 10, and 15 (SC)LH)
(260-262).

31

11.

pC.., met, Lp82. nCL·2

11,12, 13, 14

nCL
nCL·2'
CAPNJ

p94 (C pain 3)

CAPN5, 6

hTRA-3(C

u

CAPN7

PalBH (C8lpain 1)

>-

CAPN15

SOLH

CAPN10

Calpain 10 a-h

fi

ain 5),

AS2
Ipain

'Go

C

.

.

.. . ...

m

m'

Figure 1-6. Schematic diagram of the known mammalian calpain isoforms
This cartoon illustrates the known mammalian calpain isoforms. The gene and protein
names are illustrated along with the overall domain structure for each species. This
representation also points out the differences in domain structures betweeen the typical
and atypical calpains. *Note - For calpain 6, the green dot above domain IIa denotes a
change in the active site cysteine to a valine.
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The typical calpains contain four n1ajor protein dOll1ains froll1 the N to C-·tern1inus
(I-IV) (Fig. 1-7). 001nain I is located at the N-tern1inus and is an autolytic don1ain often

cleaved after calpain activation and displays 72-86?/o h01l1010gy an10ng different species
(hU1l1an,

chicken~

rae pig, and rabbit) (245). 00n1ain II is con1prised of two subdonlains

(lla and lIh) and contains the active site of the enzyn1e. Three key an1ino acids \vithin
00111ain II n1akc up a catalytic triad including a cysteine residue in 00n1ain IIa and both
an asparagine and histidine residue in 00n1ain lIb (263). Recently, X-ray
crystallographic studies have den10nstrated the abi lity of both 00n1ains I1a and lIb to
cach hind one at0l11 of Ca 2+ ~ thereby aligning the active site cleft and allowing subseqllent
activation orthe enzyn1e (264). 00n1ain III links the two calciun1-sensitive don1ains and
contains two potential EF-hand n10tifs, one at the 00n1ain II/III border and another at the
00n1ain III/IV boundary, respectively (245). 00n1ain III is thought to playa role in
phospholipid binding via the presence of a C2-like don1ain (265), Lipid binding to
[)olnain III has been shown to enhance calciun1-binding to the calpains and n1ay help
lo\\'er the ill

\'l\'{)

calciun1 requiren1cnts for full enzyn1e activation (2()5). 00n1ain III is

a Iso thought to help regulate the enzyn1e' s activity via its participation in critical
clectrostatic interactions (266, 267). 00n1ain IV of the typical calpains is highly
hon10logous to that of 00n1ain VI of its 28 kOa sn1all subunit binding partner (245). This
d0l11ain contains five calciun1-binding EF-hand 1110tifs and is thought to be the n1ajor
player in regulating calpain sensitivity to cellular calciun1 (248).
The atypical ll1c111bers of the calpain

f~lnlily

contain highly divergent all1ino acid

sequcnces ill [)on1ain IV. Thc functions of the atypical calpains arc not clear at this
point. Ho\vcvcr, the absence of a typical 00111ain IV suggests that these isofor111s 111ay

33

not he c0l11plctely regulated by calciuI11-binding, that they 111ay not din1erize \\'it11 the
sn1al1 28 kDa calpain subunit (calpain 4), and that they n1ay have con1plctely novel
functions, substrate affinities, and/or activation/inhibition nlcchanisnls.
The sn1all calpain subunit (calpain 4) is the norn1al binding partner for both
calpains 1 and 2 (245). This subunit consists of two don1ains (V and VI) (Fig. 1-7).
00n1ain V is con1posed of a glycine-rich region with 110 known function other than its
ability to heterodin1erize with the C-te1111inal region ofOon1ian IV of the typical calpains
(\vitl1 the

exception of calpain 3) (268). 00n1ain VI is a recapitulation of 00n1ail1 IV

found in the typical calpains and contains a calciu1l1-binding penta-EF-hand 1110tif(269).
Interestingly, a novel calpain sn1all subunit (css2) has been identified and can fonn
functional hctcrodin1ers with nl-calpain (270), however, css2 is not fully redundant for
calpain 4 since honlozygous knockout n1icc (CAPN4(271 ).
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denl0nstrate enlbryonic lethality

Large Subunit
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Figure 1-7. Schematic representation of the typical calpain domain structure along
with its heterodimer (the calpain small subunit).
The protein depicted above is typical of the EF -hand containing calpain isoforms. Each
red asterisk represents a novel Ca2+-binding site while each black asterisk represents an
area of reported phosphorylation clustering. Protein domains; dl represents the autolytic
domain, dlla and dllb represent the active site of the enzyme, dIll contains a C2-like
phospholipid element, dlV contains a penta-EF hand Ca2+-binding domain, dV is the
autolytic domain of the small calpain subunit, and dVI is a recapitulation of the penta-EF
hand motif seen in the large calpain subunit.
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Calpastatin is the only known specific and endogenous prolein inhibitor of the
calpain fanlily. Ho\vever, both H- and L-kininogen and a2-nlacroglobulin arc protein
species vvhich can also inhibit the calpains in addition to their o\vn endogenous substrates
(272). Studies on calpastatin have been historically very difficult because its llligration
011

SI)S-PAGE analysis is variable (245). In addition to its anon1alous n1igration

characteristics, calpastatin is highly resistant to denaturation by heat

(273)~

SDS. urea.

and trichloroacetic acid treatn1ent (274, 275). Adding to the problen1 are the existence

or

8 calpastatin splice variants (18.7-85 kDa) (274, 276. 277) (278), n10st ofvv'hich do not

rUIl truc to thcir 11101ecular weights upon SDS-PAGE analysis
calpastatin isoforl11 (85 kDa) contains six

donlains~

(279~

280). The largest

XL, L, L II, III, and 1\1 (Gol)).

Donlain XL contains three PKA phosphorylation sites (281), don1ain L has no
functiolL and [)onlains I-IV are n1arginally hon1010gous inhibitory dOll1aills

kll0\\ 11

contaillin~]

three subdonlains, A, B. and C, critical for n1axin1un1 inhibitory activity (245). Each

or

the separate don1ains I-IV den10nstrate inhibitory activity against both calpains 1 and .2
'Nith varying degrees of efficacy~ donlain I> donlain IV > d0111ain III > donldin fL fiT)lll
the nlnst to least effective (282). Subdol11ain B (12 an1ino acids) is required Ic)r
calpastatin's inhibitory

activity~

but possesses no activity 011 its o\vn (282,283),

Hcnvcvcr. a larger version of subdonlain B (27 an1ino acids) does posses inhibitor)'
activity \vith an Ie:=;() of ~25 nM (calpain 2) to 800 nM (calpain 1) (283), but is not as
elTcctivc as the conlplete calpastatin 11101ecule. The binding of calpastatin requires (~a~j
(2S4. 285) and involves the association of subdonlains A, B. and C with calpain donlains
1\'. II, and \t'1 (sn1all subunit), respectively (286-288). Taken together, these observations

denlonstrate that calpastatin binds to the typical calpains in association with the sn1al1
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calpain subunit. This would suggest that calpastatin n1ay be incapable of inhibiting the
atypical calpai ns or those typical calpains that do 110t heterodin1erize with the sn1all

calpain subunit (calpain 3).

(:alpain Inhibition. Calpain inhibitors are quite diverse and vary considerably.
A l1u111bcr of representative calpain inhibitors fr0l11 varioLls inhibitor classes are listed in
Table 1-3.
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Representative Calpain Inhibitors
Inhibition

Molecule

Reference

Protein Inhibitors
Calpastatin

pM range

(245)

Kininogen

36 nM

(289)

u2-macroglobulin

500 nM

(289)

Leupeptin

140 nM

(290)

Phevalin

1.3 uM

(291 )

Natural Products

6.2-8.8

E64

~lM

(292)

Penicillide

7.1 pM

(293)

Calpeptin

40 nM

(294)

Peptidyl Aldehydes

1

MDL-28170

~lM

(295)

7.5 nM

(296)

ALLN

190-220 nM

(297)

ALLM

120-230 nM

(297)

PD150606

210-370 nM

(298)

SJA-6017

Non-peptide Inhibitors

260 nM - 5.3

PD151746

87 pM

Peptide Biphenyls

~lM

(298)
(299, 300)

Table 1-3. Representative caJpain inhibitors
Listed above are calpain inhibitors frolll various inhibitor classes including protein
inhibitors~ inhibitors derived fron1 natural products, peptidyl aldehydes, and non-peptide
inhibitors. IC_~(l values are listed for each individual calpain inhibitor.
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Protein inhibitors include calpastatin, kininogen, and a2-111acroglobulin (245,
272), and inhibit via disruption of the calpain active site. Reversible calpain inhibitors
such as C'alpain inhibitor I or calpeptin are generally sn1a11 peptidic n10lecules that act as
high affinity ca1pain substrates thereby blocking the active site fron1 other protein targets.
Conversely, the irreversible inhibitors consist of acetylating agents, epoxides, and
dia/onlethylketones \vhieh all pern1anently n10dify the active site cysteine residue of
presull1ahly all the calpain large subunit isofornls (excluding calpain 6 which lacks an
active sitc cysteine).
The search for calpain inhibitors has been ongoing since the discovery of calpain
over 30 years ago. The first generation of inhibitors lacked potency and selectivity and
included a variety of rather dissinlilar lllolecules such as EDTA and EGTA (ea2chclators), iodoacetic acid, 5,5'-dithiobis(2-nitrobenzoic acid), N-ethyln1aleinlidc.
1l1crsalyL iSocoulllarin, and diisopropyl phosphorofluoridate (301).
A second generation of conlpounds, natural calpain inhibitors, \vere disc()\'crcd
and isolated fronl the Strepto171yces sp. and include peptidyl aldehyde, diketopiperazine,
and pyrazinonc derivatives. Exanlples of this generation of inhibitors include IClIpcptin,
(l\c-Leu-Leu-Arg-H) (302), antipain ([(S)-1-carboxy-2-phenylethyl]-carbanloyl-L- V'alArg-H) (303), strepill P-1 (N-i-valeryl-Tyr-Val-Arg-H) (301) and the pentapeptides
staccopin P-l and P-2 (Val-Val-Val-Val-Phe-H and Val-Val-Val-Val-Tyr-H,
respectively) (JOl). However, these peptide aldehydes lacked cell pernleability and
selectivity for the calpains over other protease systenls. Subsequently, investigators
began vv'orking '.\lith the peptidyl aldehydes, consequently inlproving inhibitor potency
through structure-activity relationship analysis and cell pernleability and stability by the
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addition of hydrophobic N-tern1inal capping groups (301). The inhibitor derivatives froll1
these efforts include calpeptin (304), MOL 28170

(295)~

and calpain inhibitors I and II

(Ac-Lcu-Lcu-Nlc-H and Ac-Leu-Leu-Met-H) (297). Other, n10re recent, calpain
inhibitors f)'on1 the Streptolllyces sp. include 3-benzyl-6-isopropyl disubstitutcd 2( 1)prazinonc (Pheval in) (291),

diketopiperazine~

and tetrapeptide (305).

Other naturally occurring calpain inhibitors include dan1nacanthal fron1 the root of
I\I/orillc/(/ citrij'o/io (306), penicillide fron1 the culture broth of the Pcnicil/illlJl species

F607()O (293), and tralls-epoxysuccinyl-Lleucylan1ido-4-guanidino-butane (E-()4)
isolated fi'on1 the fungus AspergillllsjapolliclfS TPR-64 (307). Of these three inhibitors,
E-()4 has been the n10st intensely studied. E-64 and its cell-pern1eable derivative E-64d
are irreversible inhibitors orthe calpains and exert their inhibitory effects via covalent
binding of the active site thiolate (301). These epoxysuccinyl peptides are highly
selective for the cysteine proteases, but are unfortunately not selective for calpains (308).
Follo\ving the successful isolation and characterization of natural calpain
inhibitors, an eft(]rt to lise the inforn1ation gained fron1 these studies to develop 11101'('
speci flc sn1all 11loiecuic inhibitors was initiated. These efforts can be seen as the
developn1ent of the third generation of calpain inhibitors. Atten1pts at sl11a11 1110lccule
devcloplllcnt and synthesis have been bolstered recently by the availability of crystal
structures of calpain 2 and of the core catalytic regions of both calpains 1 and 2 alk)\ving
for enhanced inhibitor design (263, 309-312). Most investigators have endeavored to

design pcptide ll1inlctics containing chell1ical 'warheads' that replace the scissile all1idc
bond \vith an electron deficient center that can either bind reversibly or irreversibly with
the thiolate n10icty of the active site cysteine (301). Electrophilic carbonyl-containing
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functional groups that have been used as chen1ical 'warheads' include (X-diketoncs (313).
ex-kcto phosphorous con1poullds (314), aldehydes (294. 295, 297, 304. 315, 31 ()), and

(x-

keto carbonyl con1pounds such as ex-ketoacids, cx-ketoanlides, and cx-ketoestcrs (313,
J 17-310). It \vas later discovered that irreversible inhibitors could be produced by

replacing the scissile bond of calpain substrates with ll1cthylsul foniun1 salts (320-322),
disulfide linkages (323), epoxysuccinates and their derivatives, vinyl sulfoncs (324), and
ketorncthylenes (322, 325-329), Of note, a nunlber of "non-warhead' peptide biphenyl
hybrid con1pounds have been synthesized, the 1110St potent of\vhich exhibits an IC)() of87
pM (299. 3(0).

The fourth. and perhaps n10st exciting generation of calpain inhibitors are the
non-peptide COll1pounds (301,330). These con1pounds include the natural products
danlnacanthal (30(»), Phevalin (291), diketopiperazine, and tctrapeptide (305) as
n1entioned earlier. but also include the novel <x-nlercaptoacrylates (301) as first described
by \;\!ang
r[)

cf

af in 1996 (298). The n10st potent cx-n1ercaptoacrylates, PO 150606 and

15174(), \vere not only cell pern1eable, but were 600-fold nlore selective for calpain

over cathepsin B (298). This selectivity is thought to be derived fronl the novel binding
site

ortlle u-tllcrcaptoacry1ates as cOlnpared to active-site calpain inhibitors. Indeed,

recent x-ray crystallographic data have shown that P0150606 hinds to don1ain \lI orthe
sJ11a11 calpain subunit (calpain 4) and n1ay function in a sinlilar fashion as subdolllain C of
the calpastatin inhibitory donlain (331,332). It is also possible that the

(1-

1l1crcaptoacrylatcs n1ay exert their effects through inhibition of the calpain donlain IV EFhands sillce this dOlnain is highly conserved with don1ain VI of calpain 4. If this is true,
it \vould suggest that this class of COlllpounds nlay only be useful for inhibiting the
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typical calpains. as the atypicals lack the penta-EF-hand don1ain and prcsun1ably do not
heterodin1crize \V1th calpain 4. Two other non-peptide inhibitors of the calpains include
aurintricarboxylic acid CA. T A) (333) and the quinolinecarboxyan1ides (334), ho\vever. the
exact nlcchanislll of inhibition for these con1pounds is not fully understood and 111ay
rcsult Crolll binding to an allosteric sitc other than the calpain activc site.
The design of calpain inhibitors has enjoyed a long and circuitous route. We have
gOlle It"0111 the identification of potent natural inhibitors lacking selectivity and cell

perJncahility to both peptidyl and non-peptidyl inhibitors exhibiting excellent potency.
SerLlnl stability, and cell pern1eability. However, we have not yet been able to produce
inhibitors sufficiently selective for calpains over other cysteine proteases, nan1ely the
cathcpsi I1S. 111 fact, the n10st selective calpain inhibitor to date is t- 80c- Lcu- Phe( 0 L)CH~F

\vhich is 450-fold and 680-fold nlore selective for calpain lover cathepsins Band

L, respectively (326). followed closely by the a-n1ercaptoacrylates (298). This is not

surprising since the proteolytic n1echanisnl for all of the cysteine protease fanlily
1l1cIl1bcrs is virtually the saIne. At present, n10st inhibitor design has centered on using
structure activity relationships to design peptide n1in1etic inhibitors. These efforts have
also focused on the unprinled side of the scissile bond and have left the prinled side
virtually unexplored. Future efforts for drug discovery in this area would be best served
by designing inhibitors that span the P-S-P' bond in the active site cleft or by searching
for secondary allosteric sites capable of regulating calpain activity. In

fact~

the latter

suggestion could create specific calpain inhibitors for the diverse group of atypical
calpains. of\vhich 111allY are involved in hU11lan disease processes.
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Mechanisms of calpain activation. Calpains are described as Ca 2 +-dependent
cysteinc protcases. This 1l1eanS that therc is an absolute Ca 2+ requirenlcnt for full
activation orat least the typical calpain isofol111S.

However~

it has been clear for quite

SOlllC till1C that the ill vitro (~a2+ concentrations necessary for activation of both calpains 1
and 2 \\'crc substantially higher than the 50-30n nM Ca 2+ concentrations found in living
cclls (335). [n f~lCL ill an ill vitro setting LLsing purified bovine calpains 1 and 2, the Ca~+
concentrations nccessary for their full activation were 6-1 00
respectively (336).

Consequently~

~lM

and 0.8-1.6 111M,

investigators have cndeavored to identi fy Illechanisllls

for rcducing the Ca~t- rcquiren1ents for the ubiquitous calpains under physiological

conditions. In the

litcrature~

nun1crous nlcchanisn1s have been identified, but have

produced fe\\:' conclusive answers (Fig. 1-8). These n1echanisll1s include autolysis (337339); dissociation fron1 the sn1all calpain subunit (340), phospholipid binding (341-346).

translocation (347-349), phosphorylation (245, 350), and interactions \vith various
'activator' nlo\ccu\es (351-355).
NUIl1crous investigators have posited the idea that calpains are proenzynlcs and
1l1USt undergo autolysis to bcconlC active. It has been shown that both calpains 1 and 2
undergo N~tcnninal autolysis \vhen incubated with Ca 2+ (337-339), producing 76 and 78
k[)a proteins, respectively (356). Autolysis of the calpain n101ecules has been shown to
reduce the Ca~ i concentration required for half-n1axinlal proteolytic activity of calpain 1
fronl 3-50 to 0.5-2 pM and that of calpain 2 froll1 400-800 to 50-150

~lM

(357).

Ho\vcvcr. the reduction ofCa~+ required for half-n1axinlal activation is a 11100t point since

the Ca

2i

concentration needed for autolysis itselfis roughly equal to that required for

cnzynlc activation (337, 358, 359). Interestingly, it has been shown that both
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unautolyzcd calpains 1 and:2 retain proteolytic activity (336,337,360), while others have
dClllollstratcd that autolysis precedes proteolytic activity (358, 361-3(3).
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Figure 1-8. Mechanism of calpain activation
Depicted above are the known mechanisms of typical calpain activation. These
mechanisms include direct Ca2+ activation, autolysis, dissociation of the large and small
subunits, degradation of the endogenous inhibitor calpastatin, membrane translocation,
phospholipid binding, phosphorylation, and interaction with various 'activator'
molecules.
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v\lhi Ie it is clear that autolysis is not necessary for enzyn1e

shown that autolysis does occur under ill vivo conditions

activation~

(336~ 364)

it has been

and n1ay playas yet

undiscovered roles for calpain function. One exciting role for this autolysis lnay be to
generate active polypeptides, S01l1e of\vhich have been shown to exhibit chcnlotactic
activities tovv'ards in1n1unocytes (365) and neutrophils (365. 366).
The 28-kDa sn1all calpain subunit is known as the endogenous calpain regulatory
subunit hctcrodin1crizes with the large calpain subunit, and has been reported to contain
chaperone activity necessary for proper folding orthe large subunit (3()7). Reports in the
carly 1()8()s suggested that calpain activation was dependent upon dissociation of the
large and sn1all subunits after exposure to Ca 2+ and appropriate substrates (34U, 3(8).
Years later, Yoshizawa e/ 01 den10nstrated that the large and s111a11 calpain subuni1s could
dissociate after treatnlent \\/ith Ca 2+ and that the large subunit retained proteolytic activity
and reduced Ca 2 ' requirenlents under these conditions. One physiological prnbk'ili \\ith
this echoes observations nlade on calpain autolysis; the an10unts of Ca 2-+ necessary to
induce subunlt dissociation are orders ofnlagnitude higher than that seen in living cells.
Conversely, calpains and their sn1all subunit heterodinlers have been sho\vn to be
assoclatccl follo\\'ing activation \vith Ca 2+ in living cells (369). While a nUlllber ofstuciies
havc s}lO\Vn associated snlall subunit labi lity and calpain activation (3 70~ 371 ) and the
ability of the core catalytic region to proteolyze tluorogenic substrates (264. 372). it is
nlore likelv that these observations are artifactual in nature and that the in \'h'o activatiol1
ofcalpain (typical calpains) is regulated to S0l11C degree by S111a11 subunit interactions.
A third n1cchanisn1 proposed for decreasing the Ca2+ require111ents necessary for
calpain activation involves the binding of phospholipid species. The typical calpains
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have been shown to be activated by a nun1ber of lipids including phosphatidylinositol
(343), phosphatidylinositoI4,5-bisphosphate (PIP 2 ) (345,346), gangliosidcs (342,373),

and Illixturcs of various lipids (341,342,344), of which PIP 2 is the n10st effective. The
intcraction bct\vcen the calpains and phospholipids is an attractive n1echanisn1 of
activation due to the presence of a C2-like phospholipid binding n10tif found in donlain
III orthe typical cal pains (265). This n1echanisn1 would also unify the concept of cal pain

activation aftcr translocation to the plasn1a nlen1brane (347-349) where the calpains
would be in a position to encounter phospholipids, transient Ca 2+ influxes, and
endogenous substrates. Unfortunatel y, it is sti 11 di fficult to explain calpain activation
\vith th is theory si nce extrenlely high nlolar ratios of lipid to calpai n (375-4100: 1) are
necessary to decrease the an10unt ofCa2+ necessary for enzynle activation (337, 345,
34()). It is unlikely that endogenous calpains would encounter lipid concentrations this

high ill

\'i1'o,

and \vould suggest that phospholipid regulation of calpain activity is not the

"holy grail"' of calpain regulation that has been sought for so long. Of note, it has been
also sho\\'11 that the individual conlponents of phospholipids (fatty acids and
Iysophospholipids) can n10dulate calpain activity through activationlinhibition orthe
enzynlc (374, and unpublished data by Arrington).
The post-translational nlodification ofprotcins by phosphorylation plays a

substantial role in regulating lllany enzynle and signal-transduction path\vays, and the
calpains arc no exception. The phosphorylation status of calpains 1 and 2 has been
elucidated by· using antibodies specific for

phospho-Ser~

phospho- Tyr~ and phospho-Thr

and by iv1ALDI-TOF lnass spectronletry. These analyses denlonstrated 9 and 8
phosphorylation sites on calpains 1 and 2, respectively (375) These phosphorylation sites
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arc located in clusters on both calpains 1 and 2 and can be found near the don1ain IIII
junction and at the N-ternlinal region of donlain lIb (245). Analysis of the an1ino acid
sequcnces surrounding these clusters predict two PKA (calpain 1) and one PKC site
(calpai n 2)~ one PKCi site, one casein kinase I site, and two calnlodulin kinase II sites
(245), 11\11 of the sites are not phosphorylated on each calpain isoforll1 at all tinles, and it

appears that there are 2-4 phosphates/nlolecule on average (245). Studies directed at
dcphosphorylating the calpains has deternlined that the phosphates cannot be rell10ved in
thc presence

or phosphatases unless exposed to Ca~-+ concentrations in excess of 500 ,uNL

and that rcnloval of all phospho-Ser and phospho-Thr residues reduces calpain activity to
<15(Yc) (245). More recent data suggest that calpain 2 can be activated by the EC.F

reccptor via activation of the ERK/MAPK pathway (376). This activation occurs through
phosphorylation of Scr-50 \\/hich is not found in calpain 1, and results in full activation of
the cllzyrnc (350). This \vork is validated by findings that MEKK I-deficient fibroblasts
losc calpain activity, show reduced cleavage of cytoskeletal proteins (377), and that MEK
inhibitors inhibit EGF-induced calpain activation (376). It is clear that calpain
phosphorylation can playa signiflcant role in n1ediating protease activity.

Moreover~

it is

conceivable that phosphorylation of key residues n1ay activate calpains in the absence of
Ca 2 ' and playa pivotal role in the activation/inhibition of the atypical calpains \v11ich lack
a Ca~'--sensitivc dornain IV.
;\ final 1l1cchanisnl reported for the activation of calpains involves their
interaction \\/ith so-called 'activator' nlolecules. The flrst of these n10lecules is
isovalerylcarnitine which has been shown to reduce the Ca 2+ requirenlent necessary for
hal f-n1axilllal activation of calpain 2 but not of calpain I (353,354). Again, ho\vcver. the
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1110lar ratio of isovalerylcarnitine to calpain (20,000: 1) necessary for this effect is n10rc
than likely not attainable ill vivo. A nun1ber ofproteinatious calpain activator nlolecules
have also been described. The first of these protein activators, a heat-stable 40-45 kDa
protein, reduces the half-ll1axin1al Ca 2+ concentration necessary for calpain 2 activation to
less than 20

~lM,

and has been isolated fron1 both hun1an neutrophils (352) and rat

skeletal ll1uscle (378). A sin1ilar 40 kDa protein purified fron1 erythrocytes \vas sho\\/n to
reduce the Ca

2t

concentration required to activate calpain 1 fron1 50 to 0.2 ~lM (355).

Another activator nlolecule, a 15 kDa protein, functions as a h0l110dill1er and reduces the
Ca 2 ! requirenlent necessary for calpain 1 proteolytic activity to 0.4-0.5 pM (351 ).
Sequence analysis has shown that this protein is virtually identical to a goat liver protein,
UK 114. This particular calpaill 'activator' protein is active at 1: 1 UK 114 to calpain
ratios (J51). Subsequently, a 10 kDa protein that functions as a 20 kDa hon10dinlcr \vas
identified as acyl-eoA binding protein and reduces the Ca 2+ requirenlent of calpain 2 to
()- 7 ~lM. This protei n activator functioned in a 1: 1 n101ar ratio with calpain 2 but not
calpain 1 (379). Other, less potent, protein activators of the calpains have been descrlbcd
and increase the catalytic activity of the calpains by 2, (380), 10 (381), and 25-fold (382).
A lthough there have been nun1erous reports of conditions and rlloleculcs that
See1l1 to reduce the absolute Ca~-i requiren1ent necessary for calpain activation, nlany of
these reports arc confined to ill vitro experin1ents or to those in which there is no
evidence 0 r activation under ill vivo conditions. Therefore, it is likely that such
1l10lecules do exist but that their relevance in nortnal physiological or pathological
conditions renlain to be verified.
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Physiological Roles for the Calpains. The physiological roles orthe calpains
have been under investigation since their discovery over 30 years ago, and are in large
part still unclear. C'alpains are different than 1110St proteolytic syste111s in that they cleave
peptidcs at a lil11itcd l1unlber of sites and leave large, often fully active protein fragn1cnts.
u that they 111ay playa critical role in reu-ulatory or siunalin u l)athwavs.
slloocstin
bb
b
b
b
b
""

Calpains 111ay also posses regulatory functions outside of their ability to cleave peptide
honds since sonle n1enlbers and splice variants of the calpain fan1ily lack active sites
(calpain ] 0) (383) or specific residues of the catalytic triad necessary for proteolytic
activity (caipain 6) (258). While still largely a n1ystery, the known functional roles for
the calpains can be broken do\vn into several categories including cell cycle progression
(384), apoptosis (385), signal transduction (386), regulation of gene expression (330),
platelet function (364. 387), and cellular n1igration (388)
Sequential progression through G 1, S, G2, and the M phases of the cell cycle is
absolutely required for n1itosis and cellular proliferation. Calpain activity has been
inlplieatcd in the proll10tioll of the G I-S phase transition point, a key step ll1ediated by
eye lin-dependent kinases (cdk2, cdk4, and cdk6) and their heterodinler partners cyclin [)
or eyelin E. Nunlerous studies have den10nstrated the ability of the ealpains to cleave
in1portant regulators of the Gl-S transition including cyclin D (384), cyclin E (389),
p27 ki l'l (a cdk inhibitor) (390), and the upstrea111 l11odulators of the G 1 checkpoint p53
(3<) 1~ 3(2)

and pI 07 (393). These observations would suggest an inlportant regulatory

role for the calpains in norn1al cellular turnover and en1bryonic devc10plllcnt. and \vhose
ovcractivation could contribute to tun10rigenesis as proposed by Carragher el a/ (394).
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Progranl1l1Cd cell

death~

or apoptosis, is the conlnlon and preferred 1110dc of cell

death in nurnerous cell types. Various roles for calpains in this process have been
reported and in S0111e cases suggest conflicting nlechanisnls and nlodes of regulation.
Calpain has been sho\vn to pronlote apoptosis via activation of caspase 3 (395), caspase
12 (396), Bax (397-399), Bid (400), p53 (401), and by the conversion of Bel-xl fronl an
antiapoptotic protein illtO a proapoptotic nl01ecule (396). Sinlilarly, calpains have been
sho\vn to participate in llun1crous n10dels of apoptosis under varying stinluli (402-406).
ReceIlt evidence also sho\\ied that the calpains have a role in the induction of caspascindependent cell death (407, 408), including the release of apoptosis inducing factor
(AIF) fron1 the Il1itochondria (408). Conversely, calpains have been denlo11strated to
inhibit apoptosis via the inactivation of p53 (409) and caspases 7 and 9 (410). Whi Ie it is
clear that calpains participate in the series of events leading to apoptosis, the role of
calpains in this process is quite varied and differs with respect to cell type and thc nature
or thc apoptotic sti nl u1us.
Signal transduction events are critical ll1ediators of nUll1erous cellular processes,
including cell survivaL

apoptosis~

and induction of gene expression. For exan1plc,

calpain-nlcdiated cleavage of PKC results in the generation of a constitutively active
enzyn1e which presun1ably regulates downstreanl signaling events (411). More recent
evidence has also inlplicated calpain in the degradation of PKC a (412-414) and (') and
subsequent hypoxia-induced neuronal cell death (413). Calpains can also inactivate
proteins such as focal adhesion kinase (FAK). Calpain-nlediated FAK cleavage
generates a 30 kDa cytosol1c fl-agnlent which acts as a donlinant negative kinase (415.
41 () and also prevents integrin-n1ediated signals froll1 reaching the PI3-kinase and
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ERK/MAPK signaling pathway (417). Calpain-n1ediated cleavage of Src (418) and the
EGF-rcccptor (419) has also been shown to inhibit their signaling functions.
Calpain can also directly cleave nun1erous transcription factors including c-fos, c.lun (420), and pS3 (391) and can regulate transcription indirectly via cleavage orthe
transcription factor repressor IKB-a, thereby facilitating NF-KB translocation to the
nucleus (421,422). The transcription factor con1plex TCF/LEF-1 is indirectly regulated
by calpain through the cleavage of the

~-catenins (423).

Calpains also indirectly

influence transcription through cleavage of the signal transducers and activators of
transcription proteins, STAT 3 and STAT 5 (424). Thus, calpains can cleave a large set
of proteins, n1any of which contain signaling and transcriptional functions.
A large class of calpain substrates includes a nun1ber of cytoskeletal proteins:
all-spectrin, u-fodrin, paxillin, vinculin, vin1entin, desnlin, ezrin, talin, FAK, cortactin,
and actin (415,416,425-433). Many of these cytoskeletal proteins are cleaved after
either calcl unl or integrin-n1ediated platelet activation (434). The calpain-n1ediated
rcn10dcling of cytoskeletal proteins plays a pivotal role not only in platelet adhesion and
aggregation but also in post-clotting events such as clot retraction (434) and pron10tion of
the shedding of pro-coagulant containing nlicrovesicles fron1 the plasnla n1en1brane of
aggregated platelets (435). The dependence of platelets on norn1al calpain function has
also been den10nstrated by the use of a calpain 1 knockout nl0use in which the authors
sho\ved abberant platelet function (436).
Many of the cytoskeletal conlponents listed above are not only involved in norn1al
platelet function but also in the signaling nlachinery necessary for cellular 111igration ..A.
subset of these cytoskeletal proteins for111 large n1ultiprotein c0111plexes that are in close
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association \vith cellular integrins (330). These associations link the extracellular n1atrix
to the cytoskeleton and provide signals that regulate cellular n1igration and other cellular
functions (437). The norn1al assen1bly and disassen1bly of focal adhesions can be altered
by calpain activation and the subsequent cleavage ofFAK, talin, and paxillin (415).
These cleavage events are thought to be necessary for the detachn1ent of cells fron1 the
ECM prior to 111igration, while inhibition of these events with calpain inhibitors
suppresses cell n10tility (394). FU11her studies utilizing calpain 4 deficient fibroblasts
denlonstrated the inability of these cells to n1igrate due to their failure to turnover focal
adhesions necessary for nligration (438, 439). However, calpains seen1 to be dispensable
for other cytoskeletal-nlediated events such as cytokinesis (438). Future work, ho\vever,
needs to be done in order to evaluate the role of calpains in 111igratory 'dysfunction' such
as that observed in n1etastatic cell lines.

Pathological Roles for the Calpains. Although calpain activity is required for
l1orn1al cellular function, it has becon1e quite clear over the last 20 years that their
activation or lack of activity is linked to a nUl11ber of disorders and disease states.
Calpain-associated pathologies can be grouped into three categories including cancer,
disorders coupled to the dysregulation of Ca2+ hon1eostasis,! and those linked to genetic
111utations in calpain isofor111s (Table 1-4).
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Table 1-4. Disease states linked to calpain isoforms
- Calpain Isoform+

Calpain 1

Disease Pathology

--

.--~.~.
__ ~~

l
Muscular
Dystrophy, Stroke, Traumatic Brain Injury, Spinal Cord Injury, I
Alzheimer's Disease, Neurodegenerative Disorders, Cataracts, Cancer, I

+
I

Atherosclerosis

I

f-------------·----Muscular Dystrophy, Stroke, Traumatic Brain Injury, Spinal Cord InjUry,-'
Calpain 2
Alzheimer's Disease, Parkinson's Disease, Neurodegenerative
Disorders, Cataracts, Cancer, Atherosclerosis

~-----"--------~"------

Calpain 3
Calpain 9

Cataracts, Limb-Girdle Muscular Dystrophy type 2A
Gastric Carcinoma

_"~C~a~e_ai_n_.1_0____-'---T-L-y'L--pe
__2_D_i_a_b_et_e_s_________________________________._____"_

Many recent studies have begun to inlplicate calpains in the progression or
suppression of tUll10r fornlation. For exanlple, elevated calpain levels have been dctcctcd
in breast canccr tissues and is highest in estrogen receptor positive tUll10rs (440).
Sinli larly, calpain overcxpression has been shown in hunlan renal cell carcinon1a (441 ).
basal cell carcillon1a, squan10us cell carcinoll1a (442), and in chronic lynlphocytic
leukell1ia (B-CLL) cells (443). In addition, calpain-ll1ediated degradation of the tUll10r
supprcssor protein neurofibroll1atosis type 2 (NF2) has been shovvn in neuronal
scl1\VannOll1as and n1eningion1as (444). Striking results froll1 the work of Man10une

e!

(II

have denlonstrated a role for calpain 2 in the invasive potential of prostate carcinon1a
cells (01.) 145 cells) (445). In contrast, at least one of the calpain isoforll1s, calpain 9,
\vas observed to bc do\vnregulated in gastric cancer tissues and cell1ines (252,446),
suggesting its role as a tunl0r suppressor gene.
Ischcn1ic tissue dan1age n10st conln10nly results froll1 the insufficient supply of
blood to an organ systen1, but nlay also stenl frolll exogenous toxicants. In n10st

circunlstanccs, tissue ischen1ia results in the elevation of cytosolic free Ca2+ and leads to
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the downstreanl activation of Ca 2 + sensitive enzynles such as phospho1ipases~ kinascs~
and proteolytic systcnls. Calpain activation has been inlplicated in a variety of ischenlic
IT10dcls both in vitro and ill vivo and have been shown to induce cell death in neuronal
(447), cardiac (448), hepatic (449), intestinal (450), and renal ischenlia (122). These
observations suggest a clear role for the calpains in ischenlia/reperfusion injury and
highlight a secnlingly universalnlechanisnl for ischenlia-induced cell death in organs
susceptible to oxygen deprivation.
Neurodegenerative disorders are conlnlonly associated with increased calpain
activation, and arc thought to be linked to the dysregulation of cellular Ca 2+ honleostasis
round in nlany of these pathologies (451). In the case of neural ischenlia, or stroke,
cellular ('a 2-+ levels increase due to the overstinlulation of the NMDA, AMPA, and
kaillite glutanlate receptors. This excitotoxicity activates intracellular cal pains,
ultinlatcly leading to neuronal cell death (452). Neuronal calpain activation during both
ischcJl1ic and other neurodcgenerative processes can often be assessed by the calpainnlediated production of all-spectrin breakdown products (453). Increased calpain
activity has also been denl0nstrated to contribute to excitotoxicity-nlediated
neurodegcneration in Huntington's disease (454, 455), anlyotrophic lateral sclerosis,
Alzheinlcr's disease (456, 457), and Parkinson's disease (458, 459). In addition to the
cxcitotoxic roles played by the calpains in neurodegeneration, calpains have also been
linked to the etiologies of both Alzheinler's disease and 111ultiple sclerosis through
cleavage ofp35 to p25 (a cdk 5 activator inlplicated in the forn1at10n of tau
neurofibrillary tangles) (120, 460, 461) and ofnlyelin and nlyelin basic protein (462),
respectively. The enhanced calpain activity seen in ischenlia and nlodels of
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nCLlrodcgeneration suggest a pivotal role for cal pains in various forll1s of neuronal cell
death. \Vc 11lay be able to exploit this knowledge therapeutically by using calpain
inhibitors to block acute neuronal cell death during ischen1ia or to prevent disease
progression in n10re chronic disorders such as Alzhein1er's or Parkinson;s disease.
I n addition to neurogenerative disorders; calpain activation has also been

observed ancr traun1atic spinal cord injuries (463). The cell death observed after acute
spinal cord traun1a is linked to local increases in intracellular free Ca 1+ concentrations
subsequent to the disruption of local vascular supply (463). Calpain protein levels have
been shown to be increased in the sites surrounding spinal cord injuries (464) and
inhibition of calpain activity using cell-penl1eable inhibitors can provide signi ficant
neuroprotcction in anin1al n10dels of traun1atic spinal cord injury (465, 4(6).
Atherosclerosis is a vaso-occlusive disorder halln1arked by the infiltration and
proliferation of vascular sn100th n1uscle cells (vSMC) into the intin1allayer of the
arteries. I)alllage to the arterial endotheliun1 induces vSMC proliferation; n10nocytc and
T lyn1phocytc infiltration, platelet aggregation, and the deposition of lipids and
cxtracell ular n1atri x proteins (467). These events lead to the forn1ation of a vascular
plaquc~

an occlusion of the arterial lU111en, and increased risk of vascular events including

stroke and n1yocardial infarction. Calpains have been in1plicated in the progression of
atherosclerosis via their effects on vSMC n1igration (468) and proliferation (469).
FurthcrnlolT, calpain inhibition has been shown to inhibit post-angioplasty restenosis in a
rabbit nlodcl of fcnloral artery atherosclerosis (470). These studies suggest the
involvcnlcnt oCcalpain isofornls in the pathogenesis of atherosclerosis and highlight a
potential therapy using calpain inhibitors in patients undergoing angioplasty.
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Cataract fOrJnation is a disease of the eye lens and is characterized by
opacification of the lens proper. There are nunlerous environnlental and hereditary
stinlllli \vhich initiate the fornlation of cataracts~ but all conlnlonly lead to the disruption
ofplasnla nlenlbrane integrity and an increase in free cellular Ca 2+ concentrations (471).
Increases in cellular free Ca 2+ activate cytosolic calpain 2, thereby inducing the cleavage
and precipitation of lens crystallin proteins a and

~

(472). The protein aggregates

produced by calpain 2 activation induce light scattering in the lens, severe lens
opacification, and ultinlate blindness unless treated surgically (472). Inhibition of cal pain
activity in aninlalnl0dels of cataract fornlation has been shown to reduce light scattering
and cataract progression (473) and nlay prove to be a viable alternative to surgery in
cataract patients identified in the early stages of the disease.
To date, virtually all known calpain-associated pathologies are believed to evolve
frolll the dysrcglllation of calciunl honleostasis. However, genetic defects in two calpain
isofornls have been identified and linked to hunlan disease states. The first of these
disease states is nluscu1ar dystrophy. In both Duchenne and Beckers nluscular dystrophy,
disruption orthe dystrophin gene leads to plasnla nlenlbrane pernleability. cellular Ca 2

1-

influx, calpain activation, and cleavage ofnlyofibrillar and cytoskeletal proteins vv'hich
produce the characteristic nlllscle wasting observed in nluscular dystrophy (474,475). In
the nlid-1990s, Richard et {II discovered that the autoso1l1al recessive condition of linlbgirdle nluscular dystrophy (Type 2A) lllapped to the nluscle-specific calpain 3 gene found
on chronlosonle 15 (476). Decreases in calpain 3 activity lead to increased levels of IkBex, decreased nuclear translocation ofNF-kB, and decreased expression of cell survival

genes resulting in enhanced ll1yocyte apoptosis (477, 478). In fact, calpain 3 knockout
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lllice veri fy that this is the likely nlechanisnl of nluscle cell death seen in linlb-girdle
nluscular dystrophy (478).
A second hUlllan disease state associated with a genetic defect in a calpain
iSOrOrlll is Type II diabetes. In

2000~

a genonle-wide scan for Type II diabetes

susceptibility genes deternlined that calpain 10 was associated with hereditary Type II
diabetes ill select populations including Mexican An1ericans and a Finnish subpopulation
(383). Decreases in calpain 10 activity have been linked to decreased insulin-nlediated
glucose turnover (479). decreased glucose-induced insulin secretion

(480)~

and

illlpairnlent in glucose production (479). Taken together, these data \vould suggest a
signi ficant role for calpain lOin regulating glucose nletabolisn1. Recently. a calpain 10
knockout nlouse \vas generated in1plicating calpain 10 as a n1ediator of ryanodineinduced apoptosis in pancreatic beta cells (481). Unfortunately, this n10use has not been
fully characterized and the glucose status of these anin1als renlains to be deternlincd.
Identification orthe physiological targets of calpain 10 and its role in glucose utilization
and diabetes nlay provide novel therapeutic strategies for the treatn1ent of Type II
diabetes.

The atypical calpains. The atypical calpains are those enzynles \vhich lack a
penta-EF hand Ca~j binding n10tifin don1ain IV and instead contain an 'atypical' donlain.
The atypical calpains consist of calpains 5, 6,7, 10, and 15 (260-262). In contrast to the
typical calpains the renlaining n1an1n1alian calpain isoforn1s do not appear to interact \vith
the regulatory calpain 4 sl11a11 subunit, and it is equally unclear as to whether or not the
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atypical calpains require Ca~+ for activation. Unfortunately~ very little is known about
the physiological or pathological roles of these enzyn1es with the exception of calpain 10.
C'aIpain 5 was first identified as a hon1010gue to the C'. elegalls sex detenllination
gene,

11'0-3

(254, 258,482). Subsequently, it was discovered that a second sex

deternlination protein TRA-2A was the endogenous

1,.([-3

substrate (483). However. it is

still unclear as to vvhether or not a hun1an h01l1010gue to TRA-2A exists. The calpa1n 5
gene product is constitutively expressed in n1an1n1alian systen1s and contains a highly
divergent T-dotnain in place of the typical calpain don1ain IV (482). Calpain 6 is also a
novel atypical calpain that denlonstrates a 47% identity to calpain 5 (258). Sequence
analysis has detern1ined that calpain 6 lacks an active site cysteine residue and is n10st
likely devoid of proteolytic activity (258). Despite an apparent lack of proteolytic
activity, calpain 6 is found on the X chron10son1e and n1ay playa role in sex
deternlination in vertebrates (254). Calpain 7 is perhaps the n10st divergent orthe
atypical calpains and retains hon1010gy to the other calpains through its possession of a
proteolytic don1ain (484). Calpain 7 is flanked by an atypical N-ternlinal dOlnain and an
atypical C'·-ternlinal donlain (PBH don1ain) (248) that displays hon1010gy to the Pal8
protease fron1 the fungus Aspergillus nidulalls reported to be in1portant in alkaline
anlbient pH adaptation (484). The latest calpain fan1ily n1en1ber (calpaill 15) was
identi fled through genon1ic scans for calpain active site d01l1ains and was fOllnd to be
highly honlologolls to the ])rosophila protein

SOL~

s1l1all optic lobes protein (260). The

calpain 15 gene encodes a protein containing zinc finger-like repeats and a calpaill-likc
protease don1ain (260). Proposed functions for this gene product include proteolysis,

59

transcription factor activity, RNA binding, and protein-protein interactions during visual
systen1 dcvelopn1cnt (260).
Perhaps the n10st well-studied 111enlber of the atypical calpains is calpain 10.
Calpain 10 \vas first described in 1999 by Braun and colleagues (original nonlenclature
tCrJllcd this isofonn as eAPN 8), and is located on chrolllosonle 2 (485). The prinlary
calpain 10 transcript encodes the largest calpain 10 isofonll (CAPN lOa) and produces
another 7 splice variants of varying nlolecular weights (383). Calpain 10 is conlpriscd of
rOLlr donlains including don1ains I, II, and III which denlonstrate nlodcratcly high levels

of hOlllology to the typical calpains. The fourth donlain, donlain III', is the n10st atypical
and inlparts as yet undetellllined functions to this calpain isofornl. Calpain lOis
conlplctcly devoid of Ca 2+ sensitive EF-hands, but has been reported to function in a
Ca~ f- -sensitive nlallner (253, 486). It is thought that Ca 2+ may regulate calpain 10 through

binding to donlains II and III which has been den10nstrated for calpains 1 and 2 (264).
Caution nlust be used when interpreting these data, however, as there have been no Ca lt _
binding studies perforn1ed using reconlbinant calpain 10. The initial studies on calpain
10 exanlined the constitutive expression of both nlRNA and protein in nunlerous tissues
and denlonstrated an age-dependent decrease in protein levels fron1 hun1an lens sanlples
(253). Subsequently, the authors den10nstrated the Ca 2+-sensitive nature of cytoplasnlic
calpain 10 \vhcn they observed the cytoplasnlic to nuclear translocation of calpain 10
after iononlycin treatnlent in alpha TNF4-1 cells (253).
Calpain 10 has been the first gene to be directly linked to the developnlent of
Type II (non-insulin dependent) diabetes nlellitus (383). Positional cloning studies
revealed a Type II diabetes susceptibility gene in a Mexican Anlcrican popUlation vvhich
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\vas subscqucntly cloned and found to be calpain 10(383). Since this finding in

2()OO~

1l11111erOllS investigators have evaluated the calpain 10 gene with respect to insulin
resistance and relative risk for Type II diabetes in various populations and have found an
association in Mexican Anlericans

(383~ 487)~

a subset of the Finnish population (383),

i\1l1erican Caucasians (488), British Northern Europeans (489), African Anlericans (490),
a subset of the Chinese population

(491)~

a subset of the Polish population (492), a South

Indian population (493), nlenlbers of the Swedish population (494), the Japanese (495),
and Koreans (496). Un fortunately, other studies have shown no association bet'vveen
calpain I () and diabetes (497-499) which n1ay be due to statistical bias fron1 factors sllch
as underlying popUlation stratification. However, ani111al models of Type II diabetes have
greatly contributed to the understanding of the role played by calpai11 lOin this disease
state. For exanlple, investigators have den10nstrated decreased calpain 10 n1RNA in the
\vhite blood cel1s of spontaneously diabetic obese rats (500), and in the Otsuka LongEvans Tokushin1a Fatty (OLEFT) polygenic type 2 diabetic rat, calpain 10 was one of 14
quantitative trait loci identified.
To date, three critical single nucleotide polynlorphisll1S have been identified for
the calpain 10 gene and include SNP-43, -19, and -63 (383). Con1binations of these
SNPs have been shown to create n10re 'at-risk' haplotypes and are designated as
haplotype 112 (SNP-43 allele 1, SNP-19 al1ele 1 and SNP-63 allele 2) and 121 (SNP-43
allele 1, SNP-19 al1elc 2 and SNP-63 allele 1) (383). Other SNPs identified in the calpain
10 gene include SNP-44 and SNP-l1 0 (a n1issense nlutation in the coding region of ex on
10 (T504A)) (501).
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Figure 1-9. Calpain 10 splice variants
The above schematic describes each variation in calpain 10 transcript splicing, the
predicted protein domain structure, and the predicted molecular weights of the translated
gene products. Data on each splice variant was compiled from the NCBI protein
database and calpain 10 gene record.
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The calpain 10 gene is cOlnposed of 15 exons with the prin1ary transcript
undergoing differential splicing to produce a fan1ily of8 calpain 10 isofonns (calpain
lOa-I Oh) (Figure 1-()) (J83). Although little evidence exists to verify the protein

expression of all 8 isoforn1s, a nunlber of calpain 10 protein isoforn1s have been
identified in both rat ocular cells (253) and pancreatic

~-cells (486).

In1nluno]ocalization

and functional studies have placed calpain 10 in association with the cytosol

(253)~

nucleus (253), secretory granules (486), and endoson1al vesicles (502) under varying
stinll11i. Hovvever, it is still unclear if all 8 calpain 10 transcripts are translated ill vivo
and vvhether or not these proteins have individual localizations and functions.
The rev.';" known physiological functions for calpain 10 have all been elucidated
fronl the correlative data linking calpai11 10 to Type II diabetes. Currently, the kno\vn
rnolecular targets for calpain 10 are linlited to pathways involving glucose nlctabolisnl
(502) and insulin secretion (486). Insulin resistance and ilnpaired glucose uptake into

skeletal 1l1uscle and adipose tissue are nlajor features of Type II diabetes (50J). A critical
rate-linliting step in insulin secretion is the insulin-n1ediated transport of glucose by the
GLUT-4 transporter (504). Previous studies den10nstrated a role for calpains in the

transport of GLUT -4 vesicles after insulin stimulation (505-507) and n10re recent
evidence has identified calpain 10 as the calpain isoforn1 responsible for this vesicle
translocation (502). In addition, calpain 10 polyn10rphisnls are associated 'Nith defects in
insulin secretion (489) and glucose tolerance (508). Subsequent studies provided
evidence that long ternl calpain inhibition in pancreatic

~-cells

inhibited glucose

nlctabolisnl, downstreanl Ca 2+ -n1ediated responses, nlitochondrial A. TP production, and
insulin secretion (480). Interestingly, a 54 kDa isofornl of calpain 10 binds the
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nlenlbrane fusion tSNARE proteins syntaxin and SNAP-25. Overexpression of calpain
lOin this systenl not only increased insulin secretion and proteolysis of SNAP-25~ but
calpain inhibition blocked the insulin secretion in this 1110del (486).
Calpain 10 has also been associated with apoptosis in nun1erous cell types.
Johnson and colleagues were the first to describe a role for calpain 10 in apoptosis and
did so by denlonstrating the inhibition ofryanodine-induced apoptosis in pancreatic

f)-

cells llsing calpain 10 knockout n1ice (481). More recently, Lu ct al uncovered a
correlation bet\veen par-4 antisense treatn1ent of PC 12 cells and a reduction in glutalllateIllcdiated apoptosis (403). While this study provided little direct evidence for calpain 10Illediated apoptosis, it did denlonstrate decreases in intracellular calciunl and of calpain
10 nlRNA levels, suggesting an interaction bet'W'een par-4 and induction of calpain 1()

(403). Subsequently, Wu cf aI, using calpain 10 antisense, den10nstrated a proapoptotic
role for calpain lOin rat renal interstitial fibroblasts (509). The authors described
enhanced calpain 10 expression and caspase-3 activity leading to increased levels of
apoptosis after treatn1cnt of these fibroblasts with lipoxin A4 (509). However, the
Illolecular targets involved in this forn1 ofapoptosis were not identified in this study.
It is clear that calpain 10 is an 1n1portant n10lecule regulating diverse cellular
events including glucose nletabolisn1, insulin secretion, and apoptos1S. However, nluch
\\'ork is needed to elucidate the exact 1l1echanisIl1s by which calpain 10 1l1ediates these
events. Future vv'ork nlust also be cOll1pleted in order to understand the true nature of
calpain 10 activation. For exall1ple, calpain 10 lacks the EF-hand dOll1ain structure found
in the typical calpain isoforn1s, suggesting that its activity 1l1ay be nlore sensitive to as yet
undiscovered regulatory nlolecules than it is to Ca2+. In addition, post-translational
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n10difications such as phosphorylation nlay playa key role in activating calpain 1() as has
been sho\vn Cor calpain 2. It is equally ten1pting to hypothesize the existence of a calpain
1O-speci fie endogenous inhibitor since it is unlikely that calpastatin interacts with this
calpain isoforn1 as it lacks a typical donlain IV and does not heterodinlerize vvith the
S111all calpain subunit.

Furthernlore~

a concerted effort to elucidate the roles for all 8

calpail1 I () isofornls should be initiated as their in vivo substrates are likely as diverse as
those identi fled for the largest nlenlber of the calpain 10 fanlily.

IVlitochondrial Calpains. One of the first nlitochondrial proteases to be purified
and \vell-eharacterizcd \vas described over 25 years ago by Mori et (1/ who denlonstratcd
a n1atrix-associatcd proteolytic activity capable of cleaving pre-ornithine
transcarban1ylase to its nlature fornl in isolated liver nlitochondria (510). The protease
involved in this cleavage was found to be sensitive to both EDTA and leupeptin. hut not
to serine protease inhibitors~ suggesting the presence of a Ca 2 +-sensitive cysteine protease
(510). This finding is the fIrst report of a "calpain-like" protease residing in the
nlitochondria~

although the authors did not link this activity to the calpains since calpa111

biology was itself still in its infancy at the tinle.
The first identification of a calciunl-dependent nlitochondrial protease \vas Inade
in 1982 by Beer ct a/. The authors denlonstrated the presence of both Ca 2 -dependent
-+

and Ca 2+ -independent proteolytic activities in extracts of sonicated rat liver nlitochondria.
There \vcrc two ('a 2 + -dependent proteolytic activities which were described to be half
n1(1xinud at 25 pM and 750 pM Ca 2-+, respectively (231). The calciunl-dependcnt
activities ohserved in this study were sensitive to EGT A, N-ethylnlaleinlide, lcupeptin,
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cytosolic extracts, and Ca 2 +-dependent protease inhibitor partially purified fronl

1l1011SC

lung (231), suggesting that the protease in question nlay have been one of the newly
described neutral cysteine proteases (calpains). Interest in these findings \vaned for
Ilearlya decade and \vas finally reevaluated by Tavares et al in 1991. Tavares and
colleagues used COIUlllll chronlatography to separate three distinct calpain activities n'on1
isolated rat liver lllitochondria. In this senlinal report of a nlitochondrial calpain, the
authors described the presence of three independent calpain activities in puri fled
lllitochondrial nlatrix and two in the inten11en1brane space (233). These activities \vcrc
found to be nlaxinlal at a neutral pH and at Ca 2+ concentrations previously reported for
both calpains 1 and 2 (30 pM and 2 nlM), although the third activity described had an
internlediate Ca 2 + requirnlent (200 ~lM) (233). Further experinlents denlonstrated the
inhibitory activity of ICllpeptin and the thiol blocking reagents N-ethylnlalein1ide and
PCMB on all three of the described calpain activities (233). The two reports detailed
above were, however, only descriptive and did not attenlpt to identify the calpain isoforn1
, responsible for the observed activity or the physiological role played by the calpains
found in the 111itochondria.
'Years later, Gores et al identified a nlitochondrial calpain-like activity n10stly
confined to the intern1enlbrane space of purified rat liver nlitochondria. The activity
denlonstrated in this study \vas calciun1-inducible and was inhibited by cysteine protease
inhibitors (230). Furthernl0re, the authors found that they were able to inhibit Ca 2 "induced MPT fo1'l11ation via pretreatnlent with calpain inhibitors. This \vas the first study
linking 111itochondrial calpain activity to a n1easurable function, be it physiological or
pathological. In 1999, Endo

e/

(1/ denlonstrated that retinal nlitochondrial aspartate
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al11inotransferase (nlAA T) lost its enzynlatic activity in a calpain-dependent nlanner after
90 1l1inutcs of retinal ischenlia (511). The authors were able to den10nstrate an increase

in lllitochondrial calpain activity and were able to in1nlu11oprecipitate calpain activity
fron1 isolated n1itochondria using n10noclonal antibodies to calpain 2. However. an
interesting point concerning these studies lies in the fact that the authors never
dcnlonstrated any in1n1unoblot data confin11ing that calpain 2 was indeed responsible for
the degradation of n1AA T (511 ).
'-

'

Further evidence of a nlitochondrial calpain and its role in n1itochondrial
physiology has been published by Casas et ([/ who described the presence of an
interlllen1brane space calpain found in isolated rat liver n1itochondria capable of cleaving
the nuclear RXRa protein into a truncated nlitocho11drial RXRa that induced the
transcription of n1itochondrial genes (512). The authors provided evidence that a
1l1itochondrial calpaill localized to the internlenlbrane space cleaved RXRa into a 44 kDa
n1itochondrial RXRa (512). The calpain-like activity observed in this study was
inhibited by Icupeptin, antipain, and ALLN, but not by the Ca 2+ chelators EDT A or
EGT A, suggesting a Ca 2+ -independent calpain isoforn1 s1111ilar to that described by Beer
el

(fl.

To this point in the discussion, only Hcalpain-like" activities have been described,
leaving the actual identity of the n1itochondrial calpain in question. Considering that
there arc 14 large calpain isoforn1 subunits and that n1any of the typical calpains arc
kno\vn to translocate to n1en1brane fractions after activation, it is conceivable that
lllltltiple nlclllbrane-bound or intra-organellaI' calpain isofornls exist. To this end,

t\VO

recent reports have been subn1itted which suggest the association of calpain 1 to the

67

lllitochondrial fraction (232,408). Polster ct 01 have recently dell10nstrated the calpaindependent release of the apoptosis inducing factor (AIF) froll1 11litochondria after Ca 2 '
overload (408). The authors de1110nstrated that isolated rat liver 111 itochondria release
AIF after incubation \vith both reconlbinant Bid and calpain 1. They \vere also able to
s!10\V that Ca~' -induced MPT [orn1ation and subsequent release of AIF was both
eye losporine A and calpeptin-sensitive, suggesting that an endogenous n1itochondrial
ealpain could also stin1ulate A.IF release (408). Analysis of these data \vould suggest that
AIF release fron1 liver n1itochondria is regulated by both an unidcntifid cndogenous
1l1itochondrial calpain and by calpain 1 which presun1ably translocates to the
internlcnlbrane space given the proper stin1ulus. Subsequent to these findings, Garcia
and colleagues dell10nstrated the localization of calpain 1 to the n1itoehondria of rat
cerebral cortex and to those of the SH-SY5Y neuroblastonla cell line (232). Ho\vcver,
the data presented in this study do not eonfirll1 the sub-organellar distribution of cal pain 1
and it is likely that the calpain 1 is n1erely associated with the outcr nlitochondrial
111enlbrane.
The n1itochondrion is a highly conserved organelle and is esscntial for various
biochenlical pathways involved in cellular 111etabolisll1 and prograll1n1ed cell death.
Cii ven this, it is feasible to suggest that lllitochondrial proteins are those that have been
selected for over tinle and should be represented in son1e fonn in 1l10re prinlitive life.
Indeed, \vhcn one observes the lower eukaryotes such as the protozoan parasites,
dranlatic sinli larities between 11litochondrial proteins and processes can be seen \vhen
c0111pared to 1110re conlplex eukaryotes such as C'acnorhahditis e/eRolls, Drosophilio
nic/ullogastcr, and the vertebrates. Recently, Arnoult ct al have identi fied the release of a
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prinlitivc cysteine protease fronl the internlenlbrane space of the giant 111itochondrion of
the parasite

Leis/znulIli{l 1l1qjor (513).

The authors identified a calpain-like sequence in

the kinctoplastid database and were also able to denlonstrate the cleavage of a kno\\/n
calpain substratc, PARP (involved in DNA repair). These observations fronl lower
cukaryotes suggest thc evolutionary conservation of calpain-like proteins in the
nlitochondrion and underscore the inlportance of these proteases in physiological and/or
pathological processes.

Project Rationale. As described

above~

acute renal failure (ARF) is a devastating

disease resulting in nlortality rates of 50% or greater. Years of research have linked the
pathology of ARF to nunlerous nlechanisnls, of which Ca2+ overload, calpain activation,
and nlitochondrial dysfunction appear to be key players. The downstreanl events
follo\ving renal ischenlia have nunlerous features, of which nlany can be tied to the
activation of intracellular calpains. Renal ischenlia leads to increased cytocolic calciunl
\vhich not only activates cytosolic calpains resulting in nlenlbrane disruption, but also
results in increascd nlitochondrial calciunl levels. Ischenlia-induced nlitochondrial
dysfunction can be due to a nunlber of factors including oxidative stress and
phospholipase activation, however, the increase of intranlitochondrial calciunl levels are
pcrhaps thc nlost destructive due to disruption of electron transport, induction of the
1l1clllbrallc pernleabi 1ity

trallsition~

and release 0 f proapoptotic proteins into the cytosol.

Nunlcrous lines of evidence have placed the nlitochondrion at the center of both
the necrotic and apoptotic cell death pathways. In forn1ation concerning the roles of the
calpain isofornlS in cell death has also been forthconling in the last 20 years. Calpain
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activation has been sho\vn to induce both necrosis and apoptosis under various conditions
and blockade of its activity is cytoprotective in lllany experinlental nlodels. Since the
early 1980s, nloul1ting evidence has supported the idea that the nlitochondrion possesses
an endogenous calpain isofornl and nlay also be the target of calpain translocation after
injury. The presence of a Ca 2+-inducible nlitochondrial ca1pain would provide great
insight into the nlechanisnls ofCa 2+-induced nlitochondrial dysfunction during ischen1ic
renal injury and n1ight also provide a novel patll'vVay for therapeutic intervention in ARF.
In this study I sought to unequivocally identify an endogenous Illitochondrial
calpain isolated fron1 renal proxinlal tubule lllitochondria and to identify its role during
ca1ciull1 overload, an event known to occur during renal ischenlia/reperfusion injury.
also proposed to identify nlitochondrial substrates for this calpain and to evaluate the
effects of decreased protein expression of the isoforn1 discovered. Future laboratory
endeavors \vil1 be designed to develop an inhibitor specific for the nlitochondrial calpain
in efforts to selectively block n1itochonclrial dysfunction during renal
ischen1ia/repcrfusioll inj ury.
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CHAPTER 2
C,i\LPAIN 10: A MITOCHONDRIAL CALPAIN AND ITS ROLE IN (~A2+_
INDUCED MITOCHONDRIAL DYSFUNCTION

ABS'TR.t\(~T

2t

Calpains~ Ca -activated cysteine proteases~ are cytosolic cnzynlcs inlplicatcd in

nLinlerOLiS cellular functions and pathologies. We identified a nlitochondrial Ca 2 'inducible protease that hydrolyzed a calpain substrate (SLL VY -AMC) and was inhibited

by active site-directed calpain inhibitors as calpain 1O~ an atypical calpain lacking dOlllain
IV. Inlnlunoblot analysis and activity assays revealed calpain lOin the nlitochondrial
outer

nletnbrane~

internlenlbrane space, inner nlenlbrane~ and 111atrix fractions.

Mitochondrial staining \vas observed when C-tern1inal GFP-tagged calpain 10 \vas overexpressed in NIH-3T3 cells and the n1itochondrial targeting sequence \vas localized to the
N-tcrnlinal 15 an1ino acids. Over-expression oftnitochondrial calpain 10 resulted in
nlilochondrial swelling and autophagy that was blocked by the n1itochondrial
pCrlllcabilily transition (MPT) inhibitor cyclosporine A. Using isolated lllitochondria,
C'a~' -induced M PT \vas partially decreased by calpain inhibitors. More Inlportantly.
C' a2- -induced inhibition of Conlplex I of the electron transport chain was blocked by

calpain inhibitors and two Conlplex I proteins were identified as targets of nlitochondrial
calpain 10, NDUFV2 and ND6. In conclusion, calpain lOis the first reported

1l1itochondrially-targeted calpain and is a n1ediator of 11litochondrial dysfunction through
the cleavage of C'olllplex I subunits and activation of MPT.

INTRODUCTION

Calpains. Ca 2 activated cysteine proteases. are involved in a nun1ber of
-1-

physiological and disease processes: calpains are linked to the pathogenesis of
Alzheilller's disease, cataracts, linlb-girdle n1uscular dystrophy, gastric carcinonla, and
Type II diabetcs (245). Calpains cleave diverse protein species including receptors (419),
ion channels (514,515), cytoskeletal conlponents (235, 516-518), proteases (410,519,
520). oncogenic proteins (521), and cell signaling n10lecules (386,522). Calpains also
are thought to participate in the induction of cellular necrosis in variolls cell types (54,
523-525) and in thc regulation of apoptosis through interactions with p53, Bid, and
caspase 3 ( 10, 519, 521). Unfortunately, in nlany cases the specific calpain responsible
for these cellular actions and disease processes has not been identified.
Whi Ic calpains are a 14-n1cn1ber fan1ily, only a few calpain isoforn1s have been
studied extensively. Calpains 1 and 2 are ubiquitously expressed cytosolic cnzyn1cs that
dilllcrizc vv'ith a sn1all calpain subunit (calpain 4). Calpains 1 and 2 are approxin1ately 80
kDa and consist of four don1ains (I-IV). 00111ain I is an autolytic don1ain often cleaved
during calpain activation. 00n1ain II contains the catalytic active site where histidine,
cysteine, and asparagine residues critical for proteolysis are located. 00n1a1n III has a
C2-like phospholipid-binding don1ain, and 00n1ain IV contains a Ca 2 + -binding penta-EFhand n10ti r COn11l10n to 1l1any Ca 2 -binding proteins. Calpains arc conln1on Iy separated
+-

into tvv'O groups, typical and atypical, based on the presence or absence of Donlain IV'

(245). The absence of a typical don1ain IV n1ay in1part novel

functions~

substrate

affinities, and activation/inhibition Inechanisn1s to the n10re understudied atypical
calpains (258).
\\1hjJe caJpajns are generaJJy thought to be cytoso)jc proteins. Hood e/ {II has
suggested that calpain 1, previously thought to be solely cytosolic, also localizes to golgi
and ER n1en1branes (526). Moreover, there are nun1erous reports of a n1itochondrial
calpain-like activity

(230~

231,233,408,512,513,527). However, cytosolic

contan1ination of the n1itochondrial preparations has been a concern, and investigators
have inconsistently described the sub-nlitochondrial location of this calpain-like activity
(nlatrix fraction versus internlen1brane space). At this tiIne, a specific n1itochondrial
calpain has not heen identi fled.
The function of a putative n1itochondrial calpain has not been elucidated.
Ho\vever Ca 2- -sensitive proteolytic activities in n1itochondria have been associated \vith
t

the cleavage of RXR-a (512), pre-ornithine transcarbanlylase processing (510), cleavage
of nuclear PARP and aspartate an1inotransferase (511), and induction ofMPT (408,527).
Further, n1itochondria are dynan1ic organelles participating in cellular Ca

2
+

regulation and

are capable of buffering large al1l0unts of cytosolic Ca2+ (528). Mitochondrial Ca

21

uptake is known to induce the 1l1itochondrial pernleability transition (MPT) and
nlitochondrial dysfunction (529, 530). In the present study, we have taken a nlolecular
approach to identity the n1itochondrial calpain and have evaluated its role in
nlitochondrial dysfunction.
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MATERL4LS AND METHODS
lVIitochond rial Isolation and Fractionation.

Kidney n1itochondria were isolated froll1 n1ale Sprague Dawley rats (C'harlcs
River

Laboratories~ Wiln1ington~

(Myrtlc~s

MA) (250 g) and fen1ale New Zealand white rabbits

Rabbitry, Thon1pson Station, TN) (2 kg) as previously described

(162~

531).

Briefly, kidney cortex \vas n1inced and hOll10gellized in ice-cold Buffer A (0.27 M
sucrose, 5 n1M Tris-HCI, 1 n1M EGTA, pH 7.4). Nuclei and cellular debris \vere pelleted
by centri fugation at 600 x g for 5 n1in. The supernatant was centrifuged at 7700 x g for 5

n1in resulting in a crude n1itochondrial pellet. The pellet was washed once in ice-cold
0.27 M Sllcrose and resuspended in Buffer B (130 n1M KCl, 9 n1M Tris-P04, 4 111M Tris-

Hel, 1 111M EGT A, pH 7.4). Crude n1itochondria were then layered onto a
sucrose/Percoll gradient and centrifuged at 20,000 x g for 20 n1in.
Puri fled renal cortical n1itochondria (RCM) were subfractionated as described
previously (532). Outer n1en1brane rupture was achieved by hypotonic lysis in icc-cold
BulTcr (' (10 111M KH 1 P0 4 , pH 7.4) for 20 n1ill at O°C. Mitoplasts were separated fron1
the supernatant by centri fugation at 7 ~ 700 x g for 5 ll1in. The outer ll1cll1brane fraction
was obtained by centrifugation of the supernatant at 54,000 x g for 30 n11n. The resulting
pellet \vas resuspended in ice-cold Buffer D (300 111M sucrose, 1 111M EGT A, 20 n1M
MOPS, pH 7.4) and sonicated five tin1Cs ill 30 s bursts. Inner n1en1brane and n1atrix
fractions were then separated by centri fLIgation at 54,000 x g for 30 n1in. Outer and inner
nlen1branc fractions were resuspended in Buffer D. Fraction purity was assayed via
nlarkcr cnzynlc analysis (outer n1enlbrane

~--

1110noanline oxidase, intern1cn1branc space

adcnylate kinase, inner nlen1brane-- cytochron1e oxidase, Inatrix

fUI11arasc). The

activities ofl11onoanlinc oxidase (533), adenylate kinase (534), cytochron1c oxidase
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~

(535)~

and funlarase (536) \verc deternlined by standard 111ethods. Fractions \vere frozen

at -70°C for subsequent inlnlunoblot analysis.

Calpain Activity.

Calpain activity vv'as assayed spectrophoton1ctrically using the calpain-spcci fic
substrate SLLVY -AMC (Bachen1), as previously described (292). Whole, energized
1l1itochondria (200 pg) were diluted in Buffer B and incubated with various
cOllcentrations ofCaCb in the presence of 50

~lM

SLLVY-AMC. Activity was nleasurcd

under linear conditions as a function of AMC hydrolysis using excitation and cnlission
\vavelengths of 355 and 444 nn1, respectively. RCM incubated in the absence of
substrate exhibited the san1e fluorescence as Buffer B alone.

Respiratory Conlplex Activity.

Conlplex I enzyn1e activity was n1easured as previously described (537). The
assay n1ediull1 was COll1posed ofantinlycin l\ (2
(130

~lM L KC'N (2

~lg/n11),

ubiquinone (65 pM). NADH

n1M) in a phosphate buffer (25 111M potassiull1 phosphate, 5 lnM

MgCI 2, 2.5 nlg/nll BSA, pH 7.2). ReM (20-50

~lg)

were then added and NADH

ox idation was nleaSllred spectrophoton1etrical1y at 340 nn1 for 3-5 l11in before the addition
of rotenone (2

~lg/n11).

Absorbance changes were n1easured for another 3 n1in. and

Conlplcx I activity reported as the rotenone-sensitive NADH:ubiquinone oxidoreductase
acti vity.
Conlplex II enzyn1e activity was n1easured as previously described (537). Briefly,
RCM (20-50 pg) \vere preincubated in assay n1edia (25 n1M potassiun1 phosphate, 5 111M

75

MgCb~

pH 7.2) and 20 n1M succinate for 10 n1in at 30

(2 n1M), rotenone (2

~lg/n11),

o

e.

Anti111ycin A (2

and 2,6-dichlorophenalindophenal (50

~lM)

~lg/n11)~

KCN

\vere added, and

absorbance at 600 nn1 recorded for 3 n1in. The reaction was then initiated with
ubiquinone (65

pM)~

and absorbance n10nitored far 3-5 n1in.

COl11plex III activity was n1easured as previously described (537). Briefly,
cytochron1c c (III) (15
llbiqllinol-.2 (35
MgCI~,

~lM)

~lM),

rotenone (2

~lg/n11),

dodecyl-b-D-111altoside (0.6 111M), and

\vere added to assay ll1edia (25 111M potassiun1 phosphate, 5 111M

2.5 111g/1111 BSA (fraction V), 2 111M KCN, pH - 7.2) and the nonenzyn1atic rate or

reduction of cytochron1e c ll1easured for 1 111in at 550 n111. To initiate the reaction, ReM
(5-.20

~Lg)

\vere added, and the initial increase in absorbance was 111easured for.2 n1in.

Measurenlent of ReM Oxygen Consumption (Q02).

Oxygen consu1l1ption \vas 1110nitored as previously described (531) using a sixchanlbered oxyn1cter and con1puter interface (Strathkelvin, 1110del

928~

Glasgo\v. lJK).

RCM were suspended at approxin1ately 1.3 nlg protein/n11 in n1itochondrial incubation
butTer \vith pyruvatc/n1alate (5/5 111M) as the respiratory substrates. In son1e eXperil11cnts,
succinate (10 n1M) or ascorbic acid/TMPD (5/0.5 111M) were added in the presence of 100

pM rotenone (a C'ol11plcx I inhibitor) or 2.5

~lM

antin1ycin A (a Con1plex III inhibitor),

rcspectively. ReM were gassed (5% C0 2 /95 % O 2 ) for 5 111in prior to treatn1cnts and
111eaSUren1ent ofrcspiration. The respiratio11 chall1ber was ll1aintained at 37°(, and stirred
n1agnetically ..After the basal rate (state 4) of O 2 consun1ption was deternlined, ADP
(final concentration=1 n1M) \vas injected to obtain state 3 respiration. Only nlitochondria
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with respiratory control ratios (RCRs- state 3/state 4) 2: 4 were used for cxperinlcnts to
ensure that test nlitochondria \vere tightly coupled.
In son1e experin1ents, respiration n1easuren1ents were perforn1ed in the presence
or absence of 1 ~LM Ca 2+ over various tin1e courses. For inhibition experin1ents, calpain
inhibitors were added 30 n1in prior to the addition of 1 pM Ca 2+ and respiration nlcasured
after 5 n1in. Ca 2+ 'Nas added to Buffer B in all experinlents such that Ca 2+ concentrations
vvcre n1aintained at 1 ~lM.

[\11 itoehn nd rial S,velli ng.
RC~M

swelling was assessed spectrophoton1etrically as previously describcd

(230). Briefly, RCM \vere suspended at a final concentration of 1 n1g/n1l of
nlitochondrial protein in Buffer B supplen1ented with pyruvate/n1alate (SIS n1M) and
absorbance n1caSlired for 10 n1in at 540 nM. After basal n1eaSllren1ents were taken, Ca 2+
was added (1 ~lM final sustained Ca 2+ concentration) and absorbance was n10nitored for
an additional 5 n1in and swelling rates

(~A/n1in)

detern1ined.

Zynlography.

Zyn10graphy was perforn1ed as previously described (538) \vith n1inor
1110di fications. Zynlogran1 gels were cast inlll1ediately prior to electrophoresis and
consisted of a 10°1<) non-denaturing acrylanlide resolving gel and an 8% stacking gel.
Resolving gels \vcre copolyn1erized with the calpain substrates FITC-casein (10 nlg/n11)
or SLLVY-AMC (50
1 and 2 (2

~Lg)

~lM).

RCM protein sanlples (200

~lg)

and purified porcine calpains

(Calbiochcll1) \vere loaded and subjected to electrophoresis in a non-
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denaturing funning buffer (125 n1M Tris-base, 625 111M glycine, 5 111M EGTi\, pH 8.0) at
120 \/ for 2 hours at 4°C. Gels were subsequently bathed in Ca 2+ incubation buffer (50
111M Tris-HCL 5 111M CaCb, 10 n1M 2-n1ercaptoethanol, pH 7.0) overnight at 4°C and
in1aged on an Alpha Innotech in1aging station fitted with a FITC filter.

I1l11l1U noblotti ng.

Isolated RCM fractions were sUbjected to SOS/PAGE (4-12 % acrylan1idc) and
transferred to nitrocellulose n1elllbranes. Men1brancs were incubated with prin1ary
antibodies to n1-calpain,

~l-calpain,

calpain 10, NOUFV2, OAP 13, and N06. The

prin1ary antibodies used were n1011oclo11al rabbit a11ti-hun1an n1-calpain (Affinity
Bioreagents -- 1: 10(0), rabbit anti-hun1an n1-calpain (doll1ain IV) (Calbiochen1 -- 1: 10(0),
rabbit anti-hun1an

~l-calpain

(don1ain III-IV) (Abcan1 - 1: 10(0), rabbit anti-rat calpain 10

(dolllain II) (generously provided by Ton1 Shearer, Oregon Health a11d Science
University, Portland, OR -- 1:2(0), rabbit anti-hun1an calpain 10 (don1ain IIr) (Abcan1 I: I DOO), rabbit anti-rat calpain 10 (don1ain II) (Biogenesis -- 1: 1000), rabbit antiNDUFV2 (generously provided by Dr. Yan1aguchi, The Scripps Research Institute, La
Jolla, C A

1:200), n10noclonal n10use anti-hun1an DAP 13 (Genway Biotech, Inc ...

pglJl1L). and 1110noclonal n10USC anti-hun1an NOC) (Molecular Probes -- 1 ~lg/n1L).

Antibody incubation was followed by a horseradish peroxidase-conjugated goat antirabbit secondary antibody (Santa Cruz - 1: 10(0). Inln1unoreactive protein \vas visualized
by enhanced chen1ilun1inesence (Anlershanl) and inlaged using an Alpha Innotech
in1aging statiol1.
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Plaslnid Construction.

cDNA ft)r hU111an calpain lOa (8C004260) \vas obtained fron1 ATCC in the
pOTS7 shuttle vector. Full length calpain 10 was anlplified by PCR (Sense: 5"TGGGAGCCCGCGGAGCCGAG-3'" Antisense: 5'-

TeATC' ACTGCCA TGACGGAGACCTC-3 ') and subcloned into pcDNA3.1-TOP()TA-C'T-GFP (pcDNA3.1-C APN 1O-GFP) (Invitrogen) producing a calpain 1O-GFP fusion
product (C-ternlinal GFP). GFP control plasnlids coding for cytosolic GFP and
ll1itochondrially targeted GFP (cytochroll1e oxidase IV signal sequence) \vere generous
gifts fron1 Dr. Douglas Sweet (Medical University of South Carolina, Charleston, SC).

('oI11pleI11cl1tary DNA sequences coding for the N-tern1inal 15 an11no acids of
calpain 10 were generated, annealed, and ligated into pcDNA3.1-TOPO-T A-CT -GFP
(pcDNA3.1-TS-GFP) to assess N-tenninal sufficiency for 111itochondrial targeting. The
negative control for this experin1ent \\I'as obtained via ligation of the above sequence into
pcDNA3.1- TOPO-T A-CT -GFP (pcDNA3.1-TSINV -GFP) in the reverse orientation.

Cell culture and Transfection.

NIH-3T3 fibroblasts were n1aintaincd in Dulbecco's Modified Essential Mediun1
(DMEf\1) containing 10°i<) fetal bovine serun1 until confluent. Cells were split and plated
onto 35-111n1 confocal dishes (MatTek) at a density of250,000 cells/plate. At 70%
conflucnce, cclls \verc transiently transfected with 1 ~Lg pcDNA3.1-CAPN 1O-GFP,
pc[)N A3.1-TS-GFP, or pcDNA.3.1-TSINV -GFP plasn1id constructs using Lipofectan1inc
2000 (Invitrogen). Selected plates were treated with 6

~LM

cyclosporine A, 5 n1M 3-

n1cthyladeninc (3-MA), or vehicle (DMSO) 4 hr after transfection. Cells were incubated
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for 24 hr and, vv'he11 indicated, exposed to 50 nM MitoTracker Red (Molecular Probes)
and/or 100 nM LysoTracker Red (Molecular Probes) for 20 n1i11 prior to confocal
nlicroscopy inlaging. Cells were in1aged using a Zeiss LSM 5 confocal l11icroscope using
l11ultiplc tracks to elinlinate fluorescent crosstalk.

Statistical Analysis.

RCM isolated fron1 one rabbit represent one experinlent (11= 1). The appropriate
ANOV A \vas pcrforn1cd for each data set by using Sign1aStat statistical soft\varc.

Individual n1eans were con1pared with Fisher's protected least significant difference test
with PS;O.05 being considered a statistically significant difference betw'een nlcan values.
Means \Nith different lettered subscripts within groups are significantly different fronl
cach other, PS;O.05. Linear regression w'as also perfornled by using Signla Stat statistical
sof1\varc.

RESUL1'S
Calpaill Activity in Isolated \1itochondria and Submitochondrial Fractions.

To detenlline the presence of calpain activity, rabbit RCM were incubated \\'ith
increasing concentrations of Ca~-t- in the presence of the calpain substrate SLL VY -Ai\vlC.
ReM cleavage of SLLVY -AMC occurred in the absence of added Ca

2

+,

was linear over

tinlC (data not shown), and increased in the presence of increasing Ca 2+ concentrations
(Fig. 2-1 A) to a nlaxinlunl of 120(~} of control at 10 pM Ca 2+. The addition of increasing
concentrations of the Ca 2+ chelator EGT A to RCM pern1eabilized with O.5(Yo digitonin, in
the presence of 1 ~LM Ca 2+, produced a nlaxinlal 50°1t) decrease in SLLVY -AMC
hydrolysis (Fig. 2-1 B). Blockade of the Ca 2+ uniporter with rllthenillll1 red also inhibited
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Ca~j-induccd hydrolysis of SLLV'{ -AMC in RCM (Fig. 2-1 C). Ca~+-activatcd SLLC'.!-

AMC hydrolysis \vas inhibited in a concentration-dependent nlanner by the calpain

inhibitors calpeptin and E-64, but not by the calpain inhibitor PD150606 (Fig. 2-1 D).
These data reveal that RCM exhibit basal calpain activity, that exogenous Ca~+ increases
calpain activity in a rutheniunl red-sensitive nlanner, that calpain activity exists in the
absence

0

r Ca:2+, and that the calpain inhibitors calpeptin and

E-64, but not PD 150606,

blocked the calpain activity. Because rutheniunl red blocks Ca 2+ uptake across the
111itochondrial inner nlenlbrane and the increase in calpain activity produced by
exogenous Ca

2f

\vas rutheniunl red-sensitive, \ve suggest that the calpain activity is

located in the nlitochondrial ll1atrix. Because the calpain activity \vas insensitive to
PO 150()06 which binds to don1ain IV of typical calpains (298), we suggest that the ReM
calpain lacks the penta-EF-hand don1ain and is a nlenlber of the atypical calpain fan1ily.
To detern1ine which sub-nlitochondrial fraction(s) contain calpain activity, RCM
\VeIT

fractionated into outer nlen1brane, internlen1brane space, inner nlen1brane, and

nlatrix ft'actions. Marker enzynles (lTIOnOanline oxidase - outer n1en1brane, adenylatc
cyclase -- intern1en1brane space, ctyochron1e oxidase -- inner n1en1brane, fun1arase 1l1atrix) \vcre used to assess n1itochondrial fraction purity (Table 2-1). Ca2-r-activatcd
hydrolysis of SLL VY -AMC was observed in each fraction with the outer 111Cnlbrane
having the highest activity and the n1atrix the least on a per nlg protein basis. Maxitnal
activity 'Nas observed at 2 111M Ca2-+- in the outer 111en1bralle and at 10 111M for the
rCI11aining three fractions (Fig. 2-1 E). These results reveal that calpain activity is present
in nlultiple n1itochondriallocations.
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Figure 2-1. n.CM calpain activity.
(A) Coupled RC'M (200 pg) were incubated vvith the calpain suhstrate SLLVY-AMC (50

pM) and increasing concentrations ofCaCb. and fluorescence 111casured for 6 n1il1 at 25
°e. (B) ReM calpain activity vvas 111casured in 0.50/0 digitol1in-pern1eabilizcd
n1itochondria in the presence of 1 pM CaCl~ and increasing concentrations ECiT/\, (C)
ReM calpain activity \vas nleasured in whole nlitochondria in the presence of 1 ~LM
CaCI~ and increasing concentrations of rutheniun1 red. (0) RCM \vere pretreated f()r 20
n1il1 on ice \vith increasing concentrations of calpeptin (closed circle). E-64 (open
triangle). and PI) 150606 (open dianl0nd). and subsequently assayed for 1 pM C~a~-j
induced hydrolysis of SLL VY -AMC. (E) Purified nlitochondrial fractions (open circle ~
n1atrix. closed circle - outer n1enlbrane. open triangle - internlen1branc space. closed
triangle - inner n1en1brane) \vere assayed for SLLVY-AMC hydrolysis in the presence or
increasing (;a~+ concentrations (0-10 111M). Data are expressed as 111eans ± SEM (N=3).
Means \vith different lettered subscripts \\1ithin each group are significantly different fron1
each other. /)<0.05.
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FITC-cascin zyn10graphy is a technique con1n10nly used to evaluate calpain
activity in cell lysates. We cll1ployed this technique to evaluate calpain activity in rabbit
ReM fractions and in the cytosol fron1 renal cortical cells. Equal anlounts of total protein
(200

~Lg)

rrOn1 cytosolic, n1itochondrial, and subn1itochondrial fractions were loaded into

individual 7yn10gran1 gels. Two bands of activity were observed in the cytosol
corresponding to calpains 1 and 2 (Fig. 2-2A), both known to exist in the cytosol of renal
proxinlal tubule cells (235). However, no bands were detected in the san1ple lanes for
\vhole nlitochondria or n1itochondrial subfractions, suggesting that the nlitochondria
harbored no endogenous calpain 1 or 2, that the ll1itochondrial preparation \vas fi-ce of
cytosolic contan1ination, and that n1itochondrial calpain exhibits a substrate speci ficity
different fronl that of the typical calpains.
We n10dified this assay to evaluate ll1itochondrial calpain activity by replacing
FITC-casein \vith SLLVY-AMC (a known ll1itochondrial calpain substrate ill l'ilro) as the
calpain substrate. AMC is liberated by proteolytic activity to generate fluorescent bands
in the gel. Purified calpains 1 and 2 were used as controls and fluorescent bands \vere
identified in the presence ofCa 2 + (Fig. 2-28). No fluorescent bands vvere observed in the
outer n1enlbranc and intern1cn1brane space fractions in the presence of Ca 2 +. In contrast.
one strongly fluorescent band and two weaker bands were observed in the nlatrix
fraction. One weaker fluorescent band of activity was identified in the inner nlen1branc
that co-nligrated \vith the bands in the n1atrix fraction and n10st likely represents fraction
in1purity (Table 2-1). These results reveal three distinct calpain activities in the n1atrix
fraction that arc Ca 2+-inducihle and are different than calpains 1 or 2. No activity \vas
observed in the outer n1en1brane and intern1en1brane space fractions.
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Table 2-1. Specific activity of marker enzymes in mitochondrial subfractions

Table 2-1. Relative specific activity of marker enzymes in mitochondrial subfractions
Fraction

Outer membrane
Intermembrane Space
Inner Membrane
Matrix

Monoamine
oxidase

Adenylate
kinase

Cytochrome
oxidase

Fumarase

100
20±1
11 ±2
1±1

9±2
100
21±5
19±3

3±1
5±2
100
2±1

9±2
1S±4
17±3
100

Enzyme activites were determined in the mitochondrial subfractions as described in the Materials and Methods.
The highest specific activity was normalized to 100% for each marker enzyme tested. Data represent the
Mean ± S.D., (n=5).
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Figure 2-2. Zymographic analysis of ReM calpain activity
R M sub-fractions were assayed for Ca2+-induced calpain activity usin g (A) FITC -casein
and (8) SLLVY -AMC zynlography. Reco111binant porcine calpain 1 and :2 (2 ~lg).
cytoso lic. nd RCM fractions (200 ~lg) were loaded and subjected to non-denaturing
PAGE. Gels were ubnlerged in a 10 n1M Ca 2+ bath for 10 n1in at 4°C and inlaged using
an Alpha Innotech i111aging station. Results are representative of five indi vidual
xp rinl nts. (Ahhrc1 ialions:
C l-calpain 1 C2-calpain 2, Cyt-CytosoL MitMitoch ndri a. OM-outer nlenlbrane, IS-internlenlbrane space, 1M-inner nlenlbrane. Matnlatri x)
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Identification of ('alpain lOin ReM Subfractions.

The protein localization algorithnl MITOP2 (http://ihg.gsf.de/n1itop2/starLjsp)
\vas used to dctenl1ine which of the 15 calpain isoforn1s would be predicted to localize to
nlitochondria. While a negative score using this algorithnl does not exclude the
possibility ofnlitochondriallocalization~ this algorithnl only returned a positive score far
c<1lpain 10. Cytosol ic and ReM fractions fron1 rabbit and rat kidney cortex \vcre probed
far calpain 10 with three separate antibodies directed against different calpain 10 donlains
using i111111unoblot analysis. The presence of calpains 1 and 2 also were cxanlined. A 75
kDa band \vas identified in all rabbit and rat ReM fractions using all three calpain 1()
antibodies~

albeit at different levels (Fig. 2-3A). An inlnlunoreactive band also v/as

identi fied in the cytosol using an antibody against calpain 10. Inlnlunoblots probed \vith
antibodies against calpains 1 and 2 revealed inlnlunoreactive proteins against thcir
respective purified proteins and cytosol but not in any of the ReM fractions (Fig. 2-3A).
These results reveal that calpain 10 also resides in the n1itochondria in at least two
species (rabbit and rat), and is present in all ReM fractions. Further, the bands of
illllllullorcactivity are consistent with the largest calpain 10 isoforn1 (Calpain lOa - 75
kOa) (539), indicating the absence ofnlitochondrial inlport signal cleavage.

The strong fluorescent band identified in the nlatrix san1ple following
zYlll0graphy \vas eluted and subjected to SDS/PAGE and inlnlunoblot analysis using an
anti-calpain 10 antibody (Fig. 2-38). These results reveal that the nlitochondrial nlatrix
calpain activity observed during zYll10graphy is calpain 10.
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Figure 2-3. C:alpain 10 is expressed in multiple mitochondrial subfractions.
(A)
Rat and rahhit RC'M suh-fractions (50 ~lg). cytosolic fractions (50 pg). and
ITC0l11hinant porcine calpains 1 and 2 (I ~lg) \vere subjected to SDS/PACj I: and then
in1111Ullohlotted 'vvith allti- calpain 10 (dIIA). anti-calpain 10 (dIIB). anti-calpain 10 (Td0I11uin). anti-calpain 1. and anti-calpain 2 antihodies. as indicated. (8) Follo\ving
cal pai n zynlography. protein fronl the active enzynlatic band indicated abovc \,vas
extracted and subjected to SI)S/PAGE and inlll1unoblotted with the anti-calpain 10 (dIIB)
antibody. Results are representative of three independent experilllcnts. eA hhreriu{ ions:
C l-calpain 1. (12-calpain 2. ()M-outer nlenlbrane. IS-internlell1brane space. 1M-inner
nlcn1branc. Mat-nlatrix. Cyt-C'ytosol)
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Calpain lOis Targeted to Mitochondria via an N-terminal Targeting Peptide.

Hun1an calpain lOa was subcloned into a TOPO-TA-CT-GFP vector (Invitrogen)
to produce a calpain 1O-GFP fusion protein containing an intact N-tern1inlls and a Ctcrn1inal GFP n10iety. This construct was chosen to avoid n10dification of the N-tenninus
which could result in the loss of putative n1itochondriallocalization n10tifs.
NIH-3T3 cells were transfected with the pcDNA3.1-CAPNI0-GFP construct
exposed to MitoTracker and/or LysoTracker Red, and in1aged via confocal 11licroscopy.
Cells also \vere transfected using GFP constructs specific for cytosol (data not sho\vn) or
lllitochondria (Fig. 2-4A) to serve as positive GFP controls for these con1partn1ents.
During initial experin1ents, we observed two distinct popUlations of cells after
transicction \vith the CAPN 1O-GFP construct. All transfected cells den10nstratcd GFP
expression that \vas localized to intracellular conlpartn1ents with

S0l11C

being punctuate ill

nature and others cxhibiting larger globular patterns of GFP expression. The latter of
these t\VO groups of cells exhibited altered cellular n10rphology, decreased plate

3dhesion~

and the fornlation of autophagocytic vesicles as shown by costaining with LysoTrackcr
Red (Fig. 2-48). The fornler of these two groups of cells exhibited norn131 cellular
Illorphology but contained swollen n1itochondria (Fig. 2-4C) conlpared to
1l1itochondrially-targetcd GFP controls (Fig. 2-4A). These data reveal the targeting of
calpain 10 to the nlitochondria and suggest that calpain 10 nlay playa role in
nlitochondrial dysfunction and/or s\velling as evidenced by the changcs seell in
Illitochondrial 1110rphology.
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Figure 2--'" C:alpain 1() translocates to mitochondria and induces mitochondrial
s\vclling.
NIH-3T3 fibroblasts \vere used for all transfections because of their distinct elongated
1l1itochondrial n10rphology. (A) Cells were transfected with a control 111itochondriallytargeted green fluorescent protein (Mito-GFP) construct and subsequently stained w'ith
MitoTracker Red. (8) Cells were transfected w'ith pcDNA3.1-CAPN lO-GFP. and
subsequently stained ~:ith LysoTracker Red. This panel depicts cells den10nstrating
glohular patterns of (JFP localization which colocalize with LysoTracker Red. (C) Cells
were transfected with pcDNA3.1-CAPN 1O-GFP. treated ~rith vehicle (DMSO) 4 hr later.
and subsequently stained \vith MitoTracker Red. These cells represent the n1ajority of the
cell population. show· n1itochondrial GFP staining. and retain their norn1al cellular
1l10rphology in culture. (D) Cells were transfected with pcDNA3.1-CJ\PN I O-l'FP.
treated 'vvith cyclosporin A (6 ~lM) 4 hr later. and subsequently stained with MitoTrackcr
Red. (E) Cells \vere transfected with pcDNA3.1-CAPN 10-GFP. treated \vith 31l1ethyladeninc (10 n1M) 4 hr later. and subsequently stained with MitoTracker Red.
Results are representative of three independent experin1ents. The 'Alhite bar in panel A
represents a distance of 20 pn1.

Mito-GFP

MitoTracker Red

Calpain 10-GFP

LysoTracker Red

Calpain 10-GFP

Overlay

Overlay

Overlay

MitoTracker Red
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Enlargement

To test the hypothesis that the N-ter111inus of calpai11 lOis responsible for
111itochondrial

10calizatio11~

oligonucleotides coding for the first 15 N-ternlinaI al11ino acid

residues (Figure 2-58) were annealed and ligated into the TOPO-TA-CT-GFP vector.
Negative controls included the san1e oligonucleotides inserted in the reverse orientation.
NIH-3T3 cells transfected with these constructs displayed cytosolic targeting and
111itochondrial targeting for the reverse and forward

orientations~

respectively (Fig. 2-5/\.).

These results reveal that the N-ternlinal 15 a111ino acids of calpain 10 are sufficient for
111itochondrial targeting. We also analyzed the N-ternlinus of calpain lOusing the LaTeX
soflvv'arc package TeXtopo designed to display peptide sequences in an alpha helix
representation (Figure 2-58). The results revealed that the N-ternlinus of calpain 10 can
fornl the classical n1itochondrial targeting 1110tif, the a111phipathic helix.

,\'litochondrial S\velling Induced by Over-expression of (~alpain lOis Sensitive to
Cyclosporine A and 3-lnethyladeninc.

A.s discussed above, over-expression of ca1pain 10 resulted in the conversion of
the llornlaI branched reticular 111itochondrial n10rphology of control cells (Fig. 2-41'\.) to
that

ofslnaller~

round and swollen organelles (Fig. 2-4C). Thus, we hypothesized that the

calpain 1O-induced nlitochondrial swelling n1ay be sensitive to cyclosporine

1~

(an

inhibitor of 1'v1PT (540») or 3-nlethyladenine (an inhibitor of MPT and autophagocytosis
(540)).

C~ells

were transfected with the calpain 1O-GFP construct, treated vv'ith

cyclosporine A or 3-nlcthyladenine, and the n1itochondria exa111incd by confc)cal
111icroscopy. Cyclosporine A and 3-nlethyladenine preserved the nornlal branched
111itochondrial n10rphology and integrity (Fig. 2-40 and 2-4E, respectively) as c0l11pared
to cells expressing calpain 1O-GFP alone, suggesting that calpain 10 l11ay n1ediatc
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11litochondrial swel1ing, in part, through the forn1ation of the MPT pore. Hovv'cver. M PT
fornlation \vas not exp1icitly exan1ined in these experill1ents and it is possible that the
nlitochondrial fl-agnlentation observed in our studies could also result fronl Initochondrial
depolarization. electron transport chain dysfunction, or changes in 11litochondrial fission
or fusion proteins.
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A
Inverted Seq-GFP

Targeting Seq-GFP

MitoTracker Red

Overlay
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Figure 2-5. The N-terminus of calpain 10 is required for mitochondrial targeting.
(A) NIH -3T3 fibroblasts were transfected with the pcDNA3 .1-TS-GFP and pcDNA3.1TSINV -GFP constructs. pcpNA3.1-TS-GFP-transfected cells were subsequently stained
with MitoTracker Red. Results are representative of three independent experiments. (B)
This helical wheel diagram shows a representation of the calpain 10 N -terminus as if it
were a helix using the TexTopo LaTeX package. The putative helix is amphipathic in
nature, containing hydrophobic and aliphatic residues on one half and positively-charged
residues on the other.
Adjacent to the helical wheel diagram is a schematic
representation of calpain 10 and its N-terminal 15 amino acids used to engineer the
calpain 10 targeting sequence-GFP construct (asterisks denote positively charged
residues). The white bars in panel A represent a distance of 10 f.lm.
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To further exanline the possible role of calpain lOin

MPT~

RC'M \vcrc treated

v.lith 1 ~LM Ca~( in the presence and absence of cyclosporine A or calpeptin, and RCM
s\vclling dctcrnlincd. The addition ofCa 2+-induced RCM swell1ng which \vas blocked by
cyclosporine A (Fig. 2-6A). Mitochondrial pretreatnlent \vith calpcptin blocked

-~JO{~)

of

Ca~i -induced RCM s\velling, indicating a role for calpain 10 in the fornlation orthe l\1PT

pore (Fig. 2-(8).

Calpain 10 lVlcdiat(~s CaH-induced Mitochondrial Dysfunction.

As sho\vn in Figure 48, calpain 10 over-expression resulted in fraglllcntcd
nlitochondrial nlorphology. This type of organellar derangenlent is seen not only during
MPT, but is also characteristic ofnlitochondria with danlaged or inlpaired C01l1pOncllts of
the electron transport chain (ETC) (541).

Thus~

calpain 10 nlay nlcdiate ETC

dysfunction. To test this hypothesis, RCM \vere isolated and suspended in incubation
buffer containing the 1l10del Conlplex I substrates pyruvate/nlalate (5/5 nlM). State 3
respiration \vas nlcasured over tinle after treatnlent with 1 ~LM Ca 2-+ in the presence of 1
111[\/1

ADP. State 3 respiration was unchanged under nornloxic and hypoxic conditions ill

the absence of C'a~ f (Fig. 2-7 A), and all future respiratory ll1easurenlents \verc pcrfornlcd
under nornlOX ic conditions. The addition of 1 ~LM Ca~+ produced a tinle-dcpendent
decrease ill ll1itochondrial state 3 respiration (Fig.

2-7B)~

and all subsequent experilllcnts

\verc conducted follo'Ning the incubation of RCM with 1 ~lM Ca 2+ for 5 nlinutes.
Pretreatlllent (30 nlin) of RCM with increasing concentrations of the active-site calpain
inhibitors calpcptin and E-64, but not the donlain IV calpain inhibitor PO 150606
preserved lllitochondrial state 3 respiration (Fig. 2-7C). Higher concentrations of E-64
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did not further preserve state 3 respiration. Sinlllltaneous nlcaSllrenlent of state 3
inhibition and ReM calpain activity denlonstratcd a strong correlation bet\vccn these t\VO
endpoints (Fig. 2-70),
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Figure 2-6. Mitochondrial calpain mediates Ca 2+-induced MPT.
1.
(A) Cyc losporin e A pretreatn1ent inhibit 111itochondrial w iling induced b-, 1 pM Ca- .
Basal n1itochondrial we lling wa n1onitored for 10 n1in afte r which Ca 2 -induced
. \vcl lin g wa. n1onitor d for an ad ditional S nlin. (8) R M \ N r pretreated 'vvith
calpcptin lor 30 n1in and 111itochondri al welling induced b treatnlent wi th 1 ~lM Ca-',
Swellin g 'vvas n1 eas llred a ' indicat d above. Data are ex pre sed a Ineans ± S -J M (N -=J),
Means with different lettered sub cript within eac h group are ignificantl y differcnt rr0111
each other. p<O.OS .
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2

Figure 2-7. Mitochondrial calpain mediates Ca +-induced respiratory dysfunction.
State J 111itochondrial respiration was 111casured using isolated RCM (].J nlg/n11) in the
presence and absence of' 1 ~lM Ca 2+ and various calpain inhibitors. (A) State J
Initochnndrial respiration \vas n1easured in the ahsence of Ca 2 t- under conditions or
norn10xia and hypoxia in the presence and absence of the COll1plex I substrates
pyruvatc/n1alatc (SIS n1M). (B) State 3 11litochondrial dysfunction \vas n1easured as a
function of tin1c in the presence of the Con1plex I substrates pyruvate/n1alatc (SIS Inrvl)
lT
and] pM Ca . (C) RCM \\"ere pretreated for 30 111in \vith a variety ofdissilnilar calpain
inhibitors. ReM \vere then challenged with 1 pM Ca l + for 5 n1in and state J
n1itochoncirial respiration nleasured. The calpain inhihitors calpeptin and E-64 protected
against state 3 dysfunction while PO 150606 did not. The solid and dashed lines represent
21
lnitochondrial state 3 respiration in the ahsence and presence of 1 ~lM Ca • respectively.
(D)
rv1 itochondrial state 3 dysfunction is positively correlated with increases in
111itochondrial calpain activity (1'2=0.93). Data are expressed as nlcans ± SEM (N=J).
Means with di fferent lettered subscripts within each group are significantly di fTerent 1'rOn1
each other. 17<0.05.
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To detennine the site of ETC dysfunction, isolated RCM were suspended in
incubation buffer containing pyruvate/nlalate (Conlplex I substrates), succinate/rotenone
(Conlplcx II substratc/Conlplex I inhibitor), or ascorbate-TMPD/antinlycin A (Conlpicx
IV electron donor/C'onlplex III inhibitor). RCM state 3 respiration was then nleasured
after trcatlllent with 1 ~lM Ca2+ for 5 n1in. Respiratory deficits were observed only in the
lreatnlcnt group containing the Conlplex I substrates (Fig. 2-8A). To veri fy these
findings,

\VC

pcrforllled specific COlllplex I, II. and III activity assays and detcrnlined that

only C0111plcx I activity was significantly decreased after Ca 2+ exposure (Fig. 2-88) and
that this activity could be preserved by pretreatlllent with calpeptin. These findings sho\v
21

that Ca -induced respiratory dysfunction is lilllited to Conlplex I under these conditions
and that electron transport in

Calpain 1()

(~Ieaves

C~onlplexes

II-IV renlains intact.

[\1 itochondrial Contplex I Subunits.

C-"olnplcx I of the ETC is con1posed of 46 individual subunits. We sought to
dctcrn1inc the c01l1plex I protein substrate(s) of calpain 10. To do this, we analyzed each

or the 4() COll1plcx I subunits for possible calpain cleavage n10tifs using the PEST-FIN [)
algori thnl ( http://srs.nchc.org.tw/en1boss-bin/enlboss.pl? _ action=input& __ app=pestfind).
The PEST-·FIND algorithnl is useful for the identification of possible calpain and
protca:,,;clll1C

substrates. but does not predict actual cleavage sites vvithin protein targcts.

Subsequent to PEST analysis, four protein species were identified as potential calpain
substrates; NDlJFV2, DAP13. NDUFS7. and ND6. Antibodies were available and
obtaincd for NDlJFV2. DAPl3, and ND6. Aliqllots fron1 ReM were treated vvith

1 ~lM

Ca~ i and subjected to in11l1unoblot analysis using antibodies against NDUFV2. DAP 13

and the ND6 subunits of Con1plex I. NDUFV2 and ND6 underwent proteolysis in the
101

presence of C£1 2+ that was cotllpletely inhibited by the calpain inhibitors ALLN and
caJpeptin but not the serine protease inhibitor bestatin (Fig. 2-8C). DAP 13 did not
undergo hydrolysis (Fig. 2-8C). Pretreatnlent with rutheniunl red also blocked NDUFV2
and ND6 degradation (Fig.

2-8C)~

suggesting that calpain 1O-nlediated proteolysis of

Conlplcx I subunits occurs in the ll1atrix. Our results denlonstrate Ca 2+-induced calpaindependent proteolysis of the COll1plex I subunits NDUFV2 and ND6, but not of the
DAP 13 subunit.
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Figure 2-8. (:olnplcx I subunits NDlJFV2 and ND6 are proteolytic targets of the
mitochondrial calpain.
2
(A) I~(>lated RClV1 \vere treated vvith 1 ~lM Ca +- for 5 111in in the presence of Con1plc\: I
suhstrates p)rUvate/ll1alate (SIS 111M). Con1plex II suhstrate and inhibitor
slIccil1111cirotcl1nnc (10 111M/1 00 ~lM). or COll1plex IV electron donor and COlnplex III
inhihitur ascnrhall' plus TIv1PJ)/antin1ycin A (5/0.5 n1M /2.5 ~lM) (8) Conlplex L II. and
I I[ en;, 'Tne activities \\:"ere Ineasured in isolated ReM as outlined in the text.
iVlitochol1dria \\ere pretreated \vith calpeptin (30 nM) or diluent for 30 n1in and
suhsequently exposed to 1 ~ll'v1 Ca 2+ for 5 n1in. Data are expressed as nleans ±: SEl'v1
(NJ). fvleans \vith different subscripts \\:'ithin each group are significantly different fr0l11
each othl'r. p<:O.05. (C~) Isolated ReM vvere pretreated vvith various inhibitorst~)r 30 l11in
in the pl'l'Sl~l1Ce or Conlplex J substrates and then exposed to 1 ~lM Ca 2+ for 5 111in.
~i.tJllplL':-) \\l~rC then prepared for \\'Yestern blot analysis and \vere prohed \\ith antihodies
;.t~(lil1st the ('rHllplex I suhunits NI)lJFV2. NI)6. and I)AP13. Results ar~ representative
or thn~c llldcpcndcnt experin1ents.
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Figure 2-9. Proposed mechanism of action for calpain lO-mediated ETC
dysfunction.
Depicted above is a schematic diagram of the proposed mechanism of calpain 10 action
following Ca2+-induced mitochondrial dysfunction. After injury, increases in cytosolic
Ca2+ are translated to the mitochondria via the ruthenium red-sensitive calcium channel
uniporter. Increases in matrix Ca2+ activate mitochondrial calpain 10, inducing cleavage
of two critical subunits of Complex I, ND6 (*) and NDUFV2 (#), leading to subsequent
respiratory deficits. Increases in mitochondrial calcium also contribute to the induction
of MPT, possibly through proteolysis of membrane pore proteins.
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DISC~USSION

Calpains arc ubiquitously expressed throughout eukaryotic organisn1s and are
involved in nunlcrous cellular functions (245). Within

nlanln1als~

calpains L

2~

4,

5~

7,

1O~ 12, and 13 are ubiquitously expressed, \vhereas calpains 3, 6, 8, 9, and 11 have n10re
tissue-specific distributions (539), in1plicating a diverse set of roles for calpain fan111y
n1en1bcrs. Ho\vcver, the physiological and pathological roles of n10st calpain isoforn1s
have not been exanlined. \Vhde calpains are thought to be cytosolic proteins,
investigators have reported calpain-like activities in isolated n1itochondria (230,231,233.
408,512,513,527). Using nll11tiple approaches, we identified a resident n1itochondrial
calpain as calpain 10 and detern1ined that it plays a role in n1itochondrial dysfunction.
Ma el uf first cloned calpain lOin 2001 and proposed that this calpain isoforn)
vvas localizcd to the cytosol and translocated to the nucleus after increases in cellular Ca

21

(253). ()ur data reveal that calpain lOis present in the cytosol and nlitochondria. \vitholll
signi ficant nuclear staining under basal conditions (Fig. 2-4C). However, \ve have not
evaluated the effects of Ca2~ overload on calpain 10 subcellular localization. We believe
that ollr cloning strategy avoids the conlplications and cross-reactivity of antibodies lIsed
fc)l' inlnlunohistochenlistry (lHC) and provides a clearer picture of the subcel1ular

10cali/atiol1 or calpain 10.
Many n1itochondrial nlatrix-targeted proteins contain either a N- or C-ternlinal
signaling 1110tif(542, 543). This n10tif1110st C01111110nly takes the fonn of an N-tcrnlinal
anlphipathic helix containing positively-charged residues on one half of the helix and
hydrophobic residucs on the other (543). We deter111ined the presence of such a Inotifin
calpail1 10 llsing the LaTeX software package TeXtopo (Fig. 2-58), designed to display
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peptide sequences in a helical representation (544). We tested the hypothesis that the Ntenninal 15 anlino acids of calpain 10 are responsible for n1itochondrial localization, and
found that cells expressing GFP conjugated to the N-ternlinal 15 an1ino acids localized to
the n1itochondria whereas cells expressing GFP conjugated to the sanlC nucleotides
inserted in the reverse orientation ren1ained in the cytosol (Fig. 2-SA).
Investigators have previously reported a Ca 2+-inducible calpain-like activity in
n1itochondria (230,231,233,408). Our data reveal that calpain activity is present in
intact n1itochondria and is increased following Ca 2 + addition. Because Ca

21

is

concentrated in the ll1itochondrial nlatrix, and rutheniu1l1 red blocked the Ca 2 -induced
f-

increase in calpain activity, we propose that the n1ajority of Ca2+-inducible calpain 10
activity in nlitochondria is localized to the nlatrix. This idea is supported by the
cxperinlcnt in which calpain 10 was identified in the nlatrix fraction follo\ving
Iyrnography. Nevertheless, using isolated RCM fractions we observed calpain activity
and calpain 10 protein in the outer nlenlhrane, internlenlbrane space. inner nlenlbrane,
and Illatrix fractions. While these results support the work of others \vho have repo11cd
calpain activity in n10re than one n1itochondrial fraction (233), calpain 10 nlay be inactive
in the rcnlaining fractions and it is not clear what function calpain 10 has in these
fl'actions.
Using pernleabi lized nlitochondria and Ca 2+ chelation, \ve observed that
approxinlately 50o~) of the n1itochondrial calpain 10 activity was Ca 2 +-dependent. It is
unclear \vhether the renlaining cysteine protease activity in the nlatrix was due to C'a2-~
independent cal pain 10 activity or due to the activity of another cysteine protease. One
explanation is that calpain lOis less Ca2 +- -dependent than the typical calpains due to its
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IllitochondriaI s\velling (529,545,546). Calpain 10 over-expression induced
nlitochondrial fragnlentation and swelling, consistent with MPT (50), and this altered
111itochondrial nl0rphology \vas blocked by two MPT inhibitors. In addition, calpain 10
over-expression induced nlitochondrial autophagy, a process blocked by 3-1'v1A and
thought to be stinlltlated by MPT induction (174, 546, 547). We denl0nstrated

30o~)

inhibition of M PT by the calpain inhibitor calpeptin, denl0nstrating that the forn1a1iol1 of
the MPT pore is nlediated by other Ca 2+ -dependent processes. Gores

el ([/

previously

reported a liver n1itochondrial calpain-like activity that regulated MPT (230,527). It is
conceivable that calpain 10 does not directly regulate MPT per SC, and the nlitochondrial
fh:lgnlcntation seen in our studies nlay be regulated via other calpain 10-nlediated
proteolytic events. Nevertheless, cyclosporine A and 3-nlethyladenine blocked the
111itochondrial fragnlentation and swelling observed subsequent to calpain 10
ovcrcxprcsslon.
The nlitochondrial ETC provides a nlechanisnl for the generation of ATP through
the oxidative phosphorylation of ADP. As previously reported (530), nlitochondrial Ca2~
overload results in decreased ETC activity.

OUf

results reveal that Conlplex I is the n105t

sensitive conlplex to Ca2+ -induced nlitochondrial dysfunction and that calpain inhibition
'vvith calpcptin protects against Conlplex I dysfunction. We sought to deternline potential
COlllplex I protein substrate(s) of calpain lOusing the PEST-FIND algorithnl
(http://srs.nchc.org). Four Conlplex I proteins were identi fled and three proteins were
tested (NDLjFV2~ DAP}3, and ND6). Ca 2+-induced inhibition ofETe \vas associated
vv'ith hydrolysis ofNDUFV2 and ND6 but not DAPt3. Further, prctreatnlent with
rutheniunl red also blocked NDlJFV2 and ND6 degradation, suggesting that Ca
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21

_

induced calpain 1O-n1cdiated proteolysis of NDUFV2 and ND6 subunits occurs in the
n1itochondrial nlatrix.
[)cf1cicncies or n1utations in various protein subunits ofCo111plexes I-IV have
been

idelltif~ed

and linked to clinical syndronlcs (548). Con1plcx I subunit nlutations are

perhaps the n10st con11110n and account for 330/0 of all respiratory chain disorders (549).
In addition~ Ricci e!

(II have shown that the proteolysis of Conlplex I subunits can also

contribute to ETC dysfunction by de1110nstrating the caspase-n1ediated cleavage of the 75
kDa NDUFS 1 subunit (550). In the current study, vve have identified

t\VO

Conlplex I

subunits, NDlJFV2 and ND6. which undergo calpain-n1ediated hydrolysis. The
NDUF\/2 subunit is a nuclear-encoded 24 kDa protein found in the ll1atrix ar111 of
Conlplex I and is required for C'on1plex I activity (551,552). Defects in this protein have
been identified previously and result in encephalopathies and bipolar disorder
The ND() subunit, a 20 kDa protein encoded by the n1itochondrial

genon1e~

(553~

554),

is a

transnlenlbrane protein kno\\/n to assist in Conlplex I assenlbly, is required for Conlplex I
acti\'ity. and \vhose n1utations are associated with Leber's Hereditary Optic Neuropathy
(LHON) (555-558). Thus, sin1ilar to the n1itochondrial calpain-induced hydrolysis of
ND6 and NDlJFV2 and the associated C0111plex I dysfunction, genetic alterations in these
proteins result in inhibition ofC'onlpIex I. Interestingly, Koopn1an et al. has sho'A;'n that
single subunit n1utations in COll1plex I not only reduce enzyn1e activity of the COll1plcx,
but arc otten associated with alterations in n1itochondrial 111orphology (541); a
phcnonlenon

\VC

observed with calpain 1() over-expression.

In sUll1111ary,

VlC

have identified the endogenous 111itochondrial calpain as calpain

10 and that it plays a role in ll1itochondrial viability. While the physiological and

111

pathological functions of calpain 10 have not been studied extensively, it has been linked
to ryanodinc-induced apoptosis, GLUT4 vcsicle translocation, pancreatic beta-cell
exocytosis, cataractogenesis, hypertriglyceridenlia, and is genetically linked to Type: II
diabetes. a disease associated with nlitochondrial dysfunction (253, 481, 486, 494, 502,
559). l\1itochondria are increasingly being thought of as cell death checkpoints at \vhich

signals for necrosis and apoptosis are sent for downstreanl processing. It will be exciting
to elucidate the role of calpain lOin orchestrating these events and ho\v we nlay be able
to lllanipulate this syste1l1 for therapeutic intervention in disease states donlinated by the
dysregulation of cellular Ca2~ honlcostasis.
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CHAPTER 3
MITOCHONDRIAL

CAL~PAIN

10 REGULATES ATP SYN1'HESIS /\'ND

CELL CURVIVAL IN RENAL PROXIMAL TUBULE CELLS

ABSTRACT
Calpains~ Ca~ r--activated cysteine proteases, are a 14-nlelllber fanlily of cytosolic

enzynlcs inlplicated in nUlllerous cellular functions and pathologies. Our laboratory
recently dctenl1ined that calpain lOis also resident in 1l1itochondria, is active in the
nlitochondrial nlatrix, and degrades two Conlplex I subunits of the electron transport
chain. To deternlinc the physiological role ofnlitochondrial calpain 10, we developed an
adenoviral-dclivered shRNA for calpain 10, infected renal proxinlal tubular cells (RPTC)
and exall1ined nlitochondrial function and viability over tinle. Mitochondrial calpain 10
expression decreased below detectable levels 3 days after infection vv'hile cytosolic
calpain 10 levels rcnlained unchanged at day 3 and decreased to

~20%

of control by day

5. Exalllination of basal and uncoupled oxygen consunlption (Q02) and ll1itochondrial
nlcillbrane potential revealed no differences anlong control, scranlble shRNA, and
calpain 10 shRNA-infected cells. Hovv'ever, cellular A TP levels increased 2-fold on day
4 and 5 in calpain 1() shRNA-treated cells as cOlllpared to controls. Calpain 1()
knockdovv'n \vas correlated with increased expression of AMP-activated protein kinase

(AM P]() and l!\TP synthase

~,

suggesting that these proteins are proteolytic targets of

calpain 10. Using isolated renal cortical nlitochondria

(RCM)~

ATP synthase

f)

\vas

cleavcd in a Ca 2 +-dcpendent 11lanner that was blocked by a calpain inhibitor. RPTC
survival also was evaluated and found to be significantly decreased by day 4 of the virus
treatll1ent. In sunlnlary, we have identified a role for calpain lOin the regulation of
AMPK and ATP synthase

~

levels, that 111arkers of 111itochondrial viability renlain

unchanged after calpain 10 shRNA treatnlent that calpain 10 can regulate cellular ATP
levels, and that cytosolic calpain 10 n1ay playa pro-survival role for RPTC.

INT'RODUCTION

('alpains, Ca 2-+--activated proteases, are n1en1bers of a larger class of cnzyn1es
kno\vn as cysteine proteases and are linked to the pathogenesis ofnunlcrous disease
states including Alzhein1er's disease, cataracts, lin1b-girdle ll1uscular dystrophy, gastric
carcinonla, and Type II diabetes (245). Calpains are responsible for the linlitcd
protcolysis ofnunlcrous protein targets including receptors (419), oncogenic proteins,
(521) and cell signaling n10lecules (386, 522). Calpains also are thought to participate in
the induction of cellular necrosis through interactions with the cytoskeleton in various
cell types (54, 523-525) and in the regulation of apoptosis through interactions with

r53~

/\IF, Bid, Bax, and caspase 3 (10,408,519,521, 560). Unfortunately, ll1any of the
calpain targets identified have been revealed through the use of non-specifIc calpain
inhibitors, calling into question which calpain isofor111 is responsible. In addition, little is
knO'NIl about the Il10lecular n1echanisn1s and protein targets for the atypical calpains that
lack [)olllian IV and whose C-tern1inal dOlnains are highly divergent as c01l1pared to their
nl0rc \vell-studied typical counterparts.

While calpains are a 14-n1enlber fa111i1y, only a few isoforn1s have been studied
extensively, and little to no \\/ork has been conlpleted on the atypical class of calpain
1110lcculcs, save for calpain 10 \vhich has been identified as a Type II diabetes
susceptibility gene (559). Recent work on calpain 10 has provided increasing evidence
that this nlolecule plays a key role in regulating glucose nletabolis111 and insulin secretion
(486,502), all of\vhich are in1portant pathways with respect to diabetogenesis.
QUI'

laboratory has recently identified calpain 10 as a Ca::!+-inducible

nlitochondrial calpain capable of cleaving electron transport chain proteins after
ll1itochondrial Ca 2 -t overload. We have also de1110nstrated that 111itocondrial calpain 10
regulates Ca 2-+ -induced state 3 respiratory dysfu11ction and that it 111ay playa role in the
fornlation oCthe nlitochondrial pernleability transitio11 (MPT) pore.
('alpain 1() has also been shown to be involved in the apoptotic process. Johnson
and colleagues denlonstrated a decrease in apoptosis in pancreatic p-cells isolated fronl
calpain 1() knockout nlice conlpared to wild-type cells after treatn1ent with ryanodine,
palnlitatc, or lo\v glucose (481). Wu et aI, using calpain 10 antisense 111ethodology,
dCI110nstratcd a proapoptotic role for calpain 10 in rat renal interstitial fibroblasts (509).
The authors denlonstrated induced calpain 10 expression and caspase-3 activity, leading
to enhanced apoptosis after treatnlent of fibroblasts with Iipoxin A4 (509).
UnrortLlllatcly~

the nlolccular targets of calpain 1O-nlediated apoptosis have yet to he

elucidated.
To deternline the physiological role of nlitochondrial calpain 1O~ we have
developed an adenoviral-delivered shRNA for calpain 10, inoculated rena] proxinlal
tubular cells (RPTC) and exanlined nlitochondrial function and viability over tinlc .
.,I
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Elucidation of the effects of calpain 10 action n1ay provide novel therapeutic targets for
disease intervention.

MA.l'ERIALS AND METHODS
Isolation.

CuIture~

and Infection of Renal Proximal Tubules.

Isolation and culture of renal proxin1al tubules were pcrforn1cd as described
previously (5() 1-563). Fenlale New Zealand White rabbits (1.5--2.5 kg) \\:ere purchased
fron1 Myrtle's Rabbitry (Thon1pson Station, TN), RPTC were isolated using the iron
oxide perfusion ll1ethod and grown in six-well tissue culture dishes under inlproved
conditions. The culture nlediunl was a 1:1 ll1ixture ofDulbecco's n10dified Eagle's
n1ediull1/ Hall1's F-12 ll1ediun1 (without glucose, phell01 red, or sodiunl pyruvate)
supplenlcnted with 15 111M HEPES buffer, 2.5 n1M Lglutal11ine, 1 ~lM pyridoxine Hel, 15
111M

sodiulll bicarbonate, and 6 111M lactate. Hydrocortisone (50 pM), scleniun1 (5 ng/nl1),

hUIlHln transferrin (5 pg/ll1l), bovine insulin (10 nM), and L-ascorbic acid-2-phosphatc
(50

~lM)

were added daily to fresh culture ll1ediull1. Isolated tubules \\'ere plated at 1 111g

ofprotein/\vell in 35 111111 dishes. On day 6, RPTC were infected with scranlble-shRNA
virus (\/ector BioLabs- 5 x lOx PFU/n11) (Mal of 10), calpain 10-shRNA virus Uv1()!

or

10), or diluent. Sall1ples were isolated on days 1-5 post-infection for subsequent analysis.

l\1itochondrial Isolation and Fractionation.

Renal cortical ll1itochondria were isolated froll1 fell1ale New Zealand \\I"hite rabbits
(2 kg) as previously described

(162~

531), Briefly, kidney cortex was nlinccd and

hOlllogenized in ice-cold Buffer A (0.27 M sucrose~ 5 n1M Tris-HCI, 1 n1M EGT A, pH
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7.4). Nuclei and cellular debris were pelleted by centrifugation at 600 x g for 5 111il1. The

supernatant \vas centrifuged at 7700 x g for 5 n1in resulting in a crude nlitochondrial
pcl1ct. The pellet \vas \vashed once in ice-cold 0.27 M sucrose and resuspended in Buffer
B (130 n1M

KCI~

9 n1M Tris-PO.+, 4 n1M Tris-HCI, 1 n1M EGT A, pH 7.4). Crude

ll1itochondria \vere then layered onto a sucrose/Percoll gradient and centrifuged at 20,000
x g for 20 n1in.
RPTC n1itochondria \vere isolated via differential centrifugation. Briefly. RPTC
\vere lysed in hon10genization buffer (50 n1M Tris-HCl, 1 111M 0-n1ercaptocthanoL I

1111\11

EDT A, 0.32 M sucrose, pH 8,f)) containing protease inhbitors with brief agitation and
sonicated Cor 10 sec. The subsequent honlogenate was centrifuged at 900 x g for 5 n1in.
The supernatant \vas centri fuged at 7700 x g for 5 n1in resulting in n1itochondrial and
cytosolic fractions. Mitochondria were resuspended ill hon1ogenization buffer for
in1n1unoblot analysis and in Buffer B for subsequent activity assays.

Calpain ,'-\ctivity.

Calpain activity was assayed spectrophotonletrically using the calpain-speci fic
substrate SLLVY -AMC (Bachen1), as previously described (292). Whole. 111itochond1'ia
(200 pg) \verc diluted in Buffer B and incubated with 10 n1M

CaCl~

in the presence

or so

pM SLL VY -AMC'. Activity was n1easured under linear conditions as a function of Al\~C
hydrolysis using excitation and en1ission wavelengths of355 and 444 nn1, respective1y.
RCM incubated in the absence of substrate exhibited the sall1e fluorescence as ButTer B
alone.
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lVlcasurClncllt of ReM Oxygcn ('onsunlption (QOz).

Q02 \vas nlonitored as previously described (562). Briefly, RPTC bathed in 37°C
culture nlediunl were gently detached fron1 culture dishes with a rubber policenlan and
transferred to a 37°C Q02 challlber. Basal

RPTC~

Q02 was 11leasured polarographically

llsing a Clark-type electrode. After the basal rate of Q02 was deternlined, FCCP (final
concentration= 10 pM) was inj ected to obtain uncoupled Q02.

ATP Synthase

f3

Degradation.

The sensitivity of ATP synthase

~

to calpain 1O-lllediated cleavage was

detern1incd using isolated rabbit RCM. Briefly, isolated rabbit RCM were incubated \vit11
1 pM Ca 2+ for 1 hr at roon1 tenlperature in the presence and absence of calpeptin (10

pM). ATP synthase

~

degradation was subsequently evaluated by inlll1unoblot analysis.

Ilnl11U noblotting.

Isolated RCM and RPTC \vere subjected to SOS/PAGE (4-12

o~)

acrylalllide) and

transferred to nitrocellulose n1en1branes. Mell1branes were incubated \\/ith prill1ary
antibodies to ealpain I, calpain 2. calpain 10, AMPK, ATP synthase

r, Hsp60, caspasc J.

and GAPDH. The prinlary antibodies used were n10noclonal rabbit anti-hunlan n1calpain (Affinity Bioreagents - 1: 10(0), rabbit anti-hunlan In-calpain (don1ain IV)
(Calbioehcn1

1: 1000), rabbit anti-hunlan p-ealpain (doll1ain III-IV) (Abean1 -- 1: 1000),

rabbit anti-rat ealpain 10 (donlain II) (Biogenesis -- 1: 1000), nl0noclonal nlouse anti-ATP
synthase

f) (Santa Cruz --

1: 1OOO)~ rabbit anti-hull1an AMPK (Cell Signaling -- 1: 10(0),

111011se anti-hlll11an Hsp60 (Abeall1-- 1: 1OOO)~ and rabbit anti-hull1an caspase 3 (Stress

118

Signaling- I: 10(0). Antibody incubation \vas followed by a horseradish pcroxidaseconjugated goat anti-rabbit or goat anti-nlouse secondary antibody (Santa Cruz - 1: 10(0).
[nlnlunorcactivc protein was visualized by enhanced chenlilunlinesence (A.nlcrshaln) and
inlaged using an Alpha Innotech inlaging station.

Adcnoviral

(~onstruct.

Three independent siRNA sequences were obtained (Anlbion) and evaluated for
their ability to inhibit calpain 10 translation. Sequence #3 produced >

95~;()

knockdo\vll

of ealpain 10 expression after a 24 hour transfeetion in HEK-293 cells. Subsequently,
oligonucleotides encoding this siRNA sequence (sense - 5'-TCGAG
CCGAGTGAGGTGT AC ATTGTTCAAGAGACAA TGT ACACCTCACTC'GGTTA-3',
and antisense - 5'-CTAGTAACCGAGTGAGGTGTACATTGTCTCTTGAA
C AATGT ACACCTCACTCGG C-3') were annealed and ligated into Anlbion's pSilencer
Adena 1.O-CMV shuttle vector. Following isolation of pure plasnlid, HEK-293 cells
v/cre co-transfccted with the provided linearized adenoviral backbone DNA and the
shuttle vector. Arter viral replication, HEK-293 ce111ysates were harvested.
Reconlbinant adenovirus anlplification was conducted by the MUSC Viral Vector Core
Faci lity \vllo provided us \vith puri tied and titered reconlbinant adenovirus (5 x 10 ~
1

partieles/lnl, 1 x 1Ol() PFU/nll).

lVleasureJl1cnt of ATP.

A TP was nlcasured via luci ferase-nlediated biolul11inescence as previously
described (564). Bricfly, RPTC were \vashed three tinles with ice-cold PBS and
subsequently lysed on icc with 100

~L1

triton/glycylglycine lysis buffer. Honlogenates
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vvere inlnleciiately centrifuged at 14.000 x g for 5 n1in at 4°C. Supernatants \vere
•

_ '~ • • • '"

',' r

collected and kept on ice. Each san1ple (50

~Ll)

was con1bined with an equal volunle of

lucifcrasc reagent (ATP Biolun1inescence Assay Kit CLS II, Roche) and inlaged
in1111cdiately using an Alpha Innotech ill1aging station fitted with a chen1ilull1inescent
tllter.

ASSCSSlllCllt of ~uclcar Morphology.

Nuclear nlorphology was assessed as previously described (565). Briefly, RPTC
\verc \vashcd t\vice \vith PBS, n1cdiunl was ren10ved, cells were fixed for 10 n1in using
] ()(~/~) bufTered forn1alin/4 % fornlaldehyde and washed with PBS. After washing, RPTC
\vere pernlabilized for 10 n1in in PBS/O.1 o/~) Tween-20. Pern1eabilized cells were washed
thrce tin1cs with ice cold PBS and treated for 10 ll1ill with DAPI (16.6 pM final
concentration) at roon1 ten1perature. Covered RPTC vv'ere washed three tinlcs with ice
cold PBS. Visualization of DAPI staining \vas perforn1ed uSillg a Nikon TE300 Eclipse
Fluorescence 111icroscope (Nikon, Melville, NY) with excitation and en1ission filters of
350 and 486 nn1, respectively. Condensed nuclei froll1 10 high powered fields were

counted for each trcatn1ent group.

[VlcasurClllcnt of IVlitochondriall\1elnbrane Potential (A\fJ m ).

Qualitative assessn1ent of 1l1itochondrial nlen1brane potentia] was evaluated by
JC-l (5,5' ,()/)' -tetrachloro-l, 1' ,3,3' -tetraethylbenzinlidazolcarbocyanine iodide) staining .
.J(~-]

10ading into 111itocholldria is detected by a shiH in fluorescence frolll

characteristic of its 1l10non1eric

forn1~

green~

\\"hich is

to red, which reflects its aggregation in

1l1itochondria. Plated RPTC were incubated with 200 11M JC-l for 20 ll1i11 at 37°C. Cells
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'were subsequently washed three tinles with 37°C culture 111edia and inll11ediately inlagcd
using a 2()X objective on a confocal nlicroscope (Zeiss LSM 5) (excitatioll 488
SilllltltlillCClUS

green Cllllssions (5l 0-525 n111) and red ell1isslons (590

11111)

11111:

ch::Ulncls using

~l

dllLlI band-·pass filter).

Statistical Analysis.

RPTC and RCf'v1 isolated fron1 one rabbit represent one experinlellt (11-=1). The

appropriate /\NO\/,t\ \vas perforn1ed for each data set by using SignlaStat statistical
software. Individual n1cans \vere conlpared with Fisher's protected least significant
eli fferellcc test \vith

1)~O.05

heing considered a statistically significant difference het\vccn

1l1Can values. Means \vith different lettered subscripts within groups are significantly

di ffcrent lI'on1 each other, P:-SO.05. Linear regression \vas also perfornled hy using SignlCl
Stat statistical software.

RESLJL'fS

Adcnovirus-111cdiatcd Knockd(HYn of C~alpain 10 Expression.
RPTC' \verc infected \vith either scranlble shRNA (scranlble) or calpain 10

shRNA (virus) and incubated for a period of 5 days. Control

RPT(~

are cells treated \vitl1

diluent. Control, scran1ble. and virus-infected l11itochondrial and cytosolic fractions \\"crc
isolated each day for 5 days and assayed via inl111unoblot analysis for calpain 10
expression. Calpain 10 levels in virus-infected cells were decreased belo\\' detectable
levels in lllitochondrial isolates by day 3 post-infection, while levels in cytosolic fractions
on day] \verc relatively unchanged and decreased to

~20%

of control by day 5 (Fig. ]-

1A). Calpain 1() levels in control and scranlble-infecteel cells renlained unchanged (Fig.
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3-\ Band 3-1 C~). These differences n10st likely reflect differential rates of calpain 10

turnover bet\veen the two C0l11partn1cnts. Veri fication of calpain 1O-speci fic knockdo\vn
was accol11plished via in1111unoblot analysis of the typical cytosolic calpains 1 and 2 (Fig.

3-1 A,B,C). These data den10nstratc that calpain 1 and 2 expression levels did not change
bct\vecn controL scran1ble shRNA, and calpain 10 shRNA-infected cells.
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Figure 3-1. Adenovirus-mediated knockdo\vn of calpain 10.
Contluent RfYfC \vere infected \vith reconlbinant adenovirus expressing either calpain 10
shRNA or scranlhlc shRNA. harvested over a 5 dav tinle course~ and suhtl'actionatcd into
cytosolic and crude lnitochondrial fractions. Resultant sanlples were subsequently
illlll1tlllohlotted for calpain 10 protein expression. Inlnlunoblots for caJpains 1 and :2
provide evidence for calpain 10-specific protein knockdown. Equal protein loading \vas
verified by inlnlunoblot analysis using a-GAPDH and a-I--Isp60 antibodies for the
cytosolic and nlitochondrial fractions. respectively. (A) C~alpain 10 shRNA-infectcd
RPTC. (B) ('ontrol RPTC (no treatnlent). (C) Scranlble shRNA-infected RPT'C.
Results are representative of three independent experinlents.
.;
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Calpain Activity is Decreased in Virus-treated

RPT(~.

Mitochondrial calpain activity was evaluated in RPTC 111itochondria isolated ft-onl
scralllble shRNA and calpain 10 shRNA-treated cells. The results reveal the 111aintenancc
of III ito chon dria 1 calpain activity in scranlble shRNA-treated cells and a tinlc-dependcnt
decrease in calpain activity in cells treated with calpain 10 shRNA (Fig. 3-2). These data
veri fy the loss of calpain 10 seen in the nlitochondria of calpain 10 shRNA-infectcd cells.

~lit()ch()ndrial

Respiration is {inchanged in the Absence of Calpain 10.

Basal and FCCP-uncoupled Q02 were nleasured in control. scranlble shRNA, and
calpain lO-treated RPTC over the five day tinle course. The rates of Q02 under basal
(Fig. 3-3,A) and unCOllp led (Fig. 3-3 B) conditions renlained unchanged bet\vccn each

trcatnlent group over tinle. We suggest that the loss of calpain 10 docs not nlediate
1l1itochondrial respiratory dysfunction under basal conditions.

'Htochondrial l\;lernhrane Potential (A\I'Ill) Remains Unchanged After Calpain 10
Knockdo·wn.

As discussed above, reduction of calpain 10 levels had no significant effect on
basal or uncoupled nlitochondrial Q02. We then nleasured the effects of cal pain 10
knockdo\vn on nlitochondrial nlenlbrane potential. L1\lfm was assessed qualitatively on
day 3 post-infection since nlitochondrial calpain 10 levels are undetectable at this

til11(,

point. JC -1 staining denlonstrated no significant differences in L1\lfJll between control,
scranlblc shRNA, or calpain 10 shRNA-infected RPTC (Fig. 3-4). In contrast. RPTC
uncoupled by a brief pretreatnlent with FCCP (1 0
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~lM)

revealed signi ficant decreases in

1l1enlhrane potential. These data suggest that calpain 10-deficient RPTC nlitochondria
are fully coupled and energized under basal conditions.
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Figure 3-2. Mitochondrial calpain 10 activity .
Mitochondrial calpain 10 activity was nleasured in whole RPTC nlitochondria in order to
verify that decreases in calpain 10 protein levels were correlated with decreases in
proteo lytic activity. Scranlble shRNA and calpain 10 shRNA-treated RPTC were
subfractionated into cytoso lic and Initochondrial fractions over a 5 day tinle course .
Mitochondria were subsequently assayed for cal pain activity as described in the text.
Data are expressed as nl eans ± SEM (N=3). Means with different lettered subscript ,
within each group are sign ificantl y different fronl each other~ p <0.05.
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Figure 3-3. Decreases in calpain 10 expression have no effect on mitochondrial
respiration.
(A) ControL scranlble shRNA, and calpain 10 shRNA-treated RPTC were assayed for
basal 111 itochondrial respiration over a 5 day til11e course. Basal respiration was nl easured
a. desc ribed in the text in the absence ADP
(B) Mitochondrial respiration was
nl eas ll red in the presence of 10 J.lM FCCP in controL scranlble shRNA, and calpain 10
shR NA -treated RPTC over a 5 day til11e course. Data are expressed as l11eans ± SEM
(N =4 ).
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Figure 3-4. Decreases in calpain 1() do not affect mitochondrial membrane
potcn tia I.

Mitochondrial 111CI11brane potential (L\\l/m) was nleasured in control. scranlble shRNA. and
calpain 10 shRNA-trcated Rlyrc on day 3 post-infection. Day 3 \vas chosen for this tin1e
point since 111itochondrial calpain 10 expression in virus-infected cells is below detectable
levels at this tinle. Briefly. RPTC were incubated vvith 200 nM JC-l (a potel1tiol11ctric
dye) for 20 111il1 prior to ilnaging. To serve as a positive controL one group of contrnl
RPTC vvere treated with the nlitochondrial uncoupler FCCP (1 a ~LM) for 5 111in prior to
JC-l loading. (Iells were then in1aged using a 20X objective on a confocal 111icroscopc
(Zeiss LSM 5) cxciled at 488 nll1 and sct to silllultaneously dctect green cll1isS10ns (510525 11111) and l\.'d clllissions (590 nnl) channels using a dual band-pass t~lter. Results arc
rcpresentative of three independent experinlents. The white bars represent a distance of
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Calpain 10 j\;lcdiates Cellular ATP Levels.

,As a final 111easure of nlitochondrial physiology, we 111easured cellular ATP levels
in RPTC lacking calpain 10. Because RPTC are cultured in the presence of glutanline

and absence of glucose, this culture 1110del enhances aerobic respiration and generates the
nlajority of cellular A TP through nlitochondrial oxidative phosphorylation, sinlilar to ill
)'ipo

conditions (566). ATP levels \vere 111easured in control, scranlble shRNA., and

calpain I () shRNA-infected cells over the five day till1e course. Cellular ,ATP levels
renlained unchanged on days 1-3 following inoculation, but increased 2-fold in calpain
10 shRNA-infccted RPTC on days 4 and 5 conlpared to control and scran1ble shRNAinfected ce11s (Fig. 3-5A).
Because knockdown of calpain 10 increased A TP levels in the absence of changes
in cellular respiration or

~\IJlll'

we exan1ined protein levels of the nlitochondrial ATP

synthase f3 subunit of the Fl conlplex via in1111unoblot analysis. Our results revealed a
tinle-dcpendent increase in A TP synthase

~

levels in nlitochondria frOll1 calpain 10

shRN!\-trcatcd RPTC but not in control or scran1ble shRNA-infected cells (Fig. 3-58),
suggesting one of 1\vo hypotheses; decreased proteolysis or enhanced synthesis of ATP
synthase

rL

To evaluate the first hypothesis, RPTC cytosol fron1 each treatnlent group was
probed for the cellular fuel sensor AMP-regulated kinase (AMPK). AMPK activation is
known to induce the nuclear transcription factor NRF-l (567) which n1ediatcs
transcription of respiratory subunits and of conlponents of the F [/Fo ATPase (568).
shRN/\-inCcctcd cells by day 3 post-infection with no change in AMPK protein
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expression in control or scran1ble shRNA-infected RPTC under basal conditions (Fig. 36A).

To address the second

hypothesis~

we isolated rabbit RCM and treated theln 'Nith

1 pM Ca 2-i ror up to 1 hour. [111111unoblot analysis for A TP synthase

0 revealed the Ca 2+-

dcpendcnt cleavage of this protein that was c0111pletely blocked by a 30 111i11 prctreatnlcnt
with the calpain inhibitor calpeptin (1 0

~lM)

(Fig. 3-68). Our results suggest that calpai11

10 helps to l11aintain cellular ATP levels under basal conditions and that 111itocho11drial

calpain 10 111ay nlcdiate ATP dcpletion during conditions of cellular Ca 2+ overload as
obscrved during ischen1ia/reperfusion injury.
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Figure 3-5. CaJpain 10 protein knockdown induces ATP synthesis.
C~) Cellular ;\TP levels 'Nere nleasured in control. scralnble~ and virus-infected RPTe

over a S day tinlC course. Data are expressed as nleans ± SEM (N=J). Means \vith
di ffcrcnt lettered suhscri pts vvithin each group are significantly different f.'onl each other.
p<O.OS. (B) Confluent RPTC were infected vvith either scranlhle or calpain 10-specific
adenoviral shRN.A constructs. harvested over a 5 day tinle course. and subli'actionated
into cytosolic and crude 111itochondrial fractions.
Mitochondrial fractions \VCIT
subsequcntly inlnlunoblotted for A TP synthase B protein expression.
Equal
nlitochondrial protein loading was verified by ilnnlunoblot analysis using an ex-Hsp60
antibod:y. Results are representative of three independent experinlents.
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Figure 3-6. Calpain 1() modulates effectors of A TP synthesis under basal and
stimulated conditions

Confluent RPTC were infected \vith either scrall1ble or caJpain 1O-speci fie
adenoviral shRNA constructs. harvested over a 5 day tinle course. and subfractionated
into cytosolic and crude ll1itochondrial fractions. Cytosolic fractions \vere suhsequently
illl1l1unoblotted for AMPK protein expression. Equal cytosolic protein loading \vas
veri lied hy inlnlunohlot analysis using an a-GAPDH antibody.
Results arc
representative of three independent experinlents. (8) Isolated rabbit ReM \vere treated
with I pM Ca 2+ in the presence or absence of 10 ~lM calpeptin for 30 nlin or I hr.
2T
Subsequent inlll1unobiotting revealed the Ca -dependent and calpain-nlediated cleavage
or AlP synthase 0. Results are representative of three independent experinlcnts.
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~

Calpain 10 Mediates RPTC Survival.

Confluent cu1tures ofRPTC were exposed to scranlble shRNA orcalpain 10
shRNA and cultures followed for five days. Each treatnlent group was evaluated by
brightfield nlicroscopy for cellular nlorphology, DAPI staining for nuclear nlorphology,
and caspase 3 activation. 8rightfield nlicroscopy revealed a loss of nlonolayer
contluency on day 4 that increased on day 5 (Fig. 3-7). Monolayer confluency did not
decrease in control nor scranlble shRNA-infected RPTC. Exan1ination of RPTC nuclear
nlorphology revealed condensed nuclei in calpain 10 shRNA-infected cel1s beginning on
day 1 (Fig. 3-8), renlaining constant on days 2 and 3, increasing on day 4 (25%), and
decreasing on day 5 to the san1e level as that observed on days 1-3 (Fig. 3-1 OA).
NUlllerous nuclear aggregates \vere also observed by day 5 in n1any of the calpain 10
shRNA-infectcd cells (Fig. 3-8). Nuclear condensation was less than

5~/o

in control and

scranlble shRNA-infected cells (Fig. 3-1 OA). Day 5 cell cultures denl0nstrated extensive
111ernbrane budding \vhich correlated with condensed nuclei inlaged via DAPI staining
(Fig. 3-9).
The condensed nuclear n10rphology in calpain 10 shRNA-infectcd cells resulted
in the further investigation of RPTC calpain 10 deficiency-induced apoptosis. Using
illllllunohlot analysis, 'we observed the appearance of cleaved procaspase 3 beginning on
day 1 and rcn1ained present over days 2-5 (Fig. 3-108). No cleaved procaspase 3 was
observed in control and scranlble shRNA-infected cells over the five day period. We
suggest that RPTC calpain lOis required for cel1 viability and that the loss of calpain 1()
results in RPTC apoptosis.
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Figure 3-7. Calpain 1() mediates RPTC survival.
Control RPTC and those infected with recoll1binant adenovirus expressing either calpain
10 shRNJ\ or scranlble shRN.A. were inlaged over a 5 day tinle course using a brightfield
111icroscope and 4X objective. Control and scranlble-infected RPTC denlonstrated
l1orn1al renal epithelial nlorphology while virus-infected cells denlonstratcd an
increasingly altered 111orphology by day 3 w'hich nlanifested itself as nlassive cell death
by days 4 and 5. Results are representative of three independent experilllcnts.
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Figure J-S. D(Hvnregulation of calpain to induces nuclear condensation.
Nuclei fro11l control RPTC and those infected \vith recon1binant adenovirus expressing
either calpain 1() shRNA or scralllhie shR.NA \vere in1aged via [)j-\PI staining over a 5
day tinlC course. Visualization of D.API staining \vas perfornled using a Nikon TEJOO
Eclipse Fluorescence 11licroscope (Nikon. Melville. NY) with excitation and el11issioll
tilters of 350 a11d 486 11111. respectively. Control and scranlble-infected RPTe
dCI110nstrated a nor111al nuclear nl0rphology while virus-infected cells denlonstrated
condensed nuclei by the first day of treatnlent which increased over the 5 day course.
Results arc representative of three independent experinlents.
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Brig htfield
Figure 3-9. Membrane blebbing correlates to RPTC nuclear condensation in the
absence of calpain 10.
Shown above, calpain 10 shRNA-treated cells were imaged by brightfield microscopy
and subsequently imaged via DAPI staining at a lOX magnification on day 5 postinfection. As can be seen, numerous RPTC have died and detached from the plate while
many are in the process of dying. There are numerous plasma membrane 'blebs' which
seem to be associated with corresponding condensed nuclei in the above DAPI-stained
section. Results are representative of three independent experiments.
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Figure 3-10. Calpain 10 knockdo,vn induces caspase-dependent apoptosis in IlP'TC'.
(A) Nuclei frol11 control H..PTe and those infected \vith recol11binant adcno\'irll~

expressing either calpain 10 shRNA or scranlble shRNA were inlaged via I)API staining
over a 5 cia:' tinle course. Condensed nuclei fronl 10 high powered fields \verc counted
for each treatnlent group. Data are expressed as nleans ± SEM (N=3). Means \",jtll
different lettered subscripts \vithin each group are significantly different fronl each other.
/J<.O.05. (B) Cytoso]ic fractions fronl control. scranlble~ and virus-infected RPTC \\Tre
probed for total and active caspase 3 to confirnl caspase-dependent apoptosis. Virusinfected cells denlonstrated the cleavage of procaspase 3 while control and scranlbleinfected cells did not. Resu]ts are representative of three independent experitnents.
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DISCUSSION
Calpains are ubiquitously expressed throughout eukaryotic organisn1s fron1
prin1itive single-celled parasites up through ll1an1n1als and are involved in nUll1erous
physiological processes (245). Manl111als contain 8 ubiquitously expressed calpains
(calpains 1, 2, 4, 5, 7, 10, 12, and 13), whereas calpains 3, 6, 8, 9, and 11 have n10re
tissue-specific distributions (539), suggesting a highly c0111plex and diverse set of roles
for these cnzynlcs. Unfortunately, the specific physiological and pathological roles for
calpains and the individual isoforn1s responsible for known calpain functions have not
been con1pletcly elucidated. While calpains are thought to be cytosolic proteins,
investigators have reported calpain-like activities in isolated nlitochondria (230,231,233,
40S, 512,513,527) and in two cases have actually identified specific isoforn1s localized

to the 1l1itochondria (calpain 1) (232) as well as to Golgi and ER nlenlbranes (calpains 1
and 2) (52()). Sill1ilarly our laboratory has previously identified an endogenous
n1itochondrial calpain as calpain 10 and have inlplicated it in Ca 2+-induced 111itochondrial
dysl'unctioll, In thc present study, we have taken a 11101ecular approach using adenoviralnlediatcd shRNA to knock do\t\fn calpain 10 protein expression in a prinlary rabbit renal
proxil11al tubule ccll1ine in order to elucidate the physiological roles for ll1itochondrial
calpain 10.
Using an adenoviral delivery systenl, we were able to introduce calpain 10
shRNA. into prinlary rabbit RPTC'. Calpain 10 protein expression was decreased belo\v

detectable levels In 1111tochondria1 fractions 3 days after infection whereas cytosolic
calpain 10 levels \vere decreased to

~20~/o

of control levels by day 5. These results

suggest di fTcrcntial rates of calpain 10 degradation between the two conlpartn1cnts. The
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rate eli ffcrcnces seen between n1itochondrial and cytosolic calpain 10 n1ay be due to the
increased oxidative stress experienced by n1itochondrial proteins in general. For
exan1ple, it is 'Nell known that oxidized cytosolic proteins are degraded nluch faster than
their non-ox idized counterparts (569).

Also~

since nlitochondria obtain virtually alIa f

their protein conlponents fronl nuclear encoded genes, it would make sense for this
organelle to n1aintain a higher protein tun10ver rate.
Our laboratory has previously identified nlitochondrial calpain 10 as a ('a 2'._
sensitive n1itochondrial protease which plays a substantial role in Ca~+ -induced
respiratory dysfunction. However, we also sought to detenlline the basal physiological
roles for n1itochondrial calpain 10. In the present study, we were able to den10nstratc that
calpain 1O-deficient RPTC nlitochondria respire at control levels and are sufficiently
coupled and energized (Fig. 3-3 and 3-4). Interestingly, however, upon nleasurenlent

0

r

cellular A,TP levels, we observed a two-fold increase by days 4 and 5 after infection. 'vVe
latcr detenllined that nlitochondrial ATP synthase

~

levels were increased in calpain 10-

deficient RPTC, indicating a role for calpain lOin the upregulation or degradation ATP
synthase

f).

Subsequent analysis revealed that calpain 1O-deficient RPTC delllonstrated
elevated AMPK levels, a central player in the regulation of cellular ATP levels.AMPK
acts as a cellular fuel sensor ~rhich n10nitors AMP:ATP ratios (570). During periods

~)f

energy depletion, AMPK activates nuclear respiratory factors 1 (NRF-1) leading 10
enhanced transcription of nuclear-encoded respiratory subunits, as well as subunits of the
Fl/Fo ATPase of the oxidative phosphorylation systenl (567, 568). We believe that
AMPK n1ay be a proteolytic substrate for calpain 10 whose levels and activity increase in

148

the absence of calpain 10. In facC recent evidence fro111 Otani

el

al n1ay support this

clain1, as they found that chronic calpain inhibition increased total and phosphorylated
AMPK levels in n1urine 111yocytes (506). However, future work is necessary to evaluate
the activation status of AMPK and its downstrean1 targets. In addition, we also \\lcre able
to den10nstrate that the A TP synthase

r) subunit is a Ca2+-dependent proteolytic target lor

Initochondrial calpain 10, suggesting a ll1echanisn1 for the severe ATP depletion seen
during acute renal failure (571) and ischen1ic dan1age in other organ systen1s (572,573).
During the course of our studies,

\\le

noticed a significant decrease in cell survival

over the 5 day viral treatn1ent which often reduced total cell nU111bers to 60-70% of
control. Caspase-dependent apoptotic cell death was confirnled by in11l1Unoblot analysis
and via nuclear Di\PI staining which showed significantly increased levels of highly
condensed nuclei. \Vhile the n1echanisn1 of calpain 1O"s involven1ent in caspasen1cdiated apoptosis has not been elucidated, it is quite clear that calpain 10 plays a pivotal
role in 111aintaining RPTC cell survival since infection with scran1ble shRNA adenovirus
docs not induce apoptosis.

One attractive n1echanisnl linking calpain 10 to apoptosis could be through
regulation of the IKB-a/NF-KB pathway. NF-KB is a transcription factor responsible for
the induction OfnUl11erOUS gene fan1ilies, n10st notably genes involved in the

inllanllllatory respollse and those regulating cell survival (477). Under nornlal conditio1ls
IK8-[( is found bound to NF-KB and n1asks the nuclear translocation signal of the p()5
subunit ofNF-KB. Upon activation, IKB-a is degraded, allowing p65 to translocatc to the
nucleus and induce gene transcription (574). In fact, both calpains 1 and 3 have
dClllonstratcd their ability to cleave IkB-a (422,477,574) and thereby regulate cell
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survival. Calpai11 3 plays such as critical role in this pathway, that 111utations in C'/lPN3
result in enhanced n1Yocytc

apoptosis~

n1uscle

degerneration~

and the clinical entity

kno\vn as lin1h girdle n1uscular dystrophy type 2,t\ (477). It is therefore conceivable that
calpain 10 n1ay regulate cell survival through the IKB-O,/NF-KB pathway in renal
proxin1aI tubules. Prelin1inary data fron1 our laboratory has recently shown that total and
phospho-AId protein levels are decreased in calpain 1O-deficient RPTC. This n1ay tic in
to the above-n1cntioned pathway since Akt has been shown to activate the IKB-a/NF-KB
path\vay and pron10te cell survival (575). An alternative ll1echanisn1 for the apoptosis
seen in calpain 1O-deficient RPTC n1ight be through decreased cleavage of a rnell1ber or
the Bcl-2 fan1ily of proteins such as Bax or Bid, t\VO proapoptotic proteins previoLlsly
shown to be typical calpain substrates (10, 560). More work is needed to elucidate these
possible n1cchanisn1s.
]n

SUn1111ary~

\ve have sho\\/n that calpain 10 plays an inlportant role in

n1aintaining cellular ATP levels under basal conditions and that it nlay serve a
pathological role by decreasing ATP synthesis under conditions of Ca 2 overload. We
+

have also den10nstrated that renal calpain 10 nlay playa significant role in renal cel1
viability \vhich could have broad in1plications for disease states such as acute renal
f~lil11re

or renal cell carcinOn1'1. To date, the 11101ecular biology of calpain 10 has been

linked to ryanodine-induced

apoptosis~

GLlJT4 vesicle translocation, pancreatic beta-cell

cxocytosis, cataractogenesis, hypertriglyceridell1ia, and is genetically linked to Type II
diabetes, a disease associated \vith ll1itochondrial dysfunction (253, 481 ~ 486, 494, 502.
559). We believe that calpain 10 n1ay also serve to help regulate not only cellular /\ TP
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levels under basal and injurious

cOllditiollS~

but 111ay also playa lTIOre global role as a

crucial cell survival 111olecule.
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CHAPTER 4
DUAL TARGETING OF THE MOLECULAR CHAPERONE

OX~'GEN

REGULATED PROTEIN 150 (ORP150) TO ER AND MITOCHONDRIf\

ABSTRACT

Oxygen-regulated protein 150 (ORP 150) is an inducible endoplaslTlic reticulu1l1
(ER) chaperone nlolecule that is up-regulated after nUlnerous cellular insults and has a
cytoprotective role in

renal~

neural, and cardiac nlodels of ischenlia/reperfusion inj ury.

ORP 150 has also been sho\vn to playa role in lnaintaining cellular calciun1 hOll1costasis.
and in turn, regulating calpain activity. In this study, we identified ORP150 in whole rat
renal cortical nlitochondria and nlatrix fractions, have denlonstrated the targeting of an
ORP150-GFP construct to the n1itochondria ofNIH-3T3 cells, and have show'n that the
N-tcrn1inaJ 13 an11no acids of ORP 150 are sufficient for this translocation. ORP 150
expression vv'as found to be regulated by the CHOP/GADD 153 transcription factor and

ORP 150 levels increased in the nlitochondria and ER of COS- 7 cells after diverse
stresses including hypoxia, serunl starvation, prolyl hydroxylase inhibition
(din1cthyloxaloylglycine), and exposure to tunicanlycin, ethidiu1l1 bronlidc, and 2dcoxyglucose. Induction of the nlitochondrial specific stress response in COS-7 cells
through expression of an ornithine transcarbanlylase nlutant

(~OTC)

induced

n1itochondrial ORP ISO levels and calpain activity. To deternline 'vvhether nlitochondrial
ORP 150 and calpain 10 interact, rat cortical ll1itochondria exposed to calciul11 resulted in
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ORP 150 cleavage in a calpain-inhibitor dependent 111anner revealing that calpain 10
regu lates ORP 150 levels. These data denlonstrate a novel cellular localization for
ORP 150 and that nlitochondrial ORP 150 is up-regulated by CHOP/GADD 153 in
response to nlitochondrial and ER stress. Our data also suggest that ORP 150 is a
substrate for nlitochondrial calpain 10 and that ORP 150 111ay play an inlportant role in
preserving nlitochondrial function after cell stress.

INTRODUCTION

Oxygen-regulated protein 150 (ORP 150) was first identified and described in
I 99() by Ku\vabara

(!f ([/

as a hypoxia-inducible protein expressed in cultured rat

astrocytes (576). Since then, ORP150 has been reported to be a stress-inducible
chaperone 1110lecule reported to be localized to the endoplasnlic reticululll in nunlerous
cell types (576-579). It is a 999 anlino acid protein with both a signal peptide and an ER
retention-like signal at the N- and C-ternlini, respectively. There are three predicted
translation products arising fronl three separate transcription start sites defined by the
presence or absence of stress signals such as hypoxia or ER stress (580), ORP 150 has a
91 (X) sequence identity to the Chinese hanlster 170 kDa glucose-regulated protein
(GRP 170) and displays a high degree of sinlilarity to the ATPase donlain of the HSP70
fanlily of proteins, suggesting the ability to bind ATP (580). Up-regulation of OR PI 50
has been observed following hypoxia, serunl starvation, ischenlia, in cancer. and
following treatnlent with tunicanlycin or 2-deoxyglucose (577,578,581-589).
The functions of ORP 150 have not been fully elucidated, but it appears to playa
role in apoptosis (577,578,582-585,587,588,590,591), insulin secretion (592, 593),

153

and protein transport as delnonstrated by previous studies in nlacrophages and wound
healing (594,595), tunlor cells at the nlargin of the vascularized zone (589), and in
cultured MOCK cells (581).

Much of what is known about ORP150 conles fron1 studies

uti Iizing antisense, adenovirus-n1ediated, or whole anin1al knockdown of protein
expression (577, 582, 584). These studies have shown the in1portance of ORP 150 in
protecting cells fron1 ischenlia/reperfusion injury in neural, cardiac, and renal in vivo
1110dels (577, 582, 583). Sin1ilarly, ORP150 has been shown to provide anti-apoptotic
signals in neuronal cell n10dels (584,587,588,590,591) and in a variety of cancers such
as prostate (586), breast (589), and bladder cancer (596,597) as well as inlproving the
l11ctastatic potential of these tunlor lines (598).
Recently, ORP150 has been shown to be cytoprotective to the renal tubular
epitheliun1 after ischenlia/reperfusion injury (582). In particular, the authors
den10nstrated enhanced renal protection in transgenic nllce overexpressing ORP 150 and
i

increased renal injury in heterozygous ORP150+ - 111ice (582). The transgenic nlice and
M DCK cells exposed to hypoxic conditions in this study denlonstrated decreased caspasc
3 activation. Sinlilarly, the sanle investigators showed a protective role for ORP 150 after
nlyocardial

inf~lrction

in the rat heart (577). Rat hearts infected with adenovirus

expressing ORP 150 exhibited a blunting of calciun1 release, cellular calpain activity,
cytochronle c release, and caspase 3 activation. The authors suggested that the a11tiapoptotic c ffeets of ORP 150 \vere upstrean1 of cytochroll1e c release and caspase
activation, and that it nlay be tied to the regulation of ER calciull1 stores and the
subsequent activation of the nlitochondria-nlediated apoptotic pathway.
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Molecular chaperones are proteins which interact with unfolded or dan1aged
polypeptides. These interactions serve to stabilize and protect bound proteins fron1
denaturation and protein aggregation (599). Misfolded and aggregated proteins are often
signals for dov/nstrcan1 transcriptional events and frequently signal apoptosis through the
ER-n1ediated unfolded protein response, (UPR) (600). Molecular chaperones, often
referred to as heat shock proteins, can be found in nUlnerous cellular conlpartnlents
including the cytosol, ER, and n1itochondria (600). Mitochondrial chaperones can be
divided into various classes depending on their function and include the Hsp70,
Cochapcrone (OnaJ type), Cochaperone (GrpE type), Hsp60, Hsp 1OO/Clp, and
cyclophilin classes. These 11101ecules participate in pre-protein translocation, protein
folding, stress protection, protein and protein conlplex assen1bly, FeS cluster biogenesis,
thern10tolerance, and peptidyl-proline-isonlerization (601). Recently, Zhao et al have
described what is known as the nlitochondrial stress response (MSR), which is
responsible for the induction ofnu1l1erous n1itochondrial-specific chaperone 1110lecules
including HspC10, n1tOna.1, Cpn60, and

l~pn 10

folloyving n1itochondrial injury (602).

Upregulation of n1itochondrial chaperones serves to protect nlitochondrial function by
facilitating the folding, repair, and proper assenlbly of vital nletabolic enzynlcs critical
for ATP production and organellar integrity (603).
In the present study, \ve hypothesized that the localization and chaperoning
functions ofC)RP150 111ay not be linlited to the endoplas1l1ic reticulunl, but ll1ay also
reside in the nlitochondria. The nlitochondriallocalization of ORP 150 would provide
n1Llch needed insight into the anti-apoptotic activities of this n10lecule observed in varioLis
ill \'ilro

and ill ph'o n10dels. The preservation of 111itochondrial energy production due to
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chaperolle acti vity could also help explain the potent protection observed during vvhole
organ ischen1ia/reperfusion injury.

l\lA'TERLL\LS AND lVIETHODS
Isolation of

ER~

l\1itochondria, and Mitochondrial Subfractions.

Kidney n1itochondria \vere isolated fro111 111ale Sprague Dawley rats (250 g) (162).
Briefly~

kidney cortex was n1inced and h01110genized in Buffer A (0.27 M sucrosc, 5 n1M

Tris-HCl, 1 n1M EGTA, pH 7.4). Nuclei a11d cellular debris were pelleted by
centri fugation at 600 x g for 5 111in. The supell1atant was centri fuged at 7700 x g for 5
n1in rcsulting in a crude 111itochondrial pellet. The pellet was washed once in 0.27 M
Sllcrose and resuspended in Buffer B (130 111M KCl, 9 111M Tris-P04, 4 111M Tris-Hel, 1
n1M EGT A, pH 7.4). Crude 111itochondria were then layered onto a sucrose/Percoll
gradient and centrifuged at 20,000 x g for 20 n1i11. Endoplas111ic reticulu111 fractions were
purified by ultracentrifugation ofcytosolic fractions at 54,000 x g for 1 hr.
Purified 111itochondria were subfractio11ated as described previously (532). Outer
1l1Clllbrane rupture was achieved by hypotonic lysis in Buffer C (10 111M KH 2P0 4, pH
7.4) for 20 111in at 4°C. Mitoplasts were separated fron1 the supernatant by centrifugation
at 7,700 x g for 5 n1in. The resulting pellet was resuspended in Buffer 0 (300 111M
sucrose, 1 n1M EGTA, 20 n1M MOPS, pH 7.4) and sonicated five ti111es in 30 s bursts.

Inner 11len1brane and n1atrix fractions were then separated by centrifugation at 54,000 x g
for 30 n1in. Matrix fractions were frozen at -70°C for subsequent i111111unoblot analysis.

Inlillunobiotting.
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Isolated n1itochondria and

subfi~actions

were subjected to SDS/PAGE (4-12

(~)

acrylalllide) and transferred to nitrocellulose nlenlbranes. Melnbranes were incubated
vvith prilllary antibodies to GRP 170 (han1ster glucose regulated protein 170, polyclonal
rabbit anti-hanlster GRP170 -~ 1:1(000), a generous gift fron1 Dr. John Subjeck
(Departn1cnt of Medicine, Inlll1unology, Cellular Stress Biology, and Urologic Oncology,
Ros\vcll Park Cancer Institute, Buffalo, NY). This antibody has been used by other
investigators to detect ORP150 due to the 91 % protein identity between GRP170 and
ORP150 (604). The prinlary antibodies used were polyclonal rabbit anti-hanlster
GRP 170 (1 : 100(0) rabbit-anti-calpain 10 (Biogenesis ~ 1: 1000),

~-actin

(Signla --

1: 1(00), and n10use nlonoclonal anti-CHOP (Alexis Biochenlicals -- 1: 1000). Prill1ary

antibody incubation was followed by a horseradish peroxidase-conjugated goat antirabbit or goat anti-1l10USe secondary antibody (Santa Cruz - 1: 1000) incubation.
Inllllllllorcactive protein was visualized by enhanced chelnilun1inesence (Anlershanl) and
in1aged using an Alpha Innotech i1l1aging station.

Plaslnid (:ollstrnctioll.

eDNA for hU1l1an ORP150 (8C072436) \vas obtained fron1 ATCC in the pCMVSPORT6 shuttle vector. Full length ORP150 was anlplified by peR (Sense: 5'TGGGAG(~CCGCGGAGCCGAG-3',

Antisense: 5'-

TC A TC ACTGCC ATGACGGAGACCTC -3 ') and subcloned into pcDNA3 .1- TOPO- TACT -GFP (pcDNA3.1-0RP 150-GFP) (Invitrogen) producing an ORP150-GFP fusion
product (C -ternlinal GFP). GFP control plaS1l1ids coding for cytosolic GFP and
n1itochondrially targeted GFP (cytochrollle oxidase IV signal sequence) \vere generous
gi fls fro111 Dr. Douglas Sweet (Medical University of South Carolina, Charleston, SC).
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C0111plcnlentary DNA sequences coding for the N-tenl1inal 13 anlino acids or
ORP 150 were generated, annealed, and ligated into pcDNA3.1-TOPO-T A-C'T-GFP
(pcDNA3.l-TS-GFP) to asses N-tenninal sufficiency for nlitochondrial targeting. The
negative control for this experin1ent was obtained via ligation of the above sequence into
pcDNA3.1- TOPO-T A-CT -GFP (pcDNA3.1-TSINV -GFP) in the reverse orientation.

Cell Culture and Transfection.

NIH-3T3 fibroblasts were 111aintained in Dulbecco's Modified Essential Mediun1
(DMEM) containing 10 % fetal bovine serun1 until confluent. Cells were split and plated
onto 35-111n1 confocal dishes (MatTek) at a density of 250,000 cells/plate. At 70°/c)
connucnce~

cclls were transiently transfected with 4

~lg

pcDNA3.1-0RPlSO-GFP.

pcDNA3.1-TS-GFP, or pcDNA3.1-TSINV -GFP plas111id constructs using Lipofectall1inc
2000 (Invitrogen). Cells were incubated for 24 hr and, when indicated, exposed to 50
nfVl M itoTracker Red (Molecular Probes) for 20 n1in prior to confocallnicroscopy

iIl1aging. Cells \vere inlaged using a Zeiss LSM 5 confocal n1icroscope.

Induction of lVIitochondrial Stress.

('OS-7 cells were nlaintained in Dulbecco's Modified Essential MediuIl1
(L)f\1EI'v1) containing IO°Ic) fetal bovine serun1. At 70% confluence, cells were treated

\vith various concentrations of ethidiull1 bronlide for 7 days in order to disrupt the
n1itochondrial genon1e, as previously described (605, 606). ORP150 expression \\'as
subsequently detcrl11ined by inlnlunoblot analysis.
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!'vlitochondrial stress was also initiated via induction of the 111itochondrial stress
response (MSR). COS-7 cells \vere transiently transfected with 4

~lg

pC AGGS-vector

only control, pC AGGS-OTC, or pCAGGS-~OTC plasnlid constructs using
Lipofectanline 2000 (plasnlid constructs were a generoLls gift fronl Dr. Nicholas
Hoogcnraad, La Trobc University, Melbourne, AU). The 11litochondrial expression of the

aTe and ~-OTC protein products was nlonitored by inl1l1Ulloblot analysis 36 hours a11cr
transfection. Induction of the (MSR) was validated by i1l1111Unoblot analysis of the
nlitochondrial chaperone Hsp60 and the stress-induced transcription factor
CHOP/GADD153.
COS-7 cells were also challenged with various chel11ical stressors to elucidate the
inducible nature of ORP150. Cells were treated with tuniCa1l1ycin (1 0

~lg/nlL),

2-

dcoxyglucose ( 10 nlM), or the prolyl hydroxylase inhibitors dinlethyloxalyl-glycin
(DMOG) (250

~lM)

or ethyl-3,4-dihydroxybenzoate (EDHB) (500

~lM)

for 24 hours.

Select cultures were also grown in serulTI-free 111edia or under hypoxia for a period of24
hours. Expression of ORP150 \vas subsequently evaluated by il11n1unoblot.

Electrophoretic !\lohility Shift Assays.

Conlplinlentary oligonucleotides enconlpassing the CHOP binding sequence \vcrc
synthesized (\\;'i Id type, 5' -CTCGGCTCACTGC AACCTCCCTGCCTGA TT -3', and
con1pl in1cntary

strand~

nlutant, 5' -CTCGGCTCACTGTCGCCTCCCTGCCTGA TT -3',

and conlplinlentary strand). All duplex oligonucleotides were annealed by con1bining
then1 in a 1: 1 1110lar ratio in 10 111M Tris-HCI pH 7.5, 1 n1M EDT A, 50 nlM KCL heating
to 100°C for 5 1111n and cooling to roonl tenlperature. The 5' ends of the annealed
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oligonucleotides were phosphorylated with [y}2 pJ ATP using polynucleotide kinase and
purified by passage through NuTrap Probe purification colull1ns (Stratagene). A 20,000
C.p.lll. aliquot of the probe \\'as incubated for 30 n1i11 at 2SoC with an aliquot ofC()S-7
nuclear extract containing 10
glycerol. :2 111M

MgCI~,

~lg

of protein and 2

~lg

of dI-dC (Pharn1acia) in 40/0 vi\'

0.5 111M EDT A, O.S 111M dithiothreitol, SO 111M NaCI, 10 111M

Tris-HCI pH 9.0, and 300

~lg/n11

BSA in a total volun1e of 20

~L1.

The reaction n1ixtures

\\'cre resolved by electrophoresis on a SOlo polyacrylan1ide gel and dried gels analyzed by
phosphorin1aging. Antibody con1petition assays used 111011oclona1 antibodies against
CHOP (Alexis Biochcn1icals) or controln10noclo11a1

anti-~-actin

(Sign1a) (2

~lg)

'Nhich

\verc incubated for 30 ll11n on icc with the nuclear extracts before the addition of the
labeled oligonucleotides.

()RP 150 Degradation.

The scnsitivity of ORP ISO to calpain 10-n1ediated cleavage was detern1ined using
isolated rat renal cortical ll1itochondria. Briefly, isolated rat re11aln1itochondria \vere
incubated \vith Ca~-+- (1 ~lM final sustained Ca 2-+- concentration) for S ll1in at roon1
tCl11pcraturc in the presence and absence of 10 pM calpeptin. ORPlS0 degradation \vas
subsequently evaluatcd by in1n1unoblot analysis.

Calpain Activity.

C'alpain activity was assayed spectrophoton1etrically using the calpain-speei fie
substrate S LLV '( -AM C (Bachen1), as previously described (292). Mitochondrial extracts
(200 ~lg) \vere diluted in Buffer B and incubated with 10 n1M eaCh (to ensure nlaxill1al
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calpain activation) in the presence of 50

~lM

SLLVY-AMC. Activity was n1easured

under linear conditions as a function of AMC hydrolysis using excitation and en1ission
wavelengths of 355 and 444 nn1, respectively. The fluorescence of n1itochondria
incubated in the absence of substrate \vas equivalent to Buffer B alone.

RESULTS
()RP150 is Dually Targeted to the ER and Mitochondria.

Evaluation of the N-tern1illus of OR PI 50 revealed an enrichn1ent in positivelycharged residues indicative of classical n1itochondrial targeting signals. The protein
localization algorithn1 MITOP2 (http://ihg.gsf.de/n1itop2/starLjsp) was used to further
evaluate the possibility that ORP 150 11lay be a ll1itochondrial protein and returned a
probability score of 54(/0. Endoplasn1ic reticulu111 and 111itochondrial fractions fro111 rat
kidney cortex \vere probed for ORP 150 using a prin1ary antibody against the han1ster
glucose regulated protein 170 (GRP170) (A generous gift fron1 Dr. John Subjeck). This
antibody has been used by other investigators for in1lTIUnodetection of ORP 150 because
orthe high degree ofsequellce identity between the two proteins (910/0) (604).
In1nlunoblot analysis revealed the presence of ORP150 in ER, 11litocho11dria, and the
n1itochondrial 11latrix fraction (Fig. 4-1 ).
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ER

Mito

Mat

4

ORP150

Figure 4-1. Localization of ORP150 to the ER and Mitochondria.

The subcellu lar localization of ORP 150 was assessed by inlll1unoblotting. Tissue fron1
rat renal cortex was isolated and separated into nlitochondrial and ER fractions by
differential centrifugation. Equal amounts of protein frol11 ER, whole Initochondri a~ and
11litochondrial lll atrix was reso lved by SDS-PAGE and probed with antibodies against
GI~P 170 (ORP 150 honlolog) . Results are representative of three individual experinlents.
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()I{P150 is Targeted to Mitochondria Via an N-terminal Targeting Peptide.

Hun1an ORP150 was subcloned into a TOPO-TA-CT-GFP vector (Invitrogen) to
produce an ()RP ISO-GFP fusion protein containing an intact N-tell11inus and a CterJllinal GFP n10iety. This construct was chosen to avoid 1110dification of the N-ternlinus
vvhich nlay result in the loss of putative n1itochondriallocalization n10tifs. NIH-3T3 cells
\vcrc transCected vvith the pcDNA3.1-0RP1S0-GFP construct for 24 hr, exposed to
MitoTracker Red (20 111in), and in1aged via confocal 111icroscopy. Cells also \vere
translceted using GFP constructs speei fie for cytosol (data not shown) or n1itochondria
(Fig. 4-2A) to serve as positive GFP controls for these con1partn1ents. The transfection
expcrinlents revealed that the ORP1S0-GFP construct is localized to n1itoehondria oC
NIH-3T3 cells (Fig. 4-28). The presence ofORP1S0 in the n1itocho11dria and its relative
absence in the rest of the eell supports the idea that the GFP 1110iety on the C-tenninlls
1l1asks the ER retention signal (KNDEL) and distupts the norn1al ER-targeting of this
protein.
To test the hypothesis that the N-tell11inus of OR PI SO is responsible for its
1l1itochondriallocalization, oligonucleotides coding for the first 13 N-ternlinal an1ino acid
residues \vere annealed a11d ligated into the TOPO-TA-CT-GFP vector. Negative
controls included the sa111e oligos inserted in the reverse orientation. NIH-3T3 cells
transfeeted \vith these constructs displayed eytosolic targeting and lnitochondrial
targeting for the reverse and forward orientations, respectively (Fig. 4-3A). These results
reveal that the N-tcrnlinal 13 an1i110 acids of ORP 150 are sufficient for n1itocholldrial
targeting. 'A/e also analyzed the N-tell11inus of ORP ISO using a helical \vheel applet
OH!.12:/~~y_~~~12igin f'o.on!..cll/lectures/index- 7.htnll)
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designed to display peptide sequences

in an alpha helix representation (Fig. 4-38). The results revealed that the N-tcrnlinus of
ORPl50 can Cornl the classical 1l1itochondrial targeting 1l10tif(the anlphipathic helix).

164

A

B

Figure 4-2. ORP150 translocates to the mitochondria ..
The localization of ORP150 was confirmed by colocalization of ORP150-GFP and the
mitochondrial-specific dye MitoTracker Red. NIH-3T3 fibroblasts were used for
localization experiments because of their distinct elongated mitochondrial morphology.
(A) Cells were transfected with a control mitochondrially targeted green fluorescent
protein (Mito-GFP) construct and subsequently stained with MitoTracker Red. (B) Cells
were transfected with pcDNA3.1-0RP150-GFP, and subsequently stained with
Mito Tracker Red. Results are representative of three independent experiments.
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Figure 4-3. The N-tcrminus of ORP150 is required for mitochondrial targeting.
(A) NIH-3T3 fibroblasts \vere transfected with the pcDNA3.1-TS-(}FP and pcDNA3.1TSINV -(JFP constructs. pcDNA3.1-TS-GFP-transfected cells were subsequently stained
\vith Mito·rracker Red. Results are representative of three independent experinlents. (B)
This hel ical vv:hcel diagranl shows a representation of the ORP 150 N -tern1inus as if it
\vere a helix. The putative helix is an1phipathic in nature~ containing hydrophobic and
aliphatic residues on one half and positively-charged residues on the other. Adjacent to
the helical \vheel diagran1 is a schen1atic representation of the N -terminal 13 an1ino acids
used to engineer the targeting sequence-GFP construct (asterisks denote positivel)
charged residues).
This helical wheel was generated using an applet found at
http://\v\v\v.bioinfo.org.cn/lectures/index-7.htn11.
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Ala

()RP150 Expression is Increased After Mitochondrial Stress.

ORP ISO is a chaperone nl0lecule best kno\\/n for its induction in the ER under
hypoxic conditions (S76). Given its presence in the nlitochondria,

\VC

sought to

deternline if this stress-responsive nl0lecule would also be induced in nlitochondria under
various cellular insults/stresses. First, we induced cellular stress using ethidiun1 brOlllidc
treatnlent because this treatn1ent has been shown to disturb nlitochondrial function by
decreasi ng n1 itochondrial gene transcription (608). COS-7 cells were treated \vith variolls
concentrations of ethidiu111 bronlide for a period of 7 days. ORP ISO expression \\/as
found to increase in the presence of ethidiunl bronlide in a dose-dependent nlanner (Fig.
4-4 ).

Subsequently, 'Ne chose to induce what is known as the nlitochondrial stress
response, or MSR, as described by Hoogenraad et al (602). The MSR is induced via
transfection of cells \\'ith a n1utant fornl of ornithine transcarbanlylase (OTC"), a protein
norn1ally expressed in liver nlitochondria. The n1utant fonll ofOTe is incapable of
folding correctly after nlitochondrial in1port and induces the expression of nlitochondriaspeci tic chaperone 1110lecules such as Hsp60, chaperonin 10, chaperonin 60, and n1tDna.l
(60.2). C'OS-7 cells \vcrc transiently transfected \\'ith wild type OTC, nlutant ~OTC, and

vector only expression vectors for 36 hr. Protein expression was verified by inl1l1Ul1oblot
analysis. and dcnlonstrated nlature and processed wild type and nlutant OTC in the
111itochondria (Fig. 4-5A). Induction of known MSR proteins (Hsp60 and
('HOP/(JADDlS3) in the flOTC-treated cells was evaluated by inllTIunoblot analysis
(Fig. 4-58). Finally. the expression of OR PI 50 was evaluated under the sanlC conditions
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and \vas found to be increased in both the nlitochondrial and ER fractions of L\OTCtreated cel)s (Fig. 4-5C).
These results reveal that two different nlitochondrial stresses result in ORP150
induction. It should also be noted that the L10TC-ll1cdiated increases in ORP 150
expression \vas not confined to the

nlitochondria~

but also increased in the ER. This

effect is 1110st likely due to conlpeting signals for subcellular localization, whereby
sinli lar anl011nts of protein are trafficked to both the ll1itochondria and ER.
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Figure 4-4. Chronic ethidium bromide treatment induces expression of ORPl 50 .

The effect of chronic ethidiunl bronlide treatlnent and ORP 150 expression was evaluated
in COS-7 cells. COS-7 kidney fibroblasts were treated with increasing concentrations (0.
0.1. 0.4. and 1.5 ~lghnl) of ethidium bromide for a period of 7 days. Mitochondrial
fract ions were iso lated and subjected to SDS-PAGE analysis and probed for the
expression of ORP 150 using pril11ary antibodies against ORP 170.
Results are
represe ntative of three independent experinlents.
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Figure 4-5. The mitochondrial MSR induces expression of ORP150.
The n1itoc hondrial stress response (MSR) can be induced via nlitochondrial expression of
a nlutated forn1 of ornithine transcarbanlylase (~OTC). ~OTC form s insolubl e protein
aggregates once inside the l11itochondria and induces the expression of nun1erous
nli tochondrial-spec ific chaperone nlolecules. (A) Diagral11111atic representation of the
wil d type OTe and deletion nlutant (~OTC) frol11 which the carbamyl phosphate-bindi ng
donlain (an1ino acid s 30-114) have been deleted. (B) Transient expression of wild type
()TC and ~OTC in n1itochondrial extracts of COS-7 cells. The p- and n1- protein s
represent precursor and signal peptide-cleaved n1ature forn1s of both OTC and ~OTC.
(C) Induction of MSR was validated by western blotting. Hsp60 and CHOP protein
leve ls w"ere increased significantl y in ~OTC-transfected COS -7 cell s. (D) Effects of the
MSR on ORP150 expression was evaluated by western blotting. ORP150 protein level s
were significantly elevated in ~OTC-transfected COS -7 cells. Results are representati vc
of three independent experinlents.
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()RP 150 Expression is Increased AJter Cellular I nsuIts.

A tter dcn1011strating the induction of ORP 150 expression by nlitochondrial
strcssors~ \\ie

sought to detern1ine if other, nlore broad chen1ical and environn1ental

stresses could induce ORP150 protein expression. COS-7 cells were treated for 24 hr ill
the presence of tunicanlycin (1 0

~lg/n11),

hydroxylase inhibitors DMOG (250

~lM)

2-deoxyglucose (10 n1M), and the prolyl
and EDHB (500

~lM).

Cells also were grovvn in

the absence of serun1 or under hypoxic conditions for 24 hr. Each treatnlent induced
ORP ISO expression above baseline (Fig. 4-()). Also, the addition of tunicanlycin induced
a splice variant of ORP 150 and showed a preference for the lower 11lolecular \veight
isofc)rnl (Fig. 4-6). These results reveal that diverse cellular stresses induce ORP 150.

()RPI50 Expression is Regulated by the Transcription Factor C:HOP/GADD153.

ORP 150 expression is highly regulated by hypoxia and the unfolded protein
response (lJPR) via presence of an endoplasn1ic reticulunl stress elen1ent (ERSE)
spanning intron 1 and exon 2 orthe ORP150 gene (580). The transcription factor CHOP
is kno\\ln to induce l1UnlerOUS stress response genes including 111itochondrial chaperones
such as C'pn60/1 0, ('lpP, and n1tOnaJ (602), has been shown to be upregulated through
the MSR and UPR (602, 609), and has an identifiable binding elell1ent (TGCA.ACC) ill
the 5' pr01110tcr region (-2645 bp upstreanl of exon 1A) of the ORP j 50 gene. We
therefore hypothesized that MSR-ll1ediated ORP150 expression in the ER and
nlitocholldria is through CHOP induction. To evaluate this hypothesis, we perfornled
electrophoretic 1110bility shi ft assays in which a 30 bp ORP 150 pron10ter fragnlent
containing the ('HOP-binding elenlent (wt) and a 111utant probe (nlutant) containing an
altered CHOP site were incubated with nuclear extracts isolated fron1 cells transfccted
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vvith various constructs or incubated with tunicall1ycin as indicated in Figure 8 and
subjectcd to PAGE and Phosphorl1nager analysis. Inln1UnOC0111petition assays were
pcrforll1cd using nuclear extracts of eOS-7 cells transfected with
(Fig. 4-7, lanes

6-8)~

~OTC'.

As can be seen

an increase in the level of a high 1l10lecular weight con1plex is

observed vvith incubation of nuclear extracts fron1 the OTe and

~OTe

COS-7 cell

transrection groups, vvith the largest all10unt of binding seen in cells expressing

~OTC.

As a positive control, extracts fron1 tunical11ycin-treated cells were used, because this
chcnlical in kno\vn to induce CHOP expression (610) and led to an increase in thc high
l110lecular v'leight c0l11plex (Fig. 4-7, lane 9). Nuclear extracts froll1 cells treated vvith
tunicanlycin or cells expressing the various constructs did not produce high nlolecular
\veight conlplexes \vhen incubated with 111utant probe DNA (Fig. 4-7, lanes 1-4). Wc
then assessed \vhether the conlplex observed was due to binding of CHOP to this
pronlotcr region. Nuclear extracts of cells expressing

~OTe

\vith n10110clonal antibodies against CHOP or control

(anti-~-actin)

were isolated and incubated
prior to conducting

the EMSA. As shown (Fig. 4-7, lanes 11-12), the cOll1plex was depleted in
inll11unocon1peted extracts, suggesting that the band shift was dependent on binding of
CHC)P to this region of DNA.
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Figure 4-6. Effects of Cellular Stressors on ORP150 Expression.

The effects of various cellular insults on ORP150 expression were evaluated in COS- 7
ce ll s. Ce ll s \ivere cultured in the presence of each chenlical reagent for a period of 24
hours (tun icanl yci n - ] 0 J.lg/nll~ 2-deoxyglucose - 10 InM, DMOG - 250 J.lM, ED I-IB 500 ~lM ). Cells cultured in the absence of fetal bovine serunl or under hypo.' ic
conditions were also harvested at 24 hr. Sanlples were subsequently prepared fo r
inll11unoblot analysis and were probed with antibodies against ORP 170. Results arc
representative of three independent experinlents.
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Figure 4-7. ()RP1S0 expression is regulated by the transcription factor ("H()P.
(A) Nucleotide sequence alignnlent of the CHOP consensus elelllent and the putati\"l~

Clle)}> binding elcnlent in the ()RP 150 pronloter. Nlllllbers indicate the distance n'onl the

transcription initiation site and shaded areas the CHOP consensus binding site. (B)
EMSA of nuclear extracts fronl COS-7 cells transfected with aTe constructs. A probt'
corresponding to a 30 bp (JRP 150 prollloter fragnlent containing the CH()P-bindint::
elenlent (vvild type) and a nlutant probe (nlutant) containing an altered CI--I()P site vvcrc
incubated \\lith nuclear extracts fronl cells transfected with varioLls constrLlcts or
incubated \\lith tunicanlycin as indicated and subjected to PAGE and PhosphorInlagcr
analysis. Inlnlunoconlpetition assays were perforIlled using nuclear extracts of C()S-7
cells transfected with ~OT(~ and incubated \vith anti-CHOP or anti-~-actin (control)
antibodies. before adding radiolabelled \vild type probe. Results are representative 01'
three independent experinlents.
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()RP150 is a j\;1 itochondrial

(~alpain

Substrate.

Recent evidence using cardiac ischenlia as a 1110del systell1 has suggested that the
ovcrexpression ofORP1S0 negatively regulates cytosolic calpain activity by blocking the
ischenlia-induced release of ER Ca 2+ stores (S77). Given that ORP 150 and calpain 10
are both localized to the nlitochondrial

nlatrix~

we deternlined whether these proteins

interact \\'ithin isolated nlitochondria. Calpain 10 protein levels and activity were
dctcrInincd in COS-7 cells after transfection \\lith vector or ~OTC. Calpain 10 activity
was found to be signi ficantly elevated in i10TC-transfected cells as conlpared to vector
alone (Fig. 4-8A).

Subsequently~

we probed for calpain 10 protein expression in cells

transfcctcd \\lith the sanlC constructs. Calpain 10 protein levels showed no difference
bet\vccn vector and

~OTC -transfected

cells (Fig. 4-88).

To further evaluate ORP lS0/calpain 10 interactions, we investigated the

possibility that ORP150 is a calpain substrate. Using the calpain substrate prediction
algorithrl1 PEST-FIND (http://srs.nchc.org.tvv/enlbossbin/Cfllboss.pl'?_action=input&_app=pestfind), \ve deternlined that ORP1S0 is a candidate
substrate for calpain-nlcdiatcd proteolysis. Subsequently, degradation experinlents \vcrc
})erfOrnlcd in \vhich isolated rat renal ll1itochondria were treated with
sllstai ned concentration) in the presence and absence of 10

~lM

'"'".

C~a-'

(1 pM

calpeptin. ORP ISO \\;as

found to be cleaved in the presence ofCa.2+~ and this degradation was significantly
inhibited by prctreatnlcnt with calpeptin (Fig. 4-8C). These results suggest that calpain
1() activity increases in response to the MSR and that this ll1itochondrial protease cleaves

ORP ISO in a calciunl-dependent nlanner.
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Figure 4-8. ()RPt 50 is a substrate for mitochondrial calpain.

Mitochondrial calpain expression and activity was evaluated under various conditions.
Mitochondrial calpain's ability to cleave ORP150 was subsequently assessed via d
calciun1-dependent degradation assay. (A) Mitochondrial fractions fro 111 vector and
i1()TC-transfected ('OS-7 cells 'vvere assayed for calpain 10-111ediated SLLVY -J\f\1C
hydrolysis in the presence of 1 ~lM Caeb. (B) Mitochondrial calpain 10 levels in C'()S-7
cells 'vvere assessed by in1ll1ulloblot analysis following induction of the rvlSR by ~()TC
expression. «(=) Rat renal cortical nlitochondria were incubated with 1 pM C~aC'12 in the
presence and absence of 10 ~lM calpeptin. ORP 150 degradation 'vvas assessed by
inlnlunoblot analysis. Data are expressed as nleans ± SEM (N=3). Means \;vith differenl
lettered subscripts within each group are significantly different fron1 each otheL p<O.05.
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DISC:USSION
There are two nlajor classes of stress proteins: (1) the

GRPs~

which are induced

by inhibition of glycosylation~ defects in calciunl honleostasis, chronic
dcprivation~

and reductive

stress~

and (2) the

HSPs~

hypoxia~

glucose

which are induced by heat, oxidative

stress, and ethanol, anlong varied other environnlental stressors (611). The GRPs are
1110Stly

found as resident ER proteins while the HSPs are generally confined to the

cytosol, nucleus, and nlitochondria, reflecting the sensitivities of these conlpartnlents to
various cnvironnlental stresses. Despite their varied localizations, they all act to preserve
the llornlal integrity and functional viability of daJllaged proteins. Their activities range
fronl, but arc not linlited to, protein stabilization, protein folding and unfolding, the
chaperoning ofnloleculcs between cellular conlpartlllents, and protein conlplex assclllhly
(612). Most of the known chaperone 1l10lecules have expression profiles that are based
on thc presencc of cellular stresses such as heat, low glucose, and oxidation (612). Under

such stresses, cells rapidly upregulate the expression of these nlolecules in attenlpts to
prevent the accunlU 1ation of danlaged proteins and ultilllately cell death.
Since the discovery of ORP150 in 1996 as a hypoxia-inducible e1enlent in
cultured astrocytes, nluch has been elucidated about its protective role in cell death.
f--Iovv'c\'cr, little is known about the actual 1l1echanislll of this protection. Nunlerous
studies have placed the site of action of ORP 150 at the ER due to its s1n1ilarity to
GRP 170 and its possession of an N-ternlinal signal peptide and C-ternlinal ER retcntiolllike signal (KNDEL)

(576~

607). Ho\vever, the possibility ofORP150 localization to the

n1itochondrial fraction has not been evaluated to date.
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Nunlcrous studies have inlplicated a role for ORP150 in blocking cell death in
various tllodels (577,578,582-584,588,590,591). Many of these studies have
denlonstrated increases in cytosolic calciunl (577, 584), cytochrollle c (577), and active
caspase,3 (577,582,584) in stressed cells, all of which were found to be decreased \vhcl1
ORP 150 expression was induced. Even nlore striking were reports of decreased calpain

activity in ()RP150 transgenic aninlals after induction of cardiac ischenlia/reperfusion
injury or glutaIllate-nlediated neuronal toxicity (584). Taken together, these observations
would suggest that although prinlarily found in the ER, the nlitochondriallocalization of
such a nlolecule could provide a novel nleans of regulating cell death through nlodulatioll
of the intrinsic apoptotic pathway or through 1l10dulatio11 of cellular calpain activity
(kno\vn to Illediate apoptosis under various conditions) (574, 613, 614).
Mitochondrial chaperone nlolecules are unique and varied in their function. Thcy'
scrve to aid in preprotein translocation, protein folding, protection against cel1ular
stressors, protein assen1bly, Fe/S cluster biogenesis, prevention of protein aggregation,
renaturation of heat-stressed proteins, thern10tolerance, peptidyl-prolyine-isonlerisation,
and can also serve as cochapero11e 1110lecules which help n1aintai11 and stinlulate the

activity of other chaperone species (613). Mitochondrial proteins encounter extrenlcly
harsh conditions and are exposed to elevated levels of ROS and

RNS~

conditions 'vvhich

ensure unending n10dificatioll and inactivation ofn1any protein species. Furthernlorc,
si nec over

9(Y~;)

of the

III itochondrial

proteollle is derived fron1 nuclear gene

prodllcts~

presence of nlitochondrial chaperones is essential for regulating protein inlport and
folding, and in Il1aintaining overall nlitocholldrial viability.
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the

In the present study, we hoped to identify the nlitochondrial localization of
ORP 1SO and elucidate conditions under which its expression is upregulated. Endogenolls
ORP 150 expression in rat kidney cOliex was found to be localized to the ER and
n1itochondria as indicated in Figure 4-1. We also evaluated ORP 150 expression in
puri fied nlitochondrial nlatrix fractions to elinlinate the possibility of ER contanlinatioll
in our lllitochondrial isolations, and found conlparable levels as conlpared to the
organellar fractions alone (Fig. 4-1). Although these data were highly suggestive of the
Illitochondrial localization of ORP 150~ we endeavored to support these findings llsing
confocal 11licroscopy as depicted in Figure 4-28. ORP 150 was cloned into the TOPOTA-CT -G FP expression vector designed to place a gene of interest in franle \vith a CtCrl11inal GFP nloiety. GFP was placed at the C-tern1inus of ORP150 in order to avoid
blocking any putative N-ternlinal n1itochondrial targeting signals.

However~

in doing so.

it is possible that we nlay have blocked exposure of the C-ten11inal ER retention signal
(KNDEL) as evidenced by a lack ofGFP not colocalized with MitoTracker Red (Fig. 428).

1'v1any nlitochondrial n1atrix-targeted proteins contain either an N or C-ternlinal
signaling nlotif. At the N-tern1inus, this n10tifoften takes the fornl of an an1phipathic
helix containing positively-charged residues on one half of the helix and hydrophobic
residues on the other (543). We deternlined the putative existence of such a 1110ti f in
ORP150 using a helical \vheel applet (http://www.bioinfo.org.cn/lectures/index-7.htnlIL
designed to display peptide sequences in a helical representation. This applet produces
the vic\v of a protein helix looking down its axis froll1 the N to C-tern1inus. The results
revealed that thc N-terll1inus ofORP150 can indeed fon11 such an anlphipathic helix (Fig.
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4-38}. \Ve tested the hypothesis that the N-tern1inal 13 an1ino acids ofORP150 arc

responsible for ll1itochondrial local ization, and detern1ined that this signal sequence is
sufficient for the targeting of ORP 150 to the n1itochondrion (Fig. 4-3A). It is likely that
the N-tern1inal nlitochondrial targeting signal and the C-tern1inal ER retention signal
C0l11PCtC \vith each other for the norn1al trafficking of OR PI 50 which nlay be altered
during stresses felt by various cell ular con1partn1ents.

The expression of n1itochondria-speci fie chaperone n10lecules can be induced by
a variety ofstressors including heat shock, oxidation, nlitochondrial inhibition, and via

accul1lLllatiol1 ofnlitochondrial protein aggregates (603). We utilized two independent
111cthods ofnlitochondrial stress induction to evaluate their effects on the expression

or

111itochondrialORPl50. Chronic dosing ofCOS-7 cells with ethidiull1 bronlide induced

~)

dose-dependent increase in nlitochondrial ORP150 expression (Fig. 4-4). Sin1ilarly, the
induction of the nlitochondrial stress response (MSR) using a truncated deletion 111utant
of ornithine transcarbanlylase increased ORP150 levels in both the ER and n1itochonciri<11
fractions (Fig. 4-5). These data suggest that ll1itochondria-speci fie stressors can induce
ORP 150 and that this ll1ay serve as a protective nlechanislTI to preserve nlitochondrial
viability. ER-localized ORP 150 expression can be nlodulated by a variety of ehen1ical
agents and cell treatn1ents including hypoxia, hyperosll10tic culture conditions, and
culture in the presence oftunican1ycin and 2-deoxyglucose (577,578,581-588). We
\vcrc able to sho\v that a l1u111ber of these treatnlents as well as SerU111 starvation and
treatn1cnt with prolyl hydroxylase inhibitors (to ll1in1ic hypoxia) were able to induce
ORP 150 expression not only in the ER, but in the ll1itochondria as well (Fig. 4-6),
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suggesting that nunlerous global cellular insults can regulate the pools of ORP 150 in both
the ER and nlitochondria.
As nlcntioned above, studies by Aleshin ct 01 and Kitao et al have in1plicatcd a
role Cor ORP 150 in regulating calciu111 hon1eostasis al1d the subsequent activation of
calpains (577,584). Recent studies have also begun to place calpains at the site of the
rnitochondrion (232,526). Therefore, an interaction between 11litochondrial calpain and
ORP 150 could provide n1uch needed insight into the antiapoptotic etTects seen in cell
inj ury nlodels \vhen overexpressing ORP 150. Furthern10re, evaluation of the ORP 150
peptide sequence via the PEST-FIND algorith111 (http://srs.nchc.org.tw/ell1bossbin/cnlboss.pl?~~action=input&_app=pestfind)

identified it as an extrenlely likely

candidate Cor calpain-nlediated proteolysis. To detect any possible relationship between
nlitochondrial calpain and ORP 150, calpain activity and protein levels were exanlined ill
COS-7 111itochondrial extracts prepared fron1 vector only and

~OTC-transfected

(Fig. 4-8A and 88). These data denlonstrate enhanced calpain activity in the

cells

t~lce

of

equal an10unts of protein and seen1 to suggest a role for n1itochondrial ORP 150 in
nlaintaining calpain function via protein stabilization and/or activation of the n10leculc.
Conversely, in the setting ofn1itochondrial Ca 2+ overload, ORP150 was found to be
degraded in a Ca 2+ and calpain-dependent fashion (Figure 4-8C). We suggest that
ORP150 n10st likely functions to 111aintain overall protein stability \vithin the nlatrix or
the n1itochondria.
disrllpted~

However~

during cellular injury in which calciulTI hon1eostasis is

lllitochondrial calpains becon1e activated and negatively regulate ORP 150.

thereby din1inishing its ability to playa functional role as a chaperone nlolecule. The los:;
of' a nlitochondrial chaperone would n10st certainly hasten 111itochondrial protein
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dysfunction and degradation and could lead to the enhanced apoptosis seen in cells and
anin1als deficient in ORP150 (577, 582, 584), however, n1any future studies are needed 1n
veri fy this hypothesis.
Finally,

\\ie

sought to detenl1ine a possible nlechanisn1 of 111itochondrial-strcss

driven ORP 150 induction. Work by Kaneda et (If have previously den10nstrated the
production of three n1RNAs driven by alternative pron10ters and have shown the
preferential induction of one species under stress conditions including hypoxia and
tunicanlycin treatnlent (580). In this study, pronl0ter analysis revealed the presence of
three transcription startsites which begin at exons 1A, 1B, and exon 2. cDNAs
containing exons I A and 1B are translated fron1 a start codon located at the 5' end of
cxon 2 \vhereas translation of cDNAs beginning at exon 2 is initiated fronl a start codon
located in exon 3. Interestingly, under norn1al conditions, the nlajority of cDNAs cont<li II
the 5' end of exon 2 while cells cultured under hypoxia or in the presence oftunical11ycin
produce n10stly cDNAs containing exon 1B at their 5' ends. The differential
transcription of the ORP 150 gene during stress is thought to be controlled by the prCSCl1Cl'
oran endoplasn1ic reticulunl stress elen1ent (ERSE) located in the pronl0ter region.
Indeed, upon analysis of the ORP 1SO pron10ter region, a 19 bp sequence was identi fled as
being alnlost identical to that of the ERSE (CCAATN{)CCACG) with only 1 bp

l11is111atch. The authors also showed that this sequence interacts with the transcription
factor ATF6 and preferentially produces cDNAs containing exon 1B due to overlap of
the ERSE sequence with the

5~

end of eXOl1 1A. Induction of the unfolded protein

response (UPR) is initiated under periods of ER stress to upregulate cellular chaperones
required to properly fold and 11laintain danlaged cellular proteins (612). Recent reports
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have also denlonstrated the uprcgulation of transcription factors such as
CHOP/GA.DD 153 and XBP-l in response to the UPR (610).
We vvcre able to denlonstrate the induction of nuclear CHOP/GADDIS3 protein
levels after the induction of ~OTC-nlediated MSR in COS-7 cells (Fig. 4-5). We \verc
subsequently able to denlonstrate the binding of CHOP to a putative CHOP binding
elelnent located 2645 bp upstreanl of exon 1A via electrophoretic nlobility shi ft assays
(Fig. 4-7). Taken together, the enhanced expression of ORP150 and

CHOP~

and the

ability ofC'HOP to bind elenlents upstreanl of the ORP150 pronloter under these
conditions suggest the ability of enhanced CHOP expression to nlodify ORP 150 levels
during periods ofnlitochondrial stress. These finding are also significant since induction
orthe UPR also upregulates cellular CHOP levels.
Our data also suggest the di fferential regu lation of ORP 150 transcripts after
induction of ER stress 'vvith tunicanlycin. We have denlonstrated the production of a
Slllallcr lllolecular \veight ORP 150 protein product after tunicanlycin treatlllent which is
not seen a ftcr treatnlent 'vvi th various other inhibitors (Fig. 4-6). \Ve suggest that stressinduced expression of CHOP subsequently induces expression of the larger nloJccuJar

\veight isofonll of ORP150. In turn, tunicanlycin-induced ER stress induces hoth CHC)Pnlcdiatcd and A TF6-nlediated induction of both nlolecular weight isofornls of ORP ISU.
In sunlnlary, we conclude that ORP150 is differentially localized to hoth the ER
and lllitochondria and that this localization is dependent on the presence of a C-ternlinal
KNDEL and N-tcrnlinal nlitochondrial targeting signal, respectively. We have also
dC1l10nstratcd that enhanced lllitochondrial expression of ORP 150 increases
1l1itoc\1ondrial calpain activity under basal conditions and that ORP150 is negatively
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regulated by the sanle calpain under conditions of Ca 2+ overload. Our studies also
provide evidence lor a novel nlechanislll of transcriptional regulation of ORP 150 by the
stress-induced transcription factor CHOP which is upregulated by both ER and
111itochondrial-speci ftc stressors. The localization of ORP 150 to the nlitochondria nlay
provide an alternative nlechanislll for the anti-apoptotic activity of this chaperone
nl0lcculc. lA.lternatively, ORP150 nlay produce anti-apoptotic signals specific to both
cellular conlpartnlents and provide additive cytoprotective effects when induced through
cell u lar stressors.
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CHAPTERS
SUlVIIVIARY, CONTRIBUTIONS, AND FUTURE

DIREC1~IONS

SUMMARY OF THE CURRENT LITERATURE

Since their discovery in 197(), calpains have been inlplicated in nUlnerous
physiological and pathological processes. Unfortunately, only isolated infonnation is
available concerning the cellular and ill vivo functions, activation, and regulation of the
diffcrcnt calpain isofornls.
It has beconle clear that pathologies dOlninated by the dysregulation of cellular

calciunl honleostasis are very often associated with increased cytosolic calciunl
concentrations and enhanced calpain activity. Sonle of these pathologies include
ncurodegenerative disorders (Alzheinler's, Parkinson's, Huntington's, anlyotropic late!",l!
sclerosis, nlultiplc sclerosis), ischenlic injury (stroke, ll1yocardial infarction, acute renal
!~li1ure),

and cataract forn1ation (120,122,447,448,454,457-461,472). These

pathologies are all associated \vith increased activities of either calpains 1 or 2, both
typical EF-hand containing calpain isofonl1s. Given that there are 9 typical calpains

\\'llh

varying tissue distributions, it is quite possible that the nlore understudied typical calpail1
species could be associated \vith nunlerous other disease states. More exacting 11101ccular
studies '0.:ill be necessary in order to elucidate the functions of the renlaining species
typical calpains.

or

The 1110st understudied class of calpains ren1ains that of the atypical isoforn1s.
These species include 5 isoforll1s which retain the conserved active site of the enzyn1c,
but lack the pcnta-EF hand regulatory calciun1 don1ain at the C-tern1inus. It is currently
unknovvn hO\\1 these isoforn1s are activated or inhibited for that 111atter. In fact, a potenti~Il
physiological role for only one of these isoforn1s (calpain 10) has been suggested in
111an1111als. The con1plex diversity of the atypical calpains at the C-tern1inus suggests a
\vide array offunctions and possible regulatory don1ains which ren1ain to be evaluated. II
is unlikely that the atypical calpains are as calciun1-sensitive as their typical counterparts
due to the absence of calciun1 binding sites at their C-tern1inus. However, recent
crystallographic studies of calpain 2 have identified potential Ca 2+-binding sites in
dOl11ail1s IIa,

IIb~

and don1ain III which 111ay be conserved in n1any of the atypical calpain

species (263,309-311). If conserved, these novel Ca2+-binding sites could 111lpart partial
Ca 2 i -sensitivity to these enzyn1es as den10nstrated by calpain activity assays using the
proteolytic core of calpain 2 in \vhich co-incubation with calciun1 enhanced the cleavage
of a calpain substrate (310). It is likely, however, that activation of these atypical calpaill
isofornls involves post-translational 11lodificatlon, translocation to sites of action, or
regulation through bi nding of allosteric proteins.
()ver the last 30 years, inforn1ation on the classical calpains has grown to include
possible ll1cchanisnls of activation and function. Much of the focus has been on the
identification of calpain substrates under conditions of cellular Ca2+ overload. Until
recently ho\\!cvcr, a substantial an10unt of work has relied on phan11acological inhibitiOJl
or calpains using inhibitors that, as described previously, are severely lacking in
speci ficity for the calpains and in selectivity between calpain isofon11s.

Thereforc~

dra\ving significant conclusions fron1 ll1allY of these studies beconles difficult and brings
nlany of these findings into question. For exanlple, nlany cOlnnlercially available calpain
inhibitors such as calpain inhibitors 1 and 2 are quite potent inhibitors of the cathepsin
f~lnlily

of cysteine proteases, Iysosonlal enzynles inlplicated in various 1110dels of cell

death. Sin1ilarly, nunlerous studies utilizing pan-caspase inhibitors such as ZVAO-FMK
to inhibit caspase-nlediated apoptosis should also be re-evaluated since concentrations
llsed to inhibit cell death in these nl0dels is sufficiently high to inhibit cytosolic calpains
as \vell. Hovvever. advances in nlolecular biology over the last decade have provided us
\vith the tools to ask better questions and the ability to answer then1 with nlore robust
technical 111ethods thereby circUll1venting the problenl of inhibitor proll1iscuity.
Significant interest in n1itochondrial proteolytic systell1s over the past 20 years
has provided great insight into the nlechanisnls controlling nlitochondrial protein inlport.
processing, turnover, and signal peptide processing. There are nunlerous proteolytic
nlcchanisnls present in various lnitochondrial conlpartn1ents whose representative
nlenlbers include serine, cysteine, and ATP-dependent proteases. The Lon protease,
present in the n1itochondrial n1atrix, is an ATP-dependent serine protease involved in the
proteo lytic processi ng of nlitochondrial proteins as well as proteins n10di tied hy
oxidation (() 15). Another class of ATP-dependent n1itochondrial proteases includes the
/\AA. proteases (171-AAA and i-Ai\A). These n1etalloproteases have been inlplicated ill
the degradation of inner nlenlbrane respiratory c01l1plexes fron1 the n1atrix and
intcnllcnlbranc space sides of the inner nlenlbrane (615). A third group of ATPdependent nlitochondrial proteases include the ClpP-ClpA/X cOll1plex. This proteolytic
conlplcx functions as a serine protease and has been in1plicated in general protein
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degradation (615). A final ATP-dependent protease, MISP I, discovered in the
internlenlbrane space is a cysteine protease containing degradative properties sin1i1ar
the cellular proteasonle. The processing of inlported nlitochondrial proteins is

OftCIl

to

a

neccssary step in producing nlature and functional nlitochondrial proteins. These
functions are carried out by a group of proteins found in the nlatrix and intern1elllbranc
space. The tirst of these proteins is MPP, or nlitochondrial processing

peptidase~

\vhich

recogni/es the N-ternlinal targeting signal on nlitochondrial preproteins. The MPP
behaves as a Zn~t- -nletallopeptidase and is inhibited by nletal chelators (615). Further
cleavage of the N-tcrnlinus of MPP-processed proteins occurs via cleavage by the
1l1itochondrial nlatrix internlcdiate peptidase (MIP), a 111etalloprotease inhibited by thiolblocking reagents such as n-nlethylnlaleanlide (615). Studies perfornled in ycast
Initochondria have identi tied yet another processing peptidase nanled inner nlenlbranc
protease I. This peptidase is thought to be localized to the 1l1itochondrial inner 111enlbral1c
and controls the release of processed preproteins into the 1l1itochondrial internlen1branc
space (() 15 ).
While kno\vn 111itochondrial proteases play clear roles in regulating nlitochondrial
protein processing and inlport, little work has been conlpleted on those proteases
involved in cell signaling or cell death. For instance, llUnlerOUS procaspase isofonlls as
\vcll as the serine proteases 01l1i/Htra have been localized to the nlitochondrial
intCrll1Clllbranc space and are prcsu1l1ably released to the cytosol subsequent to apoptotic
stinluli (() 16). Sinlilarly, llU1l1CrOUS reports over the last two decades have suggested the
presence ofnlitochondrial calpains (231-233,527). The "calpain-like" activities
ident i fled in variolls species and tissues have been inlplicated in the cleavage of variolls
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1l1olcculcs including aspartate anlinotransferase, the RXRa protein, inner nlenlbranc
bound .A.IF and ornithine transcarban1ylase, and has been denl0nstrated to be involved in
forlllation of the M PT pore (408, 510-512, 527). Recent work has even placed calpai 11 1
at the site of the nlitochondrion in rat cerebral cortex (232).
Much of the work accon1plished on the atypical calpains has focused on calpaill
10, a Type II diabetes susceptibility gene. Until recently, n10st investigators have

i'OClISC(1

on the role of cal pain 10 polyn10rphisn1s on the clinical endpoints of diabetes. For
exanlple, nunlcrOLlS studics have denlonstrated a role for calpain 10 nlutations in
producing elevated free fatty acids, triglycerides, increased body nlass indexes (BMl)
(493), elevated \vaist-hip ratios (WH R) (494), decreased sleeping nletabolic rates in SOlllC

populations (479), and decreased sensitivity to insulin stinll11ation (479) ..Analysis of
these data have provided clear evidence that, in son1e populations, calpain 10 nlutatiollS
play critical roles in the regulation of nunlerous diabetogenic phenotypes. HowevcL
functional data linking calpain 10 to these phenotypes is lacking.
Follo\ving the nunlcrous epidelniological studies conducted on diabctic cohorts,
attention shifted towards identifying the 11101ecular 111echanisnls of how calpain 10 nlight
increase diabetic susceptibilities. Insulin resistance in peripheral tissues is one of the
nLln1crOllS h£1lln1arks of Type 2 diabetes. In fact, one of the 111any rate-lill1iting stcps fc)r
insulin action is that ofGLlJT4-111ediated glucose transport (501), a process inlpaircd in
Type:2 diabetes. It was

SOOI1

discovered that chronic calpain inhibition (505) and the

llSl'

of calpain 1() antisense n1ethodologies (502) resulted in blockage of insulin-Illcdiatcd
(1 LtJT4 vesicle translocation to the plasllla ll1en1brane. HoweveL this effect \vas not

lllcdiated by PI3-kinase signaling through the insulin receptor substrate pathway, but
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\VClS

instead found to be 111ediated by regulation of cortical actin network reorganization
required for GLlJT4 vesicle translocatio11 (502).
In addition, calpain 10 has also been shown to regulate insulin secretion in

pancreatic

r~

cells (480). The insulin secretion pathway in pacncreatic

~

cells involves a

host ofsequcntial events including dynanlic changes in plasn1a nlen1brane potential,
glycolysis, and Ca 2+-dependent regulatory processes which culn1inate in the relocation

or

secrctory granules to the plasn1a ll1en1brane. Recent studies have been able to link
calpain 10 vvith deficits in this path\vay. For exanlple, long-tern1 inhibition of calpain in
pancreatic

~

cclls has been shown to depress glucose nletabollsnl with additional

suppression of do\vnstrean1 Ca 2+-n1ediated responses and insulin secretion (480).
Additionally, t\VO n1en1bers of the n1en1brane fusion fa111ily of proteins called SNAREs
(syntaxin 1 and SNAP-25) have been identified as calpain 10 binding partners,
Interestingly, the calpain 10 isofor111 responsible for this association was identi fled as a
54 kDa protcin and sho\ved an ability to partially cleave the SNAP-25 con1ponent of the
ll1cnlbrane fusion nlachinery, thereby inhibiting vesicle fusion and insulin secretion
(486). ('onversely, calpain 10 overexpression increased insulin secretion in this nlodel.
An alternative path\vay inlplicated in insulin secretion has recently been descrihed
and involves the Ca 2+-independent secretion of insulin n1ediated by the ryanodinc
receptor, and investigators speculate that deficits in ryanodine receptor protein levels or
acti\'ity (exhibited in diabetes) can lead to hyperinsulinenlia. Very recent evidence has
also denlonstrated that inhibition of type 2 ryanodine receptor-n1ediated Ca 2-+ influx in
pancreatic

~)

cells results in cellular apoptosis that is inhibited by calpain inhibitors (4S I\.
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It is clear that calpain 10 plays a critical role in glucose hOlneostasis and insulin

secretion. The ovenvhelnling epidenliological data and forthconling 1l101ecular findings
arc

110\\/

placing calpain 10 at the top of the list as a key target for therapeutic interventio11

in Type II diabetes. It will be interesting to deternline the conlplete repertoire ofcalpaill
10 functions and whether or not the proteolytic functions of each isoforn1 are redundant
for one another.

Fe\v other functions are ascribed to calpain 10 and nl0stly involve its contribution
to the apoptotic process. T\vo independent studies have provided cOITelative evidence
that calpain 1() can function in a proapoptotic n1a11ner (403, 509). The first of these
studies dcnlonstrated that trcatnlent of PC 12 cells with par-4 (a tun10r suppressor gene)
antisense reduced glutan1ate-1l1ediated apoptosis with conconlitant decreases in
intracellular Ca 2+ and calpain 10 nlRNA (403). Subsequent studies perfornled by Wu and
colleagues \vere able to show that treatn1ent of rat renal interstitial fibroblasts vv'ith the
toxin lipoxin A4 induced calpain 10 protein expression and caspase 3 activity leading to
increased levels of apoptosis (509). These data suggest a novel role for calpain 10 ill
initiating or regulating the apoptotic cascade. However, these studies provide 1110Stly
correlative data and 111ust be validated with 1110re rigorous techniques.
[ntercst in calpain 10 physiology has grown rapidly over the last 5 years. The
apparent association between calpain 10 dysfunction and Type 2 diabetes has generated
an increased desire to elucidate the nl01ecular 111echanisnls linking calpain 10 to glucose
llletabolisrll and insulin handling. Given that Type II diabetes is a disease affecting 20.S
ll1illioll Anlcricans and costing over $130 billion dollars in direct and indirect costs each
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year (http://\v\v\v.diabetes.org/about-diabetes.jsp), it is likely that the interest in calpaill
10 biology

\\'i

II continue unabated for years to conle.

CONTRIBUTIONS TO THE FIELD

As described above, ll1itocholldrial proteases play key roles in nlaintaining viable
and healthy ll1itochondria ..A.ny disturbances in the regulation of these nlolecules can
severely perturb 111itochondrial functions including nletabolisnl and oxidative
phosphorylation. NUIllerous pathologies are also associated \vith Illitochondrial
dysfunction including ischenlia/reperfusion injury, neurodegenerative disorders
(AlzhciIller's, Parkinson's), and Type II diabetes to nanle a few. With the recent
discovery associating calpain 10 dysfunction with Type II diabetes, it is beconling clear
that the activation/inactivation of nlitochondrial proteases n1ay be a final endpoint in
lllllllerOllS disease states.
Mitochondrial respiratory dysfunction is one of the 111any hall111arks of acutc
I~li lure

rCll;.\l

and has been denlonstrated in nun1erous ill vivo 1110dels (171-173, 198, 218, 221,

222). It has been hypothesized by nUll1erous investigators that these respiratory deficits

arc a result of1l1itochondrial

('a.2+

overload subsequent to ischell1ia/reperfusion injury

(172, 218). Our laboratory had previously de1110nstrated that isolated renal nlitochondri;:
exhibited severe deficits in state 3 respiration which could be protected by pretreatnlcnt
\\ith various calpain inhibitors.
The research presented in this dissertation was undertaken to elucidate the icictllil\
and nature of the lllitochondrial calpain responsible for the ll1ediation ofCa 2- -induced
i

lllitochondrial dysfunction. Previous work on nlitochondrial calpain activity focused
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the ability of this enzyn1e to cleave typical calpain substrates, but did not endeavor to
identify the actual calpain isoforn1 involved. We identified a Ca~+-inducible calpain
activity in isolated renal n1itochondr1a that was inhibited by the Ca 2+ chelator EGTA,
calpain inhibitors, and rutheniunl red. In fact, subfractionation ofRCM preparations
dClllonstrated (~a~f sensitive activities in each fraction. It is conceivable that these
activities resulted fron1 partial in1purity of the n1itochondrial fractions.

We also

den10nstratcd that the nlitochondrial calpain activity was sensitive to both calpeptin and
E-()4, but not to the 00n1ain IV specific inhibitor PO 150606. Since the atypical calpains

lack this donlain, we found it unlikely that the ReM calpain could be a n1en1ber of the
typical

t~nni Iy

of calpains.

For J11any years, calpain activity has been routinely assayed via FITe-casein
zyn10graphy, an assay in which proteins are separated via non-denaturing PAGE and
assayed for the cleavage of the co-polynlcrized casein substrate within the gel. To furthlT
characterize our ReM calpain, \ve en1ployed this technique as well as a n10dified vcrsi(1)
oCthe assay in \vhich the peptidic fluorophore

SLLVY-AMC~

(a substrate proteolyzcd by

the ReM calpain) \vas used as the substrate. The RCM calpain was unable to cleave the
typical calpain substrate FITC-casein, but effectively cleaved SLLVY -AMC in this

aSS(l~'.

In addition, RC~rvl subfractionation den10nstrated that viliually all of the Ca2-+-induced
activity in this assay was lin1ited to the 111itochondrial n1atrix fraction and did not co111igrate vvith purified porcine kidney calpains 1 and 2. These data suggested to us that
the ReM calpain was not calpain 1 or 2 and that it denl0nstrated a different substrate
speci flcity than the typical calpains.
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The identity of the RCM-specific calpain isoforn1 was subsequently detern1ined
via three independent techniques. Firstly, each calpain isoforn1 \vas analyzed by the
ll1itochondrial protein prediction algorithn1 MITOP2. This algorithn1 produced a positi\'i..'
hit for calpain 10, but not for the ren1aining 13 large subunit calpain isoforn1s. Secondly,
calpain 10 \vas identified in RCM subfi·actions via in1n1unoblotting using three dissinliLlr
calpain 10 antibodies. In addition, calpain 10 was identified by in1n1unoblotting protein
species eluted fron1 bands ofn1atrix fraction zyn10gran1 activity. Finally, calpain lO-(JFP
constructs \vere found to be colocalized with the nlitochondrial-specific dye ivlitoTrdckcr
Red in transfected NIH-3T3 cells. Interestingly we also detell11ined that the N-tern1inal
IS an1ino acids of calpain 10 are sufficient for n1itochondrial targeting.

[)uring our initial transfection experin1ents with calpain 1O-GFP, we noticed

t\\

0

distinct populations of cells expressing GFP. The first of these populations exhihited
large globular patches of GFP staining which colocalized with the lysosonle-specific dye
LysoTrackcr Red. These cells also dell1011strated an altered cellular 1110rphology and
decreased plate adhesion. The second population of cel1s observed in these studies
exhibited a norn1al cellular n10rphology and punctuate GFP staining which colocalizcd
\vith MitoTracker Red. Interestingly, the n1itochondria observed in this population

or

cells appeared fragn1ented and swollen in conlparison to the norn1al branched reticular
pattern of 11litochondria seen in these cel1s. Mitochondrial swel1ing and fragn1cntation

are con1n10n to a nun1ber of insults including fOll11atio11 of the MPT, 111assive
depolarization, electron transport chain (ETC) dysfullction, and perturbation of the
n1itochondrial fusion and fission proteins. We chose to evaluate the possible forn1atiol1 (,,-
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MPT in order to explain the altered n1itochondrial n1orphology observed in our confocal
expcrin1cnts.
()ur

initial studies using calpain 1O-GFP and LysoTracker Red suggested the

for111ation oCautophagocytic vesicles, a process suggested to be induced by the

forn1atiol~

of MPT (174,546). Sin1ilarly, the conversion ofnorn1al branched l1litochondria to thOSl'
with a fragn1ented and swollen n10111hology also suggested the possible illvolven1ent

or

calpail1 1() in the [orn1ation of MPT (Fig. 5-1). To exanline this hypothesis, NIH-3T3
cells vverc treated \\/ith the MPT inhibitors cyclosporine A and 3-n1ethyladenine prior to
transfcction \vith calpain 10-GFP. Subsequent confocal analysis den10nstrated
preservation of the norn1al nlitochondrialtTIorphology. Experil11ents using isolated RC\ r
also del110nstratcd a role for calpain lOin the [orn1at1011 of MPT by inhibiting Ca=:+induced n1itochondrial swelling by ~30%. However, it is difficult to nlake broad
generalizations concerning calpain 10 and MPT since classical endpoints such as
cytochr0l11c c release \vere not n1easured. Future experinlcnts nlust be conducted to
conlplctcly validate these data.
Jt\s nlcntioned earlier. ETC dysfunction is conl1110nly associated vvith

111itochondrial Ca 2-'- overload. Since previous experinlents in our laboratory had
den10nstrated Ca=:+ -induced decreases in RCM state 3 respiration, \ve decided to cvahl~lll'
allY possible calpain 10 involvenlent in Ca2+-nlediated ETC dysfunction. Our initial

investigations dcn10nstrated the ability of calpain inhibitors to protect against Ca

2t

_

induced state 3 dysfunction and that this dysfunction was confined to C0l11plex lofthe
respiratory chain. Subsequent analysis revealed that, in our systell1, Conlplcx I

198

dysfunction 'vvas due, in part, to the Ca 2+-dependent calpain 1O-nlediated degradation or
the NDlJFV2 and ND6 subunits of Conlplex I (Fig. 5-1 ).
To further explore the nlitochondrial effects of calpain 10 action. \ve constructed
an adenoviral cassette containing an shRNA sequence specific for calpain 10 to block
calpain 10 synthesis. Infection ofprinlary rabbit RPTC induced conlpartnlent specific
knockdo'vvn of calpain 10 expression. Cytosolic calpain 10 expression decreased to less
than

20(~~)

of control over a 5 day tinle course, while that in isolated nlitochondria

decreased bclo\v levels of detection by day 3. These data suggested significant
di fferences between the rates of calpain 10 degradation between the two cOlllpartnlCl1ts.
Dccreased calpail1 10 expression was also verified by calpain activity analysis that
sho\ved slistained activity in scranlble-infected cells and decreased activity in virllsinfected cells over a 5 day tinle course. Mitochondrial paranleters including respiration,
ATP generation. and nlenlbrane potential

(~\Iflll)

were evaluated and conlpared to control

and scralllblc-infccted cells. Basal and FCCP-uncoupled nlitochondrial respiration 'vverc
unchanged between all treatnlent groups. ATP levels renlained unchanged in the control
and scralllble treated cells, while ATP production increased two tinles control levels in
the virus-infected cells. Interestingly, qualitative assessnlent ofnlitochondrial nlcnlbratlC
potential sho\ved no difference between all treatnlent groups.
The above data presented an interesting question; how is the absence of calpaill
10 increasing cellular ATP in the absence of a glycolytic substrate and unchanging

respiratory rates and nlcnlbrane potential? To answer this question, we initially probed
nlitochondrial sanlples fron1 calpain 10 shRNA-infected cells for protein species foulld ill
Conlplex I orthe ETC and for the ATP synthase
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~

subunit of the Fl/Fo conlplex. We

found that the expression of ATP synthase

~)

increased significantly over the 5 day ti1l1C

course. This increase in protein levels could be explained by two

hypotheses~

1)

decreased proteolysis, or 2) increased expression. Decreased proteolysis of A TP
synthase

f)

\vas denlonstrated by incubating RCM with Ca 2+ in the presence or absence (!~'

the calpain inhibitor calpeptin. In addition, cytosolic extracts fronl virus-infected

cell~

vvcrc probed for AMPK, a nlolecule sensitive to AMP:ATP levels (570). AMPK levels
\;\Y!CI"C increased~40(Yc)

by day 5 of the treatnlent suggesting regulation of ATP levels

through this path\vay (Fig. 5-1). Recent studies by Otani et af also have sho\vn increased
AM PK levels after chronic calpain inhibition in nlyocytes, suggesting that AMPK is
indeed a calpaill substrate (506). Taken together, we believe that these data reveal that
cellular ATP levels are regulated in our 1110del at the level of ATP synthase

Bin Conlplc\

\1 of the electron transport chain. Under basal conditions, it appears as if calpain 10 acts

to lllaintain steady state levels of ATP production through regulation of .AMPK and its
do\vnstreanl target ATP synthase r), whi Ie under conditions of nlitochondrial Cal,
oYcrlo(1cL calpain 10 can act as a negative regulator of oxidative phorphorylation through
cleavage of .ATP synthase

r) (Fig.

5-1). Ho\vever, future experill1ents validating the

phosphorylation status of AMPK and the activation of its downstreall1 targets 111Ust be
perCorn1cd. Sin1i larly, ill vitro experinlcnts dell10nstrating Ca 2+ -induced cleavage of ATP
synthase

r) nlllst be perfornled to fully validate calpain

1O's role in this process. These

results are quite significant in light of the fact that Ca 2+-induced cellular danlage, as seen
in IlUll1CrOUS nl0dels of ischell1ia/reperfusion injury, is known to produced severe deficits
in cellular ATP often leading to necrotic cell death (218).
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During the 5 day course of our experin1ents involving viral1y-n1ediated calpain 10
knockdown, we noticed significant changes in RPTC survival rates between control,
scranlblc, and calpain 1O-shRNA-treated cells. Control and scranlble-treated cells
renlained conflucnt and retained their n01111a1 cellular 1110rphology over the tinle course
\vhile cell survival in the virus-treated group decreased to

~40-50%

by day 5. Cell death

was analyzed by nuclearDAPI staining and via inlll1unoblotting for activated caspase 3.
Virus-infected cells den10nstrated significant an10unts of condensed nuclei over the tilllC
coursc and increased levels of active caspase 3, indicating apoptotic cell death. These
results indicate a pro-survival role for calpain 10 and n1ay Inediated by the cytosolic
isofc)rnl since gross cell death in culture is not evident until day 4 of the viral treatnlcnt.
We propose the above hypothesis because nlitochondrial calpain 10 is conlpletely absent
by \vcstern blot on day 3 while it takes considerably longer to knock down calpain 10
levels in the cytosol (the days on which we see n10st cell death). Future experinlcnts arc
planned to detennine the Inechanisnl of this cell death.
As discussed above, the significance of calpain lOin the pathobiology of Type II
diabetes has placed this protease at the forefront of calpain research. The known
1110lecular ll1echanisnls for calpain 10 and those elucidated by Ollr work suggest that
calpain lOis involved in the regulation of insulin secretion, glucose ll1etabolisnl, and
regulation of A TP levels and nlitochondrial viability. These data link calpain 10 to
diabetes at IlUll1erOUS entry points and suggest to us that a nunlber of other diabctesassociated gene products n1ight also be potential calpain 10 substrates. Upon an
extensive literature

search~

we identified a nun1ber of potential protein targets that \\;'el'C

both inlplicated in the pathogenesis of Type II diabetes and identified as possible calpaill
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substrates as detern1ined by the PEST-FIND algorithn1. We chose to evaluate the
llloiccular chaperone nlolecule ORP150 (oxygen regulated protein 150).
ORP150 has been shown to nlediate insulin secretion (592, 593), to be
downregulated in diabetic cohorts (617), and contains nlultiple PEST n10tifs in its
prilnary anlino acid sequence. Upon further evaluation of the ORP150 an1ino acid
sequence, we identified a putative n1itochondrial targeting signal. This observation led us
to the hypothesis that ORP150 nlay be localized to the nlitochondria \vhere it would be

III

a position to be regulated by calpain 10 action. Indeed, we identified the nlitochondrial
localization of ORP 150 by illlnlunoblot analysis and inlnlunolocalization bet\veen
.~litoTracker

Red dye and a transfected ORP150-GFP construct. We also deternlined

th~lt

the N-tern1inal 13 a111ino acids of ORP 150 are sufficient for nlitochondrial targeting.
Subsequent analysis of the ORP150 gene product revealed that its expression ill
both the ER and n1itochondria is induced by nlitochondrial specific stressors (ethidiulll
bronlicic,

~OTC

transfection) and nl0re global cellular insults including serunl starvation.

hypoxia, and treatnlcnt \vith tunicanlycin, 2-dcoxyglucose, and the prolyl hydroxylase
inhibitors DMOG and EDHB. In fact, while sonle of this induction is controlled by the
cndoplaslllic reticulunl stress elenlent (ERSE) in the 5' pronloter region of OR PI 50
(580), \ve also detern1ined that the induction of the transcription factor CHOP can
uprcgulate ORP 150 expression in the ER and 111itochondria by binding to a CHOP
consensus sequence farther upstreanl of the ERSE.
Investigation of the interaction between calpain 10 and ORP 150 provided
evidence that overexpression of ORP 150 is correlated with increases in 111itochondria I
calpai11 activity \vhich are 110t related to increased calpain 10 protein levels after
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transfection \vith the MSR-inducing construct

~OTC.

We also were able to den10nstratc

that ORP 150 is indeed a substrate for calpain 10 (Fig. 5-1), and lTIay be negatively
regulated during periods ofn1itochondrial Ca 2+ overload as seen during
ischen1ia/reperfusion inj ury. In addition, the san1e insults which increased ORP 150
expression did not produce a conco111itant increase in calpai11 10 levels across all
treatn1cnts (data not shown), suggesting that increases in tTIitochondrial calpain activity
after induction of ORP 150 expression is n10st likely due to stabilization of calpain 10
through the chaperoning activity of ORP 150.
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Figure 5-1. Calpain 10 Substrates
The schematic above depicts the mechanisms of action for calpain 10 elucidated in this
dissertation. Mitochondrial calpain lOis responsible for the Ca2+-induced cleavage of
ATP synthase B, ORP150, and the electron transport chain subunits NDUFV2 and ND6
(* and #, respectively in the figure). Cytosolic calpain 10 was also found to regulate
expression of AMPK, and is important in RPTC survival.
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FUTURE DIRECTIONS

Our overall goals for future studies are 1) to identify the anti-apoptotic role ft.)!"
::alpain lOin cultured RPTC and to exanline the effects of nephrotoxic ants in calpain I ()

deficient RPTC, 2) to elucidate a potential rolc for calpain lOin caspase-indcpendent
apoptosis, and 3) to evaluate the effects of calpain lOon renal recovery after
ischell1ia/reperfusion injury.
A.s shown in Chapter 4, reduction of calpain 10 expression in RPTC leads to
subsequent apoptotic cell death which correlates \\/ith the loss of cytocolic calpain 10.
Previous literature has delll0nstrated a pro-apoptotic role for calpain lOin IlUnlCrOUS cell
types including pancreatic

~

cells, PC 12 cells, and rat renal interstitial fibroblasts (403,

48 L 5(9). Evidence fron1 t\VO of these studies has provided only con-elative evidence

or

calpain 10 involvenlent in apoptosis, ho\vever the third study conducted in pancreatic

I)

cells benefited 1'ron1 the usc of a calpain 10 knockout n10use n10del (481). In this study.
the authors \verc able to den10nstrate the inhibit10i11 of ryanodine-induccd apoptosis, alld

rcnlains the only direct evidence placing calpain lOin the apoptotic cascade. Our data
arc not consistent with the findings n1entioned above, and this n1ay be due to

difTercnc(:~

in cell types.
Nurncrolls ll1cchanisll1s exist to either inhibit apoptosis or to proillote cell
survival. Son1e of these n1echanisll1s involve expression of anti-a pop to tic 11101ccules

slIel]

as Bc1-2 or inhibitor ofapoptosis protein (lAP) \vhile others function via induction of
pro-survival cellular pathways often linked to activation of growth factor receptors.
C01l11l10n do\\'nstrcan1 111echanisI11 pron10ting cell survival is that orthe NF-KB

()I1C

path\V~I~

The NF-kB patll\vay functions in conjunction \Nith its n101ecular binding partner IKH-u.
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Under norn1al unstinlulated

conditions~

IKB-a is found in a heterodinler conlplex \vith

NF-KB and shields its nuclear localization signa1. During periods of cellular stress~ IKBCt.

is phosphorylated and cleaved thereby releasing NF-KB to the nucleus (574). There

<Ire

Illll11erous signals which induce phosphorylation of IKB-a~ however, these events
cul!llinate in the calpain-nlcdiated cleavage of IKB-a and the translocation of NF-KB to
the nucleus which then transcriptionally induces pro-survival and cel1ular defense gcnes
(574). In

fact~

llunlcrous studies have den10nstrated the ability of cal pains to cleave the

IKB-(1 suppressor (422,477,574) thereby, proll10ting cell survival during stress. Rccellt
results have even shown that defects in calpain 3 (responsible for linlb girdle nlllscular
dystrophy) induce n1yocyte apoptosis via inhibition ofNF-KB translocation (477).
Ho\vevcr, while both calpains 1 and 3 have been shown to cleave IKB-a, it is not clear

,IS

to vvhcther or not these are the only cal pain isoforn1s that can perforn1 this function or if
different isofonl1s are responsible are necessary for this function in different tissues.
We have pcrfornled prelinlinary experinlents to evaluate \vhether or not calpain
10 plays a role in

th~

IKB/NF-KB pathway in RPTC. The signaling kinase Akt has been

inlplicated as an upstrean1 regulator of IKB-a phosphorylation (575). As

such~

we

evaluated total Akt and phosph-/\kt levels in control, scranlble-infected, and virusinfected RPTC. We detected decreases in total Akt and phospho-Akt levels in virusinfected cells (Fig. 5-1). These data suggest that calpa1n 10 rnay regulate Akt levels
and/or activation \vhich n1ay trans1ate to decreased IKB-a phosphorlyation and decreased
translocation ofNF-KB to the nucleus. We suggest an alternative hypothesis in vvhich
IKB-u is actually a calpain 10 substrate in RPTC, thereby inhibiting a pro-survival
pathway in the absence of calpain 10. Future experinlents will be necessary to dctcrlllil1l'
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ifcalpain 10 plays a role in regulating the NF-KB pathway.

However~

elucidation ofa

role for calpain 1O-nlediated cell survival would significantly add to our understanding (\ r
calpain I (fs association to Type II diabetes.
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Figure 5-2. Akt and phospho-Akt levels are decreased in response to calpain 10
knockdown.

onfluent RPTC were infected with either scramble shRNA or calpain 10-specific
adenoviral shRNA constructs, harvested over a five day time course, and subfractionatcc.!
into cytosolic and crude n1itochondrial fractions. Mitochondrial fractions were
subs quentl y in1111ul1oblotted for total and phospho-Akt protein expression. Equal
Co' 1os01ic protein loading was verified by ilumunoblot analysis using an a-GAPDH
antih )d y. Re ult are representative of three independent experill1ents.
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Recent work in our laboratory has focused on the role of calpain 10 as it relates tn
apoptosis. Our initial findings den10nstrated that the absence of calpain 10 was
dctrinlcntal to cell viability. Subsequent studies using RPTC treated with 1l10del
toxicants such as the ionophore A23187 (1 0

~lM)

and nephrotoxicant cisplatin (50 pM)

have dell10nstrated that our RPTC are significantly 1l10re sensitive to these toxicants in
the absence calpain 10 expression (Fig. 5-2). Elucidation of the ll1echanisnl of this
sensitivity \vould provide nluch needed insight into calpaill 10 biology. These
prelilllinary data are also exciting due to their inlplications for cancer research. For
exanlple, chell10therapeutic regill1ens nlight benefit fron1 a calpain 10 inhibitor that could
hclp sensitizc cancerous cells to nlore standard therapeutic agents.
Progranlnlcd cell death is a conlplex process that proceeds via caspase-dependcllt
or independent nlechanisnls. Caspase-dependent apoptosis is a well-understood process.
However. the nlolecular events leading to caspase-independent apoptosis are less \\lcll
knovvn. One underlying event in this process is the release of apoptosis-inducing

t~lctor

(AIF) frolll the nlitochondria after an apoptotic stinlulus. The nlechanisl11 controlling lhi~

release has been ascribed to proteolytic cleavage of AIF froll1 the inner ll1enlbranc and
release of the nlolecule to the cytosol and nucleus where it behaves as a nuclease.
Calpain-nlcdiated release of AIF has been docull1ented by two separate investigators

\\hl'l

propose that calpain 1 is responsible for this proteolysis. Interestingly. Polster ct (// havl'
suggested this nlcchanisnl using isolated 111itochondria and purified calpain 1, although
they do concede that an endogenous 111itochondrial calpain could also be responsible
(408). Recent reports have used C APN4- ' - nlouse ell1bryonic fibroblasts (MEFs) to
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investigate the role of the typical calpain species in AIF release, and concluded that the
calpains arc responsible for this proteolysis.
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Figur'c 5-3. C:alpain 10-deficient RPTC are more susceptible to toxic agents.

Confluent RPlC' \vere infected \\lith calpain 10 shRNA or diluent and lllaintained for
three days in culture. Subsequently. RP1'C were treated with either 10 ~lM A23187
(ionophore) or 50 ~lM cisplatin (nephrotoxicant) in1aged via brightfield nlicroscopy at 4.
12, and 24 hr.
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The nlolecular studies presented above provide a sonlewhat clear picture of the
nlcchanisnls involving AIF release. However, we find it difficult to believe that a protei 11
species as large as calpain 1 (~~80 kDa) can gain entrance into the nlitochondria given ib
lack of any identi fiable 111itochondrial targeting signal. It 111ay, however. be able to signal
events at the 111itochondrial outer 111elllbrane which translate to the internlelllbrane space
and induce AIF cleavage there. We suggest the altenlative hypothesis that an
endogenous rnitochondrial internlen1brane space calpain nlediates this cleavage. The
calpain 10

f~lnlily

is conlposed of 8 splice variants, al1 of which contain a nlitochondrial

targeting signal at the N-ternlinus. Seven of these splice variants retain an intact protease
dOl11ain and, in theory, could serve as functional enzyn1es. In our experinlents, \ve have
characterized calpain activity in each of the fOllr 11litochondrial subfractions and have
dcternlined that the nlajority of this activity is found in the intern1en1brane space (Fig. 53), a finding observed by Gores

ef

01 in lever nlitochondria. Interestingly, in rat

internlell1brane space fractions, we have observed a calpain activity that is Ca2'independent and can recognize FITC-casein as protein substrate (Fig. 5-4) (527).
In1nlunoblot analysis of protein eluted fr0111 bands of activity in these FITC-casein
/Ylllogranls revealed a calpain 10 isoforn1

~58

kDa in size which could represent calpail1

10 isoforn1s c or d (Fig. 5-4). Future studies will be en1ployed to deternline the effects

oj"

ca1pain 10 knockout on AIF translocation after caspase-independent specific stinluli.
This endeavor n1ay prove difficult, however, as knockout of individual calpain 10 splice
variants would be nearly inlpossible. This problen1 will no doubtedly plague future
efforts to elucidate the functions of the various calpain 10 splice variants.

213

1 4 8+5 -

·1

28+5 -

Q)
(.)

1

[18+5

(.)
tJ)
Q)

8.08+,'1

c:
Q)

:....
0

:J

u::
~
a::

G.Oe+4 -

4.1]8+4 -

2 Oe+4

-

I

1] [1

OM

I
1M

IS

I

I

I

I

Mat

Figure 5-4. Ca lpain activity in rat mitochondrial subfractions.
I urified 111itochondrial fractio n (Mat - 111atrix, OM - outer ll1ell1brane, IS internlenlbran , pace. 1M - inner 111el11brane) were assayed fo r SLLVY-AMC hydr lvsis
in the aboencc of a2+,
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Figure 5-5. Rat intermembrane space contains a calpain 10 splice variant.
Following calpain zymography, protein from the active enzymatic band indicated above
was extracted and subjected to SDS/PAGE and immunoblotted with the anti-calpain 10
(dIIB) antibody.
Results are representative of three independent experiments.
(Abbreviations: IS-intermembrane space)
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Fil1ally, \ve would like to explore the effects ofcalpail1 10 on renal recovery alter
ischen1ia/reperfusion injury. To accon1plish this, we have obtained calpain 1() knockollt
1l1icc (Dr. Polollsky, Washington lJniversity, St. Louis, MO) and are currently
characterizing their basic nletabolic profiles. Little is currently known about the renal
status of these al1il11als. Ho\vever, qualitative aSSeSS1l1ent of these ani111als has
dcn10llstrated polyuria which n1ay or 1l1ay not be indicative of depressed renal function.
This \vould, however, be a very interesting finding since our ill vitro studies have

alrcad~:

revealed decreased cell survival in the absence of calpain 10. Our calpain 10 knockout
Inice and agc-n1atchcd controls \vill be challenged with 30 n1in of bilateral renal artery
occlusion. The anin1als will be nlonitored for 48 hours, at which point blood and tissuc
sdlllples \vll1 be obtained for purposes ofn1easuring serun1 creatinine and the extent oj'
tubular injury, respectively. Based on our prelin1inary ill vitro expcrin1ents \ve expect to
sec higher serunl creatinine levels and increased epithelial cell danlage in the knockouts
as cOll1parcd to controln1ice.
In conclusion, we have revealed the identity of a nlitochondrial calpain as calpain
10 and have den10nstrated its role in Ca 2+ -induced n1itochondrial dysfunction. Calpaill
lOis increasingly gaining attention as a central player in glucose n1etabolisrn and, in pur
hands, has been shown to n1ediate electron transport chain
regulation

or A.TP synthesis.

dysfunction~

apoptosis. and

,Also, our findings involving the negative regulation of

nlitochondrial ()RP150 indicates to us that calpain 10 and its splice variants nlay 1l1cdiatl
illllllcrOllS

other n1itochondrial and cytosolic pathways. The link betvveen calpain 10 and

Type II diabetes \vill also be an area of furtive investigation in the future, especially i r

calpain 10 can be placed in a signaling cascade relevant to this disease process. The
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1dcnti fication of calpa1n 10 as a Ca~~-induc1ble lllitochondrial protease and regulator

or

apoptosis, as well as its role in glucose and illsulin l11etabolislll lllake th1s nlolecule and
the pathways it regulates wonderful targets for therapeutic intervention in llUl11CrOUS
d1sease states including Type II diabetes, cancer, and pathologies nlediated by the
dysregulation of Ca 2 + honleostasis.
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